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“Meno ignorante sei, più ignorante diventi.” 
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The transition from pluripotency to differentiation is a key event in the life of all 
complex multicellular organisms. In the development of the mouse, the pluripotent 
epiblast undergoes gastrulation and gives rise to three multipotent germ layers, which 
will in turn form the tissues of the adult body. The events leading up to gastrulation 
have been extensively studied in vivo in developing embryos, and modelled in vitro 
making use of embryonic stem (ES) cells. 
Bone morphogenic protein (BMP) signalling plays a key role in these processes. 
BMP can in fact maintain ES cells in a self-renewing state by inhibiting their 
differentiation into neural ectoderm, whilst at the same time being required for the 
specification of mesoderm in the developing embryo (Winnier et al. 1995, Ying et al. 
2003a). A key intracellular target of BMP is the transcriptional regulator Id1, which 
can recapitulate the effects of BMP in the preservation of ES cell pluripotency and in 
the inhibition of neural specification from pluripotent cells (Ying et al. 2003a). 
This thesis will focus on understanding the roles of this molecule in the early 
decisions affecting the transition from pluripotency to differentiation. In particular, I 
aim to study the expression pattern of Id1 in cultures of pluripotent cells, and to 
clarify which extracellular and intracellular molecules regulate the expression of the 
factor; I aim to understand how forced Id1 expression inhibits the differentiation of 
pluripotent cells, and whether Id1 may play a similar role in the regulation of the 
asynchronous exit from pluripotency observed in differentiating wild-type cells; 
finally, I aim to characterise the expression pattern of Id1 in the early stages of post-
implantation development at the single-cell resolution, and to understand how the 
expression of the molecule correlates with the previously characterised expression 
patterns of key signalling molecules and transcription factors. 
The generation of a reporter ES cell line expressing the yellow fluorescent protein 
Venus fused to the C-terminus of Id1 allowed me to assess the expression of the 
factor in culture on a single-cell basis, making use of immunofluorescence and flow 
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cytometry. I observed that expression of Id1 is reliant on active BMP signalling and 
low Activin/Nodal signalling, and I characterised the combinatory effects of the two 
pathways on Id1 expression. Furthermore, I demonstrated that high Nanog 
expression is incompatible with high Id1 expression in ES cell cultured in the 
presence of LIF and serum, which raises the possibility that Nanog may be affecting 
the expression of Id1 in vivo, both in pre-implantation and in post-implantation 
embryos. 
I generated ES cell lines overexpressing Id1 and observed that the factor inhibits 
differentiation of pluripotent cells into neural ectoderm by delaying their exit from a 
post-implantation epiblast-like pluripotent state, and ultimately favouring 
mesodermal specification. This suggests that Id1 is acting at a specific stage of 
differentiation and that the differentiation process itself is following a similar 
developmental pathway to what is observed in the peri-gastrulation stage embryo. 
I performed single-cell transcriptional analysis on differentiating wild-type ES cells 
and observed that Id1 is not expressed at an appropriate point in time to affect the 
asynchronous the exit from pluripotency observed in neural adherent monolayer 
differentiation, which suggests that other factors must be responsible for this 
phenomenon. 
Finally, I addressed the expression pattern of Id1 protein in the embryonic tissue of 
gastrulating mouse embryos by imaging chimaeric embryos generated using the Id1-
Venus reporter ES cells. I observed that Id1 is expressed in the proximal regions of 
streak stage embryos; in the epiblast and migrating mesendoderm of bud stage 
embryos; in cardiac, lateral and allantoic mesoderm and in foregut endoderm in 
headfold stage embryos. These expression patterns fit with the reported expression of 
BMP molecules at these stages of development, and suggest that Id1 expression is 
primarily dependent on BMP expression in early post-implantation embryos. 
However, I also observed Id1 expression in a ring of cells surrounding the node in 
headfold stage embryos, a previously uncharacterised expression pattern not directly 
attributable to BMP expression. This raises the intriguing question of what is 







Complex organisms such as mammals develop from a single egg cell fertilised by a 
single sperm cell. Over the course of the pregnancy, this fertilised egg cell divides 
multiple times and gives rise to all cells which form the foetus at birth. This 
transition from a single cell with the capability to form all cells of the body to 
multiple specialised cells such as neurones and muscle cells is governed by many 
genes and proteins, and the roles of many of these are poorly understood. 
In order to study the role of one such protein called Id1, I made use of mouse 
embryonic stem (ES) cells. These cells are derived from a mouse embryo at a stage 
in which all of its cells can give rise to all tissues of the adult mouse, and they can be 
used to study some of the events that happen in the mouse embryo without having to 
sacrifice mice. I generated ES cells that produce a yellow fluorescent protein 
whenever Id1 is normally active, and monitored their fluorescence to study how 
various molecules affect the presence or absence of Id1 in these cells. I also 
generated ES cells that produce more Id1 protein than normal cells, and discovered 
that they tend to produce more mesoderm (the tissue that will give rise to muscle and 
bone) than neural tissue. I also studied where Id1 is present in mouse embryos 
around the time the cells that form neural tissue, mesoderm and endoderm (the tissue 
that will give rise to gut and other internal organs) arise, and observed that it is found 
in the future heart and gut. 
This work helps us to understand the roles of a protein at the time when cells lose 
their ability to make all tissues of adult organisms. This study is therefore useful to 
paint a better picture of developmental events that, if malfunctioning, could result in 
foetal abnormalities. Furthermore, it can help improve culture methods to make 
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1.1 Embryonic stem cells 
1.1.1 The wonders and terrors of embryonic stem cell biology 
Mouse embryonic stem (ES) cells are a type of cultured cell that has captured the 
public imagination for many years because of their two defining properties: the 
capability to generate at least one identical copy of themselves every time they divide 
(“self-renewal”) and the ability to differentiate into all cell types present in the mouse 
embryo and adult (“pluripotency”). Their capacity of integrating with a live embryo, 
and of contributing to the tissues of the adult mouse developed from that embryo, 
could have been scripted by a science fiction writer, and has brought about both 
scientific elation and widespread prejudice, both of the cell type and of the 
researchers using them. Their amenity for genetic manipulation, which resulted in the 
2007 Nobel Prize in Physiology or Medicine, has provided a platform for the study 
of the functions of molecules, complexes and pathways, for the modelling of diseases 
and the screening of novel drugs, yet the image of the mad scientist playing God is 
still a frighteningly common one amongst the public. These fears, caused by a lack of 
comprehension partially attributable to the media’s sensationalistic approach to 
science, and partially attributable to the inability or disinterest of the scientific 
community to divulge their discoveries in a manner comprehensible to the general 
public, have important implications not only in the perception of research by the 
public, but in terms of scientific investment by governments. The Sherley v. Sebelius 
US Supreme Court case could have had potentially devastating effects on the 
American embryonic stem cell community had the judges not declined to hear the 
case (Wadman 2013), and in Italy projects involving the use of human ES cells have 
been specifically excluded from a public funding call (Cattaneo et al. 2010). 
 




Embryonic stem cells have been and still are an incredibly powerful tool for the  
study of embryonic development and for the discovery of novel approaches to 
regenerative medicine. The recent drive for public engagement promoted by both 
research councils and universities alike will hopefully allow the newer generations to 
approach embryonic stem cell biology without pre-conceived prejudices. 
 
1.1.2 Historical perspective 
Scientific discoveries are rarely the result of an isolated event of momentary genius, 
but are rather the consequence of a spark of intuition rooted in the body of 
knowledge generated by years of research. 
The derivation of embryonic stem cells followed this path, and stemmed from the 
fields of embryology, developmental biology and cancer biology. A particularly 
relevant set of studies was that performed on teratomas and embryonal carcinoma 
cells. 
 
1.1.2.1 Embryonal carcinoma cells 
Teratoma is a type of germ cell tumour which spontaneously arises in some mouse 
strains, such as 129, and has the property of containing cells from one or more of all 
three germ layers (ectoderm, mesoderm and endoderm) (Stevens & Little 1954). In a 
classic experiment, Kleinsmith and Pierce (1964) demonstrated the potential of a 
subset of individual cells from these tumours, named embryonal carcinoma (EC) 
cells, to give rise to a new tumour containing derivatives of all germ layers, as well 
as extraembryonic tissues, when grafted into recipient mice. This experiment 
illustrated some key concepts that would later come to the fore in ES cell biology: 
the clonogenicity of single cells, their pluripotency, and the heterogeneity and 
 




potential lineage bias of single pluripotent EC cells, which gave rise to different 
proportions of cells from each germ layer in different tumours. 
EC cell lines derived from different tumours were adapted to grow in culture as 
adherent monolayers in basal medium supplemented with serum, in the presence or 
absence of a layer of feeder cells (Kahan & Ephrussi 1970, Rosenthal et al. 1970). 
Their morphology is strikingly resemblant to that of ES cells (Jacob 1978, Rosenthal 
et al. 1970). Importantly, injection of tumour-derived EC cells into the blastocyst 
resulted in their contribution to normal mouse development, as opposed to tumour 
formation (Brinster 1974, Illmensee & Mintz 1976, Mintz & Illmensee 1975, 
Papaioannu et al. 1975), suggesting that these cancer cells can, under the appropriate 
conditions, behave as pluripotent cells of the early embryo. Mice with tissues derived 
from cells of separate genetic identity (in this case their own embryonic cells and EC 
cells) are known as chimaeras, from the ancient Greek mythological creature 
Chimaera, the body of which was a mixture of those of a lion, a goat and a snake. 
Martin Evans and colleagues also demonstrated that cultured EC cell lines could 
result in the generation of chimaeras upon blastocyst injection (Papaioannu et al. 
1978), providing a crucial link between an in vitro established cell line and in vivo 
development. 
 
1.1.2.2 The isolation of embryonic stem cells 
The experience gained by two researchers in the field of EC cells would provide 
invaluable for the isolation of embryonic stem cells. Gail Martin worked in the 
laboratory of Martin Evans during the 1970s, where the two researchers 
experimented on EC cell biology (Martin & Evans 1974, Martin & Evans 1975). 
Martin moved to San Francisco to set up her own laboratory, whilst in Cambridge a 
talented embryologist named Matthew Kaufman started collaborating with Evans. 
The common interests of Martin and Evans and their experimental prowess allowed 
 




both research units to simultaneously isolate pluripotent cells from mouse 
blastocysts. Martin named these cells embryonic stem cells and demonstrated their 
ability to differentiate into cells of all germ layers in vitro (Evans & Kaufman 1981, 
Martin 1981). The ability of ES cells to generate chimaeric embryos was addressed 
soon after, and ES cells were shown to contribute both to chimaeric embryos and to 
their offspring (Bradley et al. 1984, Kaufman et al. 1984). 
 
1.1.2.3 Transgenesis 
The potential of ES cells for the generation of transgenic mice was of extreme 
promise, as noted by Roberston and colleagues upon their confirmation of germline 
contribution of ES cells (Bradley et al. 1984). The following year the first report of 
transgenic ES cells was published. The researchers introduced a cosmid containing 
the human type II-collagen gene into ES cells by random integration, and assessed its 
expression in chimaeric mice (Lovell-Badge et al. 1985). In doing so, they 
demonstrated the ease of genetic modification of ES cells and their potential use for 
humanised mouse models. Thomas & Capecchi (1986) performed the first gene 
targeting experiment in ES cells, whereby a sequence of DNA in the genome of the 
ES cells was replaced by another sequence by means of homologous recombination 
between flanking regions. 
ES cells genetically modified with random or targeted transgene integrations were 
then shown to successfully contribute to live animals and their offspring following 
blastocyst injection (Hooper et al. 1987, Robertson et al. 1986), proving the 
usefulness of in vitro transgenesis in ES cells for the in vivo study of the phenotype 








1.1.3 Pre-implantation development of the mouse 
Embryonic stem cells were isolated from the inner cell mass of the mouse blastocyst, 
and share the same capability of forming all tissue types of the adult mouse. It is 
therefore important to understand how the mouse embryo develops before 
implantation if we are to understand how ES cells are regulated. 
 
1.1.3.1 Fertilisation and development to the blastocyst stage 
When the sperm fertilises the oocyte the zygote is formed. Unlike ES cells, this cell 
is totipotent, which means it can form all cells of the adult mouse as well as all the 
conceptus-derived extraembryonic structures required for supporting the 
development of the embryo. The fertilised zygote undergoes a series of symmetric 
cell divisions during which the whole embryo does not increase in volume and the 
volume of the cells halves at every division event (Nichols & Smith 2012, Rossant & 
Tam 2009, Wennekamp et al. 2013). The individual cells, termed blastomeres, of 
these early embryos are still totipotent and can give rise to adult mice under the 
appropriate conditions (Tarkowski 1959, Tarkowski & Wróblewska 1967, Tarkowski 
et al. 2010). Once the embryo reaches the 8-16 cell stage, its cells form tight 
junctions and the structure undergoes a process known as compaction. This 
embryonic stage is known as morula (named after the Latin for mulberry, due to its 
resemblance to the fruit) and occurs approximately 2.5 days after fertilisation 
(embryonic day 2.5, noted as E2.5). At E3.5 the embryo reaches the 32-64 cell stage 
and forms the blastocyst, a structure characterised by an outer layer of epithelial 
cells, the trophectoderm, an inner cell mass (ICM), and a fluid filled cavity, known 
as the blastocoel cavity. During the course of a further day of development, the 
blastocyst expands and the cells in the ICM segregate into two cell types, the epiblast 
(sometimes referred to as primitive ectoderm), which will form the embryo proper, 
and the primitive endoderm (sometimes referred to as hypoblast), an epithelial layer 
 




of cells that underlies the epiblast and will provide patterning signals to the embryo 
during development (Figure 1.1) (Nichols & Smith 2012, Rossant & Tam 2009, 
Wennekamp et al. 2013). 
 
Figure 1.1 – Structure of the mouse blastocyst 
The blastocyst forms approximately 3.5 days after fertilisation, and contains two cell 
types, an external layer of trophectoderm, expressing the transcription factor Cdx2 
(blue), and an inner cell mass, expressing the pluripotency factor Oct4 (purple). The 
blastocyst undergoes further cell division and expansion, and the inner cell mass 
gives rise to two structures: the epiblast, which will form the embryo proper and 
expresses Nanog (green), and the primitive endoderm, which underlies the epiblast 
and expresses Gata4 (red). 
 
1.1.3.2 Emergence of the pluripotent epiblast 
When the blastocyst is formed, the cells composing it have already made a first 
crucial decision in their development: to differentiate into trophectoderm or to 
remain in the pluripotent ICM. Trophectodermal cells are now committed to 
 




extraembryonic lineages, but ICM cells are still capable of giving rise to both 
embryonic lineages and extraembryonic primitive endoderm (Nichols & Smith 2012, 
Rossant & Tam 2009, Wennekamp et al. 2013). All cells in the ICM express Oct4, a 
transcription factor also known as Pou5f1 and Oct3/4, and its expression is essential 
for the development of the ICM: embryos that lack it can only form trophectoderm 
and cannot develop further (Nichols et al. 1998, Palmieri et al. 1994). Its negative 
relationship with the trophoblast determinant Cdx2 appears to be critical for the 
segregation of trophectoderm and ICM (Niwa et al. 2005). Whilst required for the 
establishment of the pluripotent ICM, Oct4 expression is not limited to the 
pluripotent epiblast at E4.5, and is also detected in the primitive endoderm layer 
(Dietrich & Hiiragi 2007, Grabarek et al. 2011, Nichols et al. 2009, Silva et al. 
2009). 
The epiblast and primitive endoderm can be distinguished by the respective 
expression of Nanog and Gata4 (Nichols et al.2009, Silva et al. 2009, Plusa et al. 
2008). Nanog is a critical factor for the formation of the ICM, as Nanog-null 
embryos generate a non-viable unspecified ICM-like structure (Mitsui et al. 2003, 
Frankenberg et al. 2011, Silva et al. 2009). Cells in the ICM express Nanog and 
Gata4 in a mutually exclusive salt-and-pepper pattern, which allows to predict which 
cells will contribute to the epiblast and which to the primitive endoderm. Other 
factors expressed in the primitive endoderm, such as Gata6 and Pdgfra, are expressed 
in the embryo prior to Gata4, and can be co-expressed with Nanog in the early 
blastocyst. During development from the early to the late blastocyst stage, through a 
combination of cell sorting and apoptosis, these Gata6- and Pdgfra-expressing cells 
localise to the outside of the ICM and form the primitive endoderm (Plusa et al. 
2008). 
The segregation of the epiblast and primitive endoderm is mediated by Fgf 
signalling. Blastocysts deficient for Fgf signalling components or cultured in Fgf 
signalling inhibitors display an expanded epiblast and a lack of primitive endoderm, 
whereas culture of blastocysts in the presence of exogenous Fgf4 causes the 
 




downregulation of Nanog and homogeneous expression of Gata6 (Chazaud et al. 
2006, Nichols et al. 2009, Yamanaka et al. 2010). Interestingly, it is the factors that 
promote pluripotency that drive the Fgf-dependent induction of primitive endoderm. 
Nanog-null embryos fail to generate primitive endoderm due to their lack of Fgf4 
expression, and addition of exogenous Fgf4 to the cultures rescues the formation of 
primitive endoderm (Frankenberg et al. 2011). Sox2 is another key pluripotency 
transcription factor. It is expressed throughout early development and localises to the 
ICM and later to the epiblast region of the blastocyst. Sox2-null embryos die around 
implantation due to defects in the epiblast (Avilion et al. 2003, Bedzhov et al. 2012, 
Zhang et al. 2013). Oct4 and Sox2 have been found to co-operate in the direct 
activation of Fgf4 transcription in the ICM, and Oct4 is required both upstream and 
downstream of Fgf4 activation for the transcription of primitive endoderm markers 
(Fraidenraich et al. 1998, Frum et al. 2013). Its ability to direct primitive endoderm 
gene expression is achieved by switching its transcriptional activation partner from 
Sox2 to the endoderm-specific factor Sox17 (Aksoy et al. 2013). 
 
1.1.3.3 Embryonic stem cells as a model for pre-implantation development 
The development of the pluripotent ICM and epiblast, and the activity of 
pluripotency and pro-differentiation factors within these structures, are complex 
processes which are not yet fully understood. Embryonic stem cells represent a 
directly relevant in vitro counterpart to these in vivo pluripotent structures, and can 
be used as a model to study these events. They provide a number of advantages 
compared to direct experimentation on pre-implantation embryos: they can be 
maintained in a self-renewing state indefinitely, allowing the study of molecular 
relationships that may be hard to uncover in the rapidly developing mouse embryo; 
they can be cultured in bulk, providing a wealth of biological material; they can be 
maintained in chemically defined culture medium, allowing to dissect the roles of 
extracellular signalling molecules in their maintenance and differentiation; they 
 




allow rapid and straightforward transgenesis experiments to address the roles of 
specific genes in pluripotency and differentiation; they can be visualised during 
experimentation with ease in their “natural” environment for a prolonged period of 
time. 
They therefore represent a tremendously powerful tool for the study of 
developmental biology. It is however imperative that we relate ES-cell based 
findings to our knowledge of in vivo development, in order to formulate hypotheses 
that are plausible in the light of both our observations and of the events that regulate 
mouse development and that constrain developmental decisions in time and space. 
 
1.1.4 Extracellular signalling molecules involved in the preservation of embryonic 
stem cell pluripotency 
1.1.4.1 Leukaemia inhibitory factor 
ES cells were isolated by culturing them in a basal medium supplemented with serum 
on a mitotically-inactivated fibroblast feeder layer (Evans & Kaufman 1981, Martin 
1981). The feeder cells were required not only for adhesion, but because of their 
ability to secrete an uncharacterised differentiation-inhibiting activity entity (Smith 
& Hooper 1987), which could be found in Buffalo rat liver cell-conditioned medium, 
a culture medium which allowed for the dispensation of the feeder layer (Hooper et 
al. 1987). This differentiation-inhibiting activity entity was eventually identified as 
leukaemia inhibitory factor (LIF) (Smith et al. 1988, Williams et al. 1988). This 
molecule is a cytokine that binds to a heteromeric receptor formed by Lifr and gp130 
(Davis et al. 1993, Gearing et al. 1992). Upon receptor binding, LIF stimulates 
interaction of the receptors with Janus kinases, which phosphorylate the receptors 
(Stahl et al.1994), allowing their interaction with a number of molecules. Amongst 
these molecules are Stat proteins, which bind the phosphorylated receptors and are in 
turn phosphorylated and activated, and SHP-2 (Stahl et al. 1995, Wen et al. 1995). 
 




SHP-2 binding results in the activation of the mitogen-activated protein kinase 
intracellular cascade, mediated by the interaction of SHP-2 with Grb2 and Gab1, 
proteins which can both induce mitogen-activated protein kinase activation (Li et al 
1994, Takahashi-Tezuka et al. 1998). 
LIF is required for the implantation of the blastocyst to the uterine wall. The 
blastocysts of female mice lacking a Lif gene cannot implant, and enter diapause 
(Stewart et al. 1992). Diapause is a state of delayed implantation in which the 
blastocysts arrest development, whilst retaining the potential to reprise normal 
development under the appropriate conditions (Lopes et al. 2004). The activity of 
LIF is also essential following diapause: embryos lacking the Gp130 gene, encoding 
the heteromerisation partner of the LIF receptor, survive diapause but are unable to 
reprise development, due to a loss of epiblast cells (Nichols et al. 2001). 
LIF signalling is thought to maintain ES cell pluripotency primarily by the activation 
of the transcription factor Stat3. Lack of Stat3 activity results in ES cell 
differentiation (Burdon et al. 1999a, Niwa et al. 1998, Ying et al. 2008). Targets of 
this factor include the pluripotency factor Klf4 and Tcfp2l1, a recently identified 
target which can sustain pluripotency in Stat3-null ES cells in LIF and serum culture 
(Martello et al. 2013). Activation of the mitogen-activated protein kinase signalling 
cascade negatively affects ES cell self-renewal and is required for ES cell 
differentiation (Burdon et al. 1999b, Kunath et al. 2007, Stavridis et al. 2007, see 
section 1.1.4.4). It therefore appears that LIF has a dual effect on ES cells: to 
maintain them in an undifferentiated state while at the same time generating 
intracellular signals that will allow them to differentiate. 
 
1.1.4.2 Serum and bone morphogenic protein 
The second component of ES cell culture medium required for the maintenance of 
pluripotency is foetal calf serum (FCS). ES cells cultured in the presence of LIF but 
 




absence of FCS are incapable of remaining undifferentiated, and form neural 
ectoderm, albeit at a lower efficiency than cells cultured in the absence of both LIF 
and FCS (Ying et al. 2003a,b). 
The components of FCS are undefined, and may vary from one batch to another. The 
differentiation-inhibiting activity entity present in FCS was identified in 2003 as 
bone morphogenic protein 4 (BMP4) (Ying et al. 2003a). ES cells cultured in the 
presence of LIF and BMP4 can self-renew and be propagated in culture, retain 
multilineage differentiation potency and can contribute to chimaeras. BMP4 is not 
sufficient to preserve pluripotency in the absence of LIF: ES cells cultured in BMP4 
alone differentiate into non-neural fates (Ying et al. 2003a). 
BMP’s are a subfamily of proteins that is part of the transforming growth factor beta 
(TGFβ) superfamily of signalling molecules. These are secreted extracellular 
proteins that bind as dimers to heterotetrameric transmembrane serine/threonine 
protein kinase receptors. The heterotetrameric receptors are formed by two Type I 
and two Type II receptors, which recognise specific subsets of TGFβ superfamily 
ligands. The receptors associated with BMP4 recognition are Bmpr1a, Bmpr1b 
(Type I), Bmpr2, Acvr2a, Acvr2b (Type II) (Allendorph et al. 2006, Greenwald et al. 
2003, Griffith et al. 1996, Kirsch et al. 2000, Koenig et al. 1994, Nagaso et al. 1999, 
Paralkar et al. 1991, Piek et al. 1999, Rosenzweig et al. 1995, ten Dijke et al. 1994, 
Weber et al. 2007). Upon binding of BMP (or other TGFβ ligands), the kinase 
domain of the Type II receptor phosphorylates the Type I receptor, activating its 
kinase activity (Chen & Weinberg 1995, Wrana et al. 1994). Activated receptors can 
then mediate the phosphorylation of specific Smad proteins, recognised via the 
interaction of two short amino acid sequences: the L45 loop on the Type I receptor 
and the L3 loop on the Smad protein (Feng & Derynck 1997, Lo et al. 1998). BMP4 
drives the phosphorylation of Smad1, Smad5 and Smad8. Phosphorylated Smad’s 
can form a complex with Smad4 and drive the transcription of target genes (Chen et 
al. 1997b, Kretzschmar et al. 1997, Lagna et al. 1996, Nishimura et al. 1998, Suzuki 
et al. 1997). 
 




Id genes are direct targets of these active BMP-induced Smad complexes (Hollnagel 
et al. 1999, Katagiri et al. 2002, Korchynskyi & ten Dijke 2002, López-Rovira et al. 
2002, Ogata et al. 1993), and Id protein overexpression can substitute for BMP4 in 
the maintenance of ES cell pluripotency (Ying et al. 2003a). Id proteins can therefore 
preserve the capability of ES cells to self-renew in a Smad-independent manner, and 
are thus the key mediators of pluripotency in LIF and serum culture in association 
with Stat3. 
 
1.1.4.3 Activin and Nodal 
Activin and Nodal are members of a separate subfamily of TGFβ signalling 
molecules. They also signal through specific TGFβ receptors: Acvr1b, Acvr1c (Type 
I), Acvr2a, Acvr2b (Type II); a co-receptor, Cripto, is also involved in Nodal signal 
transduction (Cheng et al. 2003, Reissman et al. 2001, Willis et al. 1996). 
Activin/Nodal signals lead to the phosphorylation of Smad2 and Smad3, which upon 
binding to Smad4 form transcriptionally active complexes and modulate the 
transcription of target genes (Kretzschmar et al. 1997, Lagna et al. 1996, Nakao et al. 
1997, Wu et al. 1997). 
Nodal is an important signal in embryo patterning and germ layer specification, and 
Nodal-null embryos die shortly after implantation (Mesnard et al. 2006). ES cells 
secrete Activin/Nodal agonists and these signals positively affect cell proliferation 
(Ogawa et al. 2007). However, Activin/Nodal signalling negatively regulates the 
transcription of the pluripotency-inducing BMP targets in ES cells (Galvin et al. 
2010), and inhibition of Activin/Nodal signalling with the small molecule inhibitor 
SB431542 improves the efficiency of reprogramming mouse embryonic fibroblasts 
to induced pluripotent stem cells (Maherali & Hochedlinger 2009). Furthermore, 
Activin/Nodal-driven phosphorylation of Smad2/3 have been shown to induce 
activation of the promoter of pro-differentiation genes Gsc and Mixl1 via the 
 




formation of active Smad2/3/4 transcriptional complexes and through Smad4-
independent displacement of a chromatin compaction factor (Xi et al. 2011). 
The mechanisms by which Activin/Nodal signalling may inhibit BMP target 
transcription are various. Smad2/3 can directly bind the promoters of some BMP 
targets and repress their transcription (Kang et al. 2003, Lee et al. 2011). There may 
be competition for Smad4 binding between Smad2/3 and Smad1/5/8, although 
Smad4 overexpression does not rescue Activin/Nodal-driven BMP inhibition (Galvin 
et al. 2010). Smad2/3 can also drive the transcription of Smad6 and Smad7 (Afrakhte 
et al. 1998, Brodin et al. 2000, Hua et al. 2000). These are inhibitory Smad proteins, 
which can inhibit transcription driven by Smad1/5/8 (Smad6, Smad7) and by 
Smad2/3 (Smad7) (Hata et al. 1998, Imamura et al. 1997, Ogawa et al. 2007, 
Souchelnytskyi et al. 1998). Thus, Activin/Nodal-driven transcription of Smad6, an 
inhibitory Smad specific to BMP-responsive Smad proteins, could dampen BMP 
signalling. However, BMP can also induce transcription of Smad6 (Afrakhte et al. 
1998, Takase et al. 1998), suggesting the factor may be expressed in ES cells 
regardless of Activin/Nodal activity. To complicate matters further, Smad2 and 
Smad3 can both co-operate and antagonise each other in the promotion of the 
transcription of target genes (Míguez et al. 2013). 
The crosstalk between BMP and Activin/Nodal signals is likely to be required for the 
generation of a fine-tuned balance between different transcriptional programmes, 
critical for both the maintenance of pluripotency and the proliferation of ES cells. 
 
1.1.4.4 Fibroblast growth factor and the mitogen-activated protein kinase pathway 
Fibroblast growth factor (Fgf) molecules are key signalling components throughout 
the development of the mouse embryo. They act primarily by stimulating the 
mitogen-activated protein kinase pathway, in which sequential activation of Fgf 
receptors, Grb2, Ras, Raf, Mek and Erk lead to the transcription of target genes 
(Villegas et al. 2010). 
 




The knockout of Fgf receptors leads to developmental abnormalities (Colvin et al. 
1996, Yamaguchi et al. 1994), and knockout of Fgf4 leads to lethality shortly after 
implantation (Feldman et al. 1995). Fgf4 is first expressed at the 4-cell stage and is 
expressed in the inner cell mass of the blastocyst (Niswander & Martin 1992, 
Rappolee et al. 1994). It is also secreted by ES cells (Ma et al. 1992). Because of its 
in vivo requirement, and because of the roles of Fgf’s in promoting cell proliferation 
in other systems (Thisse & Thisse 2005), it could be expected for Fgf4 to promote 
ES cell self-renewal and proliferation. However, Fgf signalling appears to negatively 
affect ES cell self-renewal, and its inhibition promotes and homogenises the 
expression of transcription factors associated with pluripotency (Burdon et al. 1999b, 
Hamazaki et al. 2006, Kunath et al. 2007, Wilder et al. 1997, Ying et al. 2008). The 
loss of Fgf/Erk activity also has a profound effect on the blastocyst: cells of the inner 
cell mass become uniformly positive for the epiblast determinant Nanog and fail to 
correctly segregate primitive endoderm (Chazaud et al. 2006, Nichols et al. 2009). 
This is the likely cause of the lethal phenotype seen in Fgf4-null embryos. 
The pro-differentiation effect of Fgf/Erk holds true to the extent that Fgf4-null ES 
cells retain expression of the pluripotency factor Oct4 after 6 days of culture in basal 
medium devoid of LIF and BMP, and inhibition of Mek prevents the loss of Oct4 
from ES cells undergoing embryoid body differentiation (Burdon et al. 1999b, 
Kunath et al. 2007). Fgf signalling is therefore required to exit the pluripotent state, 
as confirmed by the rescue of differentiation seen following the addition of Fgf4 to 
Fgf4-null ES cells or following the removal of a Mek inhibitor from Sox1-GFP 
reporter ES cells for the first 24 hours of differentiation (Kunath et al. 2007, 
Stavridis et al. 2007). This effect of Fgf4 on differentiation was thought to be 
mediated by the mitogen-activated protein kinases Erk1 and Erk2. Erk2-null ES cells 
were in fact shown to be resistant to neural and mesodermal differentiation (Kunath 
et al. 2007). Rederivation of Erk2-null ES cells on a different genetic background, 
however, allowed Kunath and colleagues to demonstrate that the lack of Erk2 
resulted in a more homogeneous expression of pluripotency factors under self-
 




renewing conditions, but that it did not affect the differentiation competence of the 
cells (Hamilton et al. 2013). This suggests that either Fgf4 is only required to exit 
pluripotency on certain genetic backgrounds, or that Erk2 is not the main mediator of 
Fgf signalling in ES cell differentiation.  
 
1.1.4.5 Wnt 
The Wnt pathway is a complex signalling cascade involving many Wnt proteins (19 
for most mammals) and diverse intracellular responses. In canonical Wnt signalling, 
the effects of Wnt are mediated by modulating the transcriptional activity of β-
catenin. In the absence of Wnt, cytoplasmic β-catenin is associated with a destruction 
complex consisting of Axin, Dvl, APC, CK1 and GSK3β. CK1 and GSK3β are 
kinases that phosphorylate β-catenin, causing it to be recognised by the E3 ubiquitin 
ligase β-TrCP, ubiquitinated and degraded by the proteasome. Upon Wnt binding to 
a heteromeric receptor formed by Frizzled and Lrp5/6, the degradation of β-catenin is 
inhibited and the protein can translocate to the nucleus and drive transcription of 
target genes. According to the established model, Wnt association with the receptor 
results in Axin, Dvl, CK1 and GSK3β association with the Wnt/receptor complex, 
resulting in the inability of the destruction complex to phosphorylate cytoplasmic β-
catenin which is no longer targeted for degradation (Clevers & Nusse 2012, Kim et 
al. 2013, Wu & Pan 2009). A recent publication suggests that the entire destruction 
complex, including APC and phosphorylated β-catenin, associates with 
Frizzled/Lrp5/6 upon Wnt stimulation, but that phosphorylated β-catenin can no 
longer be ubiquitinated by β-TrCP and is no longer released from the destruction 
complex. It therefore saturates the destruction complex preventing the degradation of 
the remaining cytoplasmic β-catenin (Li et al. 2012). 
Regulation of β-catenin function plays an important role in ES cell pluripotency. In 
2002, Fodde and colleagues observed that lack of β-catenin phosphorylation in ES 
cells, obtained by truncation of APC proteins or with the use of mutant alleles of β-
 




catenin lacking the normally phosphorylated residues, resulted in severe 
differentiation impairment (Kielman et al. 2002). Inhibition of GSK3β with a small 
molecule inhibitor was then demonstrated to allow nuclear relocalisation of β-catenin 
and promote expression of the pluripotency factor Rex1 (Sato et al. 2004). 
Association of β-catenin with the pluripotency factor Klf4 regulates the expression of 
telomerase, ensuring long-term self-renewal capability (Hoffmeyer et al. 2012). 
Stimulation of ES cells with Wnt3, Wnt3a, Wnt5a and Wnt6 was also shown to 
promote pluripotency (Hao et al. 2006, Ogawa et al. 2006), and this positive effect 
on self-renewal could be stimulated further with a combination of Wnt and LIF or 
Fgf inhibition (Singla et al. 2006). 
 
1.1.4.6 Maintenance of ES cell pluripotency by combinatorial stimulation or 
inhibition of signalling pathways 
All of the signalling pathways described above are capable of positively or 
negatively affecting the self-renewal ability of embryonic stem cells, but stimulation 
or inhibition of no single pathway can maintain ES cells in a pluripotent state. 
Culture of ES cells in LIF alone generates neural ectoderm (Ying et al. 2003a), 
culture in BMP4 alone generates mesodermal and epithelial cells (Johansson & 
Wiles 1995, Park et al. 2004, Ying et al. 2003a), Activin/Nodal stimulation alone 
drives mesendoderm formation (Fei et al. 2010, Hansson et al. 2009, Pfendler et al. 
2005), inhibition of Activin/Nodal promotes neural differentiation (Watanabe et al. 
2005), stimulation with Fgf accelerates neural differentiation (Chen et al. 2010). 
Inhibition of Fgf signalling alone can maintain self-renewal briefly, but the cells 
exhibit proliferation defects and eventually differentiate (Meek et al. 2013, Ying et 
al. 2008). Stimulation of Wnt signalling delays the exit from pluripotency but does 
not ultimately prevent it (Wray et al. 2011, Yi et al. 2011); Wnt also promotes 
mesodermal and inhibits neural differentiation, and Wnt inhibition favours neural 
specification (Arnold et al. 2000, Hansson et al. 2009, Watanabe et al. 2005). 
 




It appears therefore that ES cell self-renewal can be promoted by multiple signalling 
events, but that a combination of these is required for long-term maintenance of 
pluripotency. The sufficiency of LIF and BMP4 for this purpose was the first to be 
characterised (Ying et al. 2003a), but other combinations of factors have successfully 
been used since. 
The observations that the inhibition of Fgf signalling and of β-catenin 
phosphorylation promoted pluripotency led Ying et al. (2008) to develop a self-
renewal medium containing only two small molecule inhibitors of Mek (PD0352901) 
and GSK3β (CHIR99021), a medium they termed “2i”. Culture of ES cells in this 
medium resulted in homogenous gene expression of pluripotency factors and allowed 
derivation of ES cells from refractory mouse strains; these effects were potentiated 
by the addition of LIF to the medium. 2i+LIF medium was also used to successfully 
derive ES cells from rat embryos, a procedure which had previously been impossible 
as rat ES cells differentiate in LIF and serum (Buehr et al. 2008, Li et al. 2008, 
Nichols et al. 2009, Ying et al. 2008). 
Smith and colleagues therefore formulated the hypothesis that these culture 
conditions allowed ES cells to remain in a “ground state”, and suggested self-renewal 
was the default option of ES cells, providing these were shielded from autocrine pro-
differentiation signals such as Fgf (Ying et al. 2008). This constitutes an attractive 
hypothesis, for it introduces the idea of ES cell culture conditions for the promotion 
of a default pluripotent state. The observation that ES cells will differentiate into 
neural ectoderm in the absence of any stimulus or the presence of LIF alone had 
previously led to the use of the anti-neural factor BMP4 as a differentiation-
inhibiting entity (Ying et al. 2003a,b), and had resulted in the formulation of the 
concept that ES cells will differentiate by default, and that the maintenance of 
pluripotency must be achieved via the inhibition of differentiation. 
The “default self-renewal” hypothesis cannot however hold true. The inhibition of 
GSK3β mimics the effects of Wnt stimulation, and therefore suggests that exogenous 
stimulation of this pathway or of its downstream effectors is required for the 
 




maintenance of pluripotency. The shielding of cells from autocrine signals with Fgf 
signalling inhibitors is not sufficient to preserve long-term self-renewal capability 
(Meek et al. 2013, Ying et al. 2008). It is intriguing that rat ES cells do exhibit long-
term self renewal in basal medium supplemented solely with a Mek inhibitor (“1i”), 
and suggestive of the fact that pluripotency states can vary between rodent species 
(Meek et al. 2013). 
Other combinations of factors have been adopted since 2008 for the long-term 
maintenance of mouse ES cells. LIF and PD0352901, as well as LIF and 
Wnt3a/CHIR99021, have been shown to sustain pluripotency in the absence of 
exogenous BMP4 (ten Berge et al. 2011, Wray et al. 2009). Two recent publications 
have demonstrated that a homogenous pluripotent state reminiscent of 2i culture can 
be generated via small molecule-mediated inhibition of Activin/Nodal signalling 
receptors (SB431542, inhibitor of Acvr1b, Acvr1c, Tgfbr1, Inman et al. 2002) and of 
Mek (PD0352901) (Hassani et al. 2012, Hassani et al. 2013). This medium, termed 
“R2i”, also allowed derivation of ES cells from recalcitrant mouse strains. The 
achievement of ground state pluripotency via inhibition of Fgf and Activin/Nodal 
signalling would appear to lend further weight to the “default self-renewal” 
hypothesis. However, it appears that R2i medium maintains ES cell pluripotency 
primarily by derepressing phospho-Smad2-inhibited BMP targets, and addition of 
BMP receptor inhibitors to R2i medium causes a collapse of pluripotency (Hassani et 
al. 2012, Hassani et al. 2013). This suggests that under these culture conditions 
BMP4 autocrine signalling is paramount to the maintenance of pluripotency, and that 
complete shielding of ES cells from autocrine signals would not result in the 
maintenance of the pluripotent state. 
In summary, it appears the maintenance of ES cell pluripotency can be achieved by 
means of activating or inhibiting a variety of signalling pathways, but that no 
signalling pathway on its own is sufficient for long-term ES cell self-renewal. The 
adaptability of ES cells to various culture conditions is likely to reflect the necessity 
 




for cells in the inner cell mass of the blastocyst to maintain pluripotency in a three-
dimensional environment whilst being exposed to a variety of signals, which may 
differ both in type and intensity between neighbouring cells. 
 
1.1.5 Intracellular mediators of ES cell pluripotency 
1.1.5.1 Oct4 and Sox2 
Oct4 is a transcription factor that is crucial for the establishment of pluripotency in 
the early embryo (Nichols et al. 1998, Palmieri et al. 1994, see section 1.1.3.2). It is 
also expressed in embryonic stem cells (Rosner et al. 1990), and it is essential for 
their self-renewal. Loss of Oct4 expression results in differentiation of ES cells 
towards the trophectodermal lineage (Niwa et al. 2000), an event reminiscent of its 
antagonism of the trophoblast specifier Cdx2 in vivo (Niwa et al. 2005). 
Sox2 is a transcription factor essential for early mouse development (Avilion et al. 
2003, see section 1.1.3.2). It is also required for embryonic stem cell pluripotency; its 
loss leads to the downregulation of Oct4 and the upregulation of markers of the 
trophectodermal lineage (Ivanova et al. 2006, Misui et al. 2007). Oct4 and Sox2 co-
operate to drive the transcription of target genes. These targets include the 
aforementioned Fgf4, the pluripotency factors Nanog and Utf1, as well as Oct4 and 
Sox2 themselves (Chew et al. 2005, Nishimoto et al. 1999, Rodda et al. 2005, 
Tomioka et al. 2002, Yuan et al. 1995). It would therefore appear likely that the 
upregulation of trophectodermal markers in Sox2- or Oct4-depleted ES cells is due to 
a loss of expression of Oct4/Sox2 target genes required for the maintenance of 
pluripotency. However, the loss of Sox2 protein is not accompanied by a rapid 
downregulation of Oct4/Sox2 target genes, the expression of which occurs in 
synchrony with Oct4 downregulation. Furthermore, restoring Oct4 levels in Sox2-
depleted cells by introduction of a transgene can rescue, at least in part, the 
expression of Oct4/Sox2 targets, the differentiation phenotype of the cells and the 
 




capability of the cells to contribute to chimaeric embryos (Misui et al. 2007). This 
suggests that Sox2 acts primarily by promoting the expression of Oct4, and that the 
expression of shared Oct4/Sox2 targets is either dispensable or can be maintained by 
other Sox family members, as is the case for Sox15, which can bind Oct4/Sox2 target 
sites with weaker affinity than Sox2 (Maruyama et al. 2005). 
Whilst Oct4 expression is essential for ES cell pluripotency, and the factor can 
substitute for the loss of the pluripotency mediator Sox2, overexpression of Oct4 also 
drives differentiation of ES cells, resulting in the upregulation of markers of 
endoderm and mesoderm (Niwa et al. 2000). Why this is the case is unclear. One 
possibility is that Oct4 can bind the promoters of both pluripotency factors and pro-
differentiation genes, but that at wild-type levels it associates with DNA binding 
partners that bind preferentially or exclusively at the promoters of genes that 
stimulate self-renewal. Upon elevation of Oct4 levels, the excess Oct4 molecules 
unbound by the saturated pro-self-renewal partners could interact with DNA binding 
proteins capable of binding the promoters of pro-differentiation genes, driving the 
exit from pluripotency. It is intriguing to think that one such partner could be the 
Oct4 in vivo primitive endoderm-specifying partner Sox17 (Aksoy et al. 2013). The 
possibility that excess Oct4 may promote the exit from pluripotency was given 
further credit by the observation that Oct4 heterozygous ES cells exhibit 
homogeneous expression of the pluripotency factor Nanog and display delayed 
differentiation kinetics compared to wild-type ES cells. These cells are also capable 
of self-renewal in the presence of LIF alone, possibly due to increased autocrine Wnt 
signalling (Karwacki-Neisius et al. 2013). Similar observations were also made in 
induced pluripotent stem cells (Radzisheuskaya et al. 2013). Oct4 has also been 
shown to interact with β-catenin and to localise at the cell membrane in complex 
with this protein and Cdh1 (commonly referred to as E-cadherin) (Faunes et al. 2013, 
Livigni et al. 2013). This suggests a mechanism by which excess Oct4 protein may 
be buffered to prevent it from driving the expression of pro-differentiation factors. 
The levels of Oct4 in 2i and 2i+LIF display a striking correlation to the levels of 
 




Nanog, whereas this correlation is less evident in LIF and serum culture (Muñoz 
Descalzo et al. 2012, Muñoz Descalzo et al. 2013, see also Figure 3.13). It is 
therefore tempting to hypothesise that a strict regulation of Oct4 levels in 2i culture, 
potentially resulting in exclusive interactions with pluripotency determinants, may be 




Nanog is a transcription factor indentified by two research groups in 2003. They 
demonstrated that its overexpression could maintain ES cells in a self-renewing state 
in basal medium without LIF supplementation, and named the gene after the 
mythological Celtic Land of Youth, Tír na nÓg (Chambers et al. 2003, Mitsui et al. 
2003). This factor displays a stronger pluripotency-inducing phenotype than Oct4 
and Sox2, and does not induce differentiation when overexpressed, but cannot rescue 
trophectodermal specification in Oct4-null or Sox2-depleted cells (Chambers et al. 
2003, Ivanova et al. 2006). It is required for the specification of the pluripotent 
epiblast in vivo (Mitsui et al. 2003, Frankenberg et al. 2011, Silva et al. 2009, see 
section 1.1.3.2), but it is dispensable for ES cell self-renewal. Nanog-null ES cells 
can be maintained in culture, retain multilineage differentiation capacity and can 
contribute to chimaeras. They display lower clonogenicity than wild-type cells and 
express markers of embryonic and extraembryonic endoderm (Chambers et al. 2007, 
Mitsui et al. 2003). These dualities indicate that Nanog is an extremely potent 
pluripotency determinant, but that it is neither sufficient nor required for ES cell self-
renewal and differentiation. 
Nanog is expressed in a heterogeneous pattern in ES cells. This heterogeneity was 
detected both at the protein level (within the Oct4-expressing pluripotent 
compartment) and at the transcriptional level, making use of transcriptional reporters 
 




replacing the endogenous Nanog open reading frame with a marker protein, GFP or 
βgeo. The cells expressing the highest levels of Nanog reporters proved to be less 
prone to differentiation than the cells expressing lower levels of Nanog reporters 
(Chambers et al. 2007, Singh et al. 2007). Sorting of the cells expressing high levels 
of the GFP reporter did not allow the long-term purification of a naïve pluripotent 
population, but rather led to the restoration of the original distribution of GFP high 
and low cells after 6 days of culture (Chambers et al. 2007). This implies that Nanog 
heterogeneity is intrinsic to LIF and serum culture, and led Chambers et al. (2007) to 
suggest that fluctuations in the levels of Nanog may offer a time window for the cells 
to escape the pluripotent state and commit to differentiation when the levels of the 
transcription factor are low. 
Nanog binds DNA as a homodimer (Mullin et al. 2008, Wang et al. 2008), and 
directly interacts with a number of pluripotency factors, with which it also shares 
common targets and neighbouring DNA binding sites. These interactors include 
Sox2 and may include Oct4, although the data available for a direct Nanog-Oct4 
interaction are discordant. Regardless of the veracity of a direct interaction, Nanog, 
Oct4 and Sox2 share a substantial number of targets, including Nanog, Oct4 and 
Sox2 themselves (Chen et al. 2008, Costa et al. 2013, Gagliardi et al. 2013, Kim et 
al. 2008, Liang et al. 2008, Wang et al. 2006). The roles of these factors in the 
promotion of self-renewal, their physical interactions and the existence of common 
transcriptional targets led to the idea that these three proteins act as master regulators 
of pluripotency, and boost the expression of each other to maintain cells in a 
pluripotent state. This, however, does not fit with the heterogeneous expression of 
Nanog observed in cells with similar expression levels of Oct4 and Sox2. Two recent 
publications have demonstrated an unexpected role for Nanog in the autorepression 
of its own transcription. Whilst Oct4 and Sox2 promote the transcription of Nanog, 
Nanog binds its enhancer region independently of Oct4 and Sox2 and drives the 
downregulation of its message. This is not only the case in LIF and serum culture, 
but also in 2i+LIF medium (Fidalgo et al. 2012, Navarro et al. 2012). 
 




1.1.5.3 Other transcription factors regulating pluripotency 
A number of other transcription factors have been implicated in the regulation of ES 
cell pluripotency. What follows is a brief description of some of the best 
characterised pluripotency factors. 
Krüppel-like factors (Klf’s) are a family of zinc finger proteins involved in many 
cellular processes. Klf2, Klf4 and Klf5 are expressed in ES cells and have been 
shown to promote pluripotency. Loss of all three factors drives differentiation of ES 
cells (Jiang et al. 2008). The data obtained for single-Klf loss-of-function 
experiments are discordant. Klf4-null mice survive until birth (Segre et al. 1999). 
Klf4 knockdown has been reported to drive differentiation (Zhang et al. 2010), 
reduce clonogenicity (Bourillot et al. 2009), or have no effect (Jiang et al. 2008). 
Loss of Klf5 has been shown to generate implantation defects and prevent ES cell 
derivation (Ema et al. 2008), drive ES cell differentiation (Parisi et al. 2008), reduce 
ES cell clonogenicity (Bourillot et al. 2009), or have no effect (Jiang et al. 2008). 
Klf2 knockout ES cells can be derived, and Klf2-null mice survive until E12.5 (Kuo 
et al. 1997). Klf2 knockdown has been reported to have no effect on self-renewal 
(Jiang et al. 2008). This variety of phenotypes may reflect differences in genetic 
background or in residual protein expression in knockdown experiments, but it is 
clear that expression of at the very least one out of the three factors is essential for 
self-renewal. In keeping with the positive role of the factors in the promotion of 
pluripotency, overexpression of Klf2, Klf4 or Klf5 can sustain LIF-independent self-
renewal (to a variable extent) (Ema et al. 2008, Hall et al. 2009, Li et al. 2005, Niwa 
et al. 2009, Parisi et al. 2008, Zhang et al. 2010). Klf factor expression is induced by 
pluripotency factors: Klf2 transcription is driven by Oct4, whereas Klf4 and Klf5 
expression is driven by LIF/Stat3 (Hall et al. 2009, Li et al. 2005). Klf factors can in 
turn promote the transcription of Oct4 and Nanog, share a number of common targets 
with these factors, and are in some cases indispensable for the expression of shared 
 




target genes, as is the case for the Oct4/Sox2/Klf4 target Lefty1 (Jiang et al. 2008, 
Nakatake et al. 2006, Parisi et al. 2008). 
Rex1 (also referred to as Zfp42) is a zinc-finger protein, identified as a factor rapidly 
downregulated at the onset of EC cell differentiation (Hosler et al. 1989). Its 
expression was later confirmed in ES cells (Rogers et al. 1991), and it is commonly 
employed as a marker of the pluripotent state (Okita et al. 2007, Toyooka et al. 2008, 
Wray et al. 2011). It is expressed heterogeneously in LIF and serum culture, and 
cells expressing high levels of Rex1 display enriched expression of other 
pluripotency factors, such as Klf factors, Nanog, Sox2, Tbx3 and Esrrb, suggesting it 
marks ES cells in a naïve pluripotent state (Toyooka et al. 2008). It is therefore 
surprising that neither its knockout nor its overexpression ostensibly affect ES cell 
pluripotency and differentiation nor embryonic development until after E17.5. Rex1-
null mice are viable, although they are found in litters in numbers lower than the 
expected Mendelian rates (Masui et al. 2007, Scotland et al. 2009). It appears that its 
primary role is that of promoting the reactivation of the inactive X chromosome by 
promoting the transcription of Tsix and inhibiting that of Xist (Gontan et al. 2012, 
Navarro et al. 2010). Rex1 is also involved in the suppression of endogenous 
retroviral expression, and may thus aid in the preservation of the transcriptional 
identity of pluripotent cells (Guallar et al. 2012). It is therefore possible that a 
combination of inappropriate X inactivation and unsuppressed retroviral expression 
may lead to developmental defects resulting in a lower number of births of Rex1-null 
mice than expected. 
Esrrb is an orphan nuclear receptor protein. It is required for placental development, 
and its knockout results in embryonic lethality between E9.5-E10.5 (Luo et al. 1997). 
It was first implicated in the regulation of ES cell pluripotency in 2006, when it was 
demonstrated that its knockdown compromised self-renewal capacity, that its 
expression was reduced upon Nanog and Oct4 knockdown and induced by Nanog 
overexpression (Ivanova et al. 2006, Loh et al. 2006). Esrrb can interact with Nanog 
 




to promote Oct4 expression, it can interact with Oct4 to promote Nanog expression, 
and it can also interact with Sox2 (Hutchins et al. 2013, van den Berg et al. 2008, 
Zhang et al. 2008). It can bind the enhancer/promoter regions of a number of other 
pluripotency factors, including Klf4, Rex1 and Sox2, and can directly interact with 
RNA Polymerase II (Feng et al. 2009, van den Berg et al. 2008, van den Berg et al. 
2010). Interestingly, the Esrrb locus appears to be a convergence point of two 
processes that promote ES cell pluripotency: Wnt signalling and Nanog 
transcriptional activity. Inhibition of GSK3β or Wnt3a stimulation can induce Esrrb 
expression by inhibiting the transcriptional repression exerted by Tcf7l1 (commonly 
referred to as Tcf3. Tcf3 is the official gene symbol for the Id1 binding partner E2A) 
(Martello et al. 2012). Esrrb is the transcript which is upregulated quickest and to the 
highest levels following tamoxifen-mediated nuclear translocation of Nanog-ERT2 
in Nanog-null ES cells. Esrrb overexpression can sustain LIF-independent self-
renewal even in the absence of Nanog, and Esrrb-null cells cannot sustain LIF-
independent self-renewal upon Nanog overexpression, suggesting Esrrb is a crucial 
Nanog target (Festuccia et al. 2012). In keeping with its in vivo phenotype and with 
its role as a mediator of Nanog, Esrrb-null ES cells can be maintained in culture and 
contribute to chimaeric embryos, despite displaying impaired clonogenicity 
(Festuccia et al. 2012, Martello et al. 2012). 
 
1.1.5.4 E-cadherin 
E-cadherin (or Cdh1, for Cadherin 1) is a transmembrane protein that is involved in 
cell-cell adhesion. Its N-terminal extracellular domain mediates the formation of 
adherens junctions through homotypic interactions with the N-terminal domains of 
E-cadherin molecules on neighbouring cells. Its C-terminal domain interacts with β-
catenin and, through this protein, with α-catenin and the actin cytoskeleton  
(Stemmler 2008). E-cadherin is expressed throughout pre-implantation development, 
and is required for embryo compaction and correct generation and segregation of 
 




trophectoderm and inner cell mass (Bedzhov et al. 2012, de Vries et al. 2004, Fierro-
González et al. 2013, Kan et al. 2007, Larue et al. 1994, Riethmacher et al. 1995, 
Stephenson et al. 2010). It is expressed in ES cells, where it is required for their 
adhesive phenotype but not for their maintenance in culture (Larue et al. 1996). 
Cdh1-null ES cells, however, display a gene expression profile reminiscent of post-
implantation epiblast and do not respond to LIF signalling, but rather appear to 
acquire dependency on Activin/Nodal signalling (although Cdh1-null ES cells can 
also be maintained in N2B27 medium supplemented with LIF and BMP4, suggesting 
they can maintain pluripotency under the control of different extracellular signals) 
(Hawkins et al. 2012, Soncin et al. 2009, Soncin et al. 2011). E-cadherin interacts 
with the LIF receptor and gp130, and its loss results in the downregulation of the two 
proteins, a phenotype that can be rescued by overexpressing the extracellular domain 
of E-cadherin. Forced expression of a constitutively active form of Stat3 can rescue 
the expression of naïve pluripotency factors in Cdh1-null ES cells (del Valle et al. 
2013). The adhesive phenotype of Cdh1-null ES cells can be resuced by expressing 
N-cadherin (or Cdh2, for Cadherin 2) or chimaeric constructs comprising the 
extracellular domain of E-cadherin and the intracellular domain of N-cadherin (and 
vice versa), under the control of the Cdh1 promoter. The re-acquisition of an 
adhesive phenotype results in the restoration of a pre-implantation epiblast-like gene 
expression pattern (Bedzhov et al. 2013). 
E-cadherin appears to mediate pluripotency in more ways than just through the 
transduction of LIF signalling. As mentioned previously, it can interact with the 
transcriptional regulator β-catenin, and through this with Oct4. The interaction of E-
cadherin with β-catenin tethers the latter to the membrane and prevents its 
transcriptional activity, and it is likely that the transcriptional activity of Oct4 is 
regulated similarly (Faunes et al. 2013, Livigni et al. 2013, Orsulic et al. 1999). 
Surprisingly, E-cadherin can also replace the requirement for Oct4 in the generation 
of induced pluripotent stem cells (Redmer et al. 2011). E-cadherin is also involved in 
the mediation of BMP signalling: we have recently shown that culture of ES cells in 
 




the absence of LIF and the presence of BMP results in the maintenance of E-cadherin 
and Oct4 expression, and that forced loss of E-cadherin rescues the BMP-driven 
block of differentiation (Malaguti et al. 2013, experiments carried out by Dr. Sally 
Lowell and Dr. Paul Nistor). E-cadherin appears to regulate BMP signalling itself, as 
Cdh1-null ES cells express approximately 80-fold lower levels of Bmp4 transcripts 
than wild-type ES cells (Soncin et al. 2011). 
 
1.1.6 Other types of pluripotent stem cells 
1.1.6.1 Epiblast stem cells 
Epiblast stem cells (EpiSCs) represent the in vitro equivalent of post-implantation 
pluripotent epiblast. They were simultaneously derived by two research groups in 
2007 from the epiblast of E5.5-E6.5 mouse embryos and from the epiblast of E7.5 rat 
embryos (Brons et al. 2007, Tesar et al. 2007). It was later shown that EpiSCs can 
also be derived from blastocysts and later stage embryos, until the onset of 
somitogenesis (Najm et al. 2011, Osorno et al. 2012). It is puzzling that the cultured 
equivalent of post-implantation pluripotent epiblast can be generated from a pre-
implantation stage embryo, but the derivation process takes place over an extended 
period of time, so it is likely that the ES cell-like ICM cells have progressed in their 
development during this time. EpiSCs can also be derived from ES cells by extensive 
passaging in epiblast stem cell culture medium (Guo et al. 2009). 
Epiblast stem cell pluripotency is reliant on different extracellular signals than ES 
cell pluripotency, and is maintained by culturing the cells in N2B27 medium 
supplemented with Fgf2 and Activin A. These factors have a negative impact on ES 
cell self-renewal, illustrating how diversely pluripotency is protected in the two cell 
types (Brons et al. 2007, Greber et al. 2010, Tesar et al. 2007). 
EpiSCs and ES cells display several differences in gene expression. Both cell types 
express Oct4 to a similar extent, but EpiSCs express lower levels of Nanog and 
 




Sox2, and express very little if any mRNA of naïve pluripotency factors such as 
Esrrb, Klf’s and Rex1. They display relatively high expression of post-implantation 
markers such as Fgf5 and T, which are expressed at low levels in ES cells (Brons et 
al. 2007, Guo et al. 2009, Najm et al. 2011, Tesar et al. 2007). 
EpiSCs also display a different capability for contribution to chimaeric embryos. 
Blastocyst injection of EpiSCs is generally accompanied by a failure of the cells to 
contribute to the developing embryo (Brons et al. 2007, Tesar et al. 2007). EpiSC 
contribution to development after blastocyst injection has been achieved, but only 
after selecting for an ES cell-like subpopulation of cells by means of a fluorescent 
reporter (Han et al. 2010), or by overexpressing E-cadherin, and thus possibly 
increasing the adhesive propensity of the cells (Ohtsuka et al. 2012). It is not 
surprising that the in vitro equivalent of a cell derived from an apical-basal polarised 
epithelial sheet struggles to integrate and interact with the three-dimensional inner 
cell mass, and raises the question of whether EpiSCs would contribute to 
development more readily if integrated in post-implantation stage embryos. This was 
proved to be the case by Huang et al. (2012), who grafted EpiSCs into gastrulation 
stage embryos, and demonstrated that EpiSCs can contribute to all germ layers and 
primordial germ cells. This result further confirms that EpiSCs represent the in vitro 
equivalent of pluripotent post-implantation epiblast. 
 
1.1.6.2 Induced pluripotent stem cells 
A groundbreaking set of experiments performed by Kazutoshi Takahashi and Shinya 
Yamanaka in 2006 demonstrated that a terminally differentiated cell could be 
reprogrammed to a pluripotent state by means of overexpression of four transcription 
factors: Klf4, Myc, Oct4 and Sox2. The type of cell generated by this method was 
termed induced pluripotent stem (iPS) cell. iPS cells are morphologically 
indistinguishable from ES cells, display a similar gene expression pattern, can 
contribute to chimaeras upon blastocyst injection and can be transmitted to the 
 




germline of the chimaeric embryos (Takahashi & Yamanaka 2006, Okita et al. 2007, 
Wernig et al. 2007). Various combination of transcription factors, signalling 
molecules, small molecules, RNAs have since been used to generate iPS cells from a 
variety of tissues (Anokye-Danso et al. 2011, Aoi et al. 2008, Chen et al. 2011, 
Esteban et al. 2010, Heng et al. 2010, Hou et al. 2013, Ichida et al. 2009, Li et al. 
2011, Miyoshi et al. 2011, Redmer et al. 2011). iPS cells have also been derived 
from human cells (Park et al. 2008, Takahashi et al. 2007), and represent a tool of 
incredible potential both for the study of patient-specific disease phenotypes in 
culture, and for the generation of patient-specific cell types for transplantation. 
Furthermore, they lack the ethical problems associated with embryonic stem cell 
generation, but present problems of their own. The use of transgenesis for induction 
of a pluripotent phenotype using oncogenes such as Myc is a prospect that should be 
avoided if the cells are to be used for transplantation, and it is unclear how derivation 
of iPS cells from different types of tissues may influence the epigenetic and 
karyotypic properties of the cells (Kim et al. 2010, Ohi et al. 2011). Various 
strategies are being developed to overcome these problems, making use of 
technologies such as RNA-based or protein transduction-based reprogramming to 
avoid genomic integration of the reprogramming factors, and of alternative Myc-free 
transcription factor cocktails to reduce the potential for long-term oncogenicity of 
iPS cells (reviewed in Bayart & Cohen-Haguenauer 2013). 
 
1.1.6.3 Human embryonic stem cells 
Human embryonic stem cells were derived in 1998 by plating inner cell masses on 
irradiated fibroblasts in serum-containing medium (Thomson et al. 1998). The 
extracellular signalling molecule requirement of human and mouse ES cells varies 
greatly: LIF signalling does not affect human ES cell self-renewal (Dahéron et al. 
2004, Reubinoff et al. 2000, Thomson et al. 1998), BMP4 promotes trophectodermal 
and endodermal differentiation (Pera et al. 2004, Xu et al. 2002), 
 




Activin/Nodal/TGFβ signals promote pluripotency (James et al. 2005, Vallier et al. 
2005, Xu et al. 2008), as does Fgf (Dvorak et al. 2005, Greber et al. 2007, Greber et 
al. 2010, Xu et al. 2005, Xu et al. 2008, Yu et al. 2011). The growth factor 
requirements of human ES cells thus resemble those of mouse EpiSCs, as does the 
cell morphology, the inability to retain pluripotency in 2i medium, the X 
chromosome inactivation status and the expression of markers of differentiated 
lineages (Hanna et al. 2010, Pera et al. 2004, Silva et al. 2008, Tesar et al. 2007, 
Thomson et al. 2008). Human pluripotent cells reminiscent of mouse ES cells were 
derived by means of reprogramming and culture in 2i+LIF with continuous 
expression of the reprogramming factors (Hanna et al. 2010). Recently, two groups 
identified culture conditions capable of sustaining a mouse ES cell-like naïve 
pluripotent state for human ES cells without the need for transgenesis, using 
combinations of growth factors and small molecule inhibitors. In both cases the 
culture medium contained Fgf2, Tgfβ1, LIF, PD0352901 and a GSK3β inhibitor 
(Chan et al. 2013, Gafni et al. 2013). These discoveries represent a great stepping 
stone for the study and the understanding of pluripotency states and of inter-specific 
differences in pre-implantation development. They also have an important cell 
signalling-specific implication: the simultaneous addition of Fgf2 and the Mek 
inhibitor PD0352901 to the culture media suggests that Fgf signalling exerts a pro-
pluripotency effect through effectors alternative to mitogen-activated protein kinase 
pathway components, an observation compounded by the loss of pluripotency 











1.2 Lineage specification 
1.2.1 Post-implantation development of the mouse 
1.2.1.1 Implantation and egg cylinder formation 
As the inner cell mass of the blastocyst develops and segregates epiblast and 
primitive endoderm, the trophectodermal cells also specialise: the polar 
trophectoderm overlying the ICM remains diploid and proliferative, whereas the 
mural trophectoderm at the abembryonic pole differentiates into non-mitotic 
polyploid giant cells (Kunath et al. 2004, Rossant 2004). As the blastocyst expands, 
trophectodermal cells derived from the polar trophectoderm flow into the non-
proliferative mural regions. The flow occurs in an asymmetrical manner 
preferentially on one side of the blastocyst, and may result in the tilt of the polar 
trophectoderm/epiblast relative to the embryonic/abembryonic axis which can be 
observed around the time of implantation (Copp 1979, Gardner 2000, Gardner & 
Davies 2002, Smith 1980, Smith 1985). 
Upon hatching from the zona pellucida, a membrane which surrounds the pre-
implantation embryo, the blastocysts implants to the uterus through attachment and 
invasion of the uterine wall by the mural trophectoderm (Cross et al. 1994, Kirby et 
al. 1967, Smith 1980, Smith 1985). The polar trophectoderm, the epiblast and the 
primitive endoderm underlying it expand into the blastocoel cavity (Beddington & 
Robertson 1999). Apoptosis is induced in the cells at the centre of the epiblast, which 
leads to the formation of an epithelial monolayer arranged in a hemispheroidal 
conformation (Coucouvanis & Martin 1985). This structure, which arises between 5 
and 5.5 days post fertilisation, is commonly referred to as “egg cup” or “egg 
cylinder”, due to its shape. The region of the epiblast in contact with the derivatives 
of the polar trophectoderm is referred to as proximal, whereas the region furthest 
away from the polar trophectoderm is referred to as distal. The proximal/distal axis 
 




of the epiblast therefore coincides with the embryonic/abembryonic axis of the 
blastocyst (Figure 1.2). 
The polar trophectoderm generates the extraembryonic ectoderm, in contact with the 
epiblast, and the ectoplacental cone, in contact with the uterus (Rossant & Tam 
2009). The ectoplacental cone displays a tilt that coincides with the future 
anterior/posterior embryonic axis, but does not predict the polarity of the axis 
(Gardner et al. 1992, Rossant & Tam 2004, Smith 1985). Smith (1985) suggested 
that the tilt of the polar trophectoderm/epiblast at implantation may coincide with the 
tilt of the ectoplacental cone, and thus with the future anterior/posterior axis, but this 
has not been unequivocally demonstrated (Figure 1.2). 
The primitive endoderm specifies two cell types: the parietal endoderm, that 
underlies the cells of the mural trophectoderm, and the visceral endoderm, which 










Figure 1.2 – Structure of the mouse embryo at E5.5 
Diagrammatic structure of the mouse embryo shortly after implantation. The polar 
trophectoderm gives rise to the ectoplacental cone, in contact with the uterus, and the 
extraembryonic ectoderm, in contact with the epiblast. Giant cells of the mural 
trophectoderm mediate implantation. The epiblast cavitates to form the egg cylinder. 
The primitive endoderm gives rise to the visceral endoderm, underlying the epiblast 
and extraembryonic ectoderm, and to the parietal endoderm, underlying the mural 
trophectoderm. Characteristic markers of these cell types are indicated in the figure. 
The proximal/distal embryonic axis is depicted, as well as the prospective 
anterior/posterior axis, as predicted by the tilt in the ectoplacental cone. 
 
1.2.1.2 Establishment of the anterior/posterior axis 
The formation of the proximal/distal axis represents the first step in the generation of 
anterior and posterior regions of the epiblast. Nodal is initially expressed throughout 
 




the epiblast (Varlet et al. 1997), but the expression of the pro-protein convertases 
Furin and Pace4, responsible for converting the inactive pro-Nodal into the active 
form of Nodal, becomes restricted to the extraembryonic regions (Mesnard et al. 
2006). Furthermore, Nodal induces the transcriptional activity of Smad2 at the distal 
tip of the embryo, and this leads to the expression of the Nodal, BMP and Wnt 
inhibitors Cer1, Dkk1 and Lefty1 (Cer1 inhibits Nodal and BMP signalling, Dkk1 
inhibits Wnt signalling and Lefty1 inhibits Nodal signalling). The expression of these 
factors, regulated in space by Smad2 activity and by the absence of BMP-induced 
Smad1 activity (which is antagonistic to Smad2 activity), specifies the distal visceral 
endoderm (DVE) (Arnold & Robertson 2009, Belo et al. 2000, Brennan et al. 2001, 
Chen & Shen 2004, Perea-Gomez et al. 2002, Rodriguez et al. 2005, Soares et al. 
2008, Waldrip et al. 1998, Wu et al. 2000, Yamamoto et al. 2009). 
DVE cells migrate proximally and establish the anterior side of the epiblast. It 
appears that Cer1 and Lefty1 are asymmetrically expressed and dictate the direction 
of DVE migration (Yamamoto et al. 2004), but it is unclear whether this asymmetric 
expression may be induced by localised repressive signals at the prospective 
proximal posterior side of the embryo, such as Wnt3 (induced by BMP4), or whether 
the inhibition of Nodal, BMP and Wnt signals by Cer1, Dkk1 and Lefty1 are 
responsible for the localised expression of the DVE-repressive signals (Arnold & 
Robertson 2009, Kimura-Yoshida et al. 2005, Rivea-Pérez & Magnuson 2005, Tam 
& Loebel 2007). 
It was long believed that the anterior migration of the DVE lead to its repositioning 
at the prospective embryonic anterior and the formation of the anterior visceral 
endoderm (AVE) signalling centre, responsible for continued inhibition of BMP, 
Nodal and Wnt. However, live imaging and clonal analysis revealed that as the DVE 
migrates anteriorly, it is replaced at the distal tip by a new set of cells that start 
expressing Cer1 and Lefty1 after E5.5. These cells follow the DVE in its migration 
and at E6.5 they localise to the anterior of the embryo, where they form the AVE, 
 




while the cells that formed the DVE localise at the proximal anterior and lateral 
regions of the embryo (Takaoka et al. 2011). 
 
1.2.1.3 Gastrulation 
The most important time in the life of the embryo is initiated upon formation of the 
primitive streak (sometimes referred to as streak for brevity). This structure arises in 
the epiblast at the embryonic/abembryonic boundary and unequivocally defines the 
posterior of the embryo. It is an elongated region of epiblast characterised by a 
furrow through which cells migrate as they lose epithelial identity. The exit from the 
epiblast and migration through the primitive streak gives rise to mesoderm and 
endoderm, whilst cells that fail to migrate through the streak will generate 
ectodermal derivatives (Beddington & Robertson 1999, Nowotschin & 
Hadjantonakis 2010). 
The induction of the primitive streak is dependent upon BMP4, Nodal and Wnt3, 
which reinforce each other’s expression in a positive regulatory loop (Ben-Haim et 
al. 2006, Brennan et al. 2001, Conlon et al. 1994, Huelsken et al. 2000, Liu et al. 
1999, Mishina et al. 1995, Tam & Loebel 2007, Winnier et al. 1995). Wnt3 
transcripts are detectable on one side of the proximal epiblast at E5.5 prior to streak 
formation, which is consistent with the inductive role of Wnt3 in streak 
determination (Liu et al. 1999, Rivea-Pérez & Magnuson 2005). The combination of 
BMP4, Nodal and Wnt signalling induce the expression of transcriptional 
determinants of the primitive streak identity, such as Eomes and T. 
T (Brachyury) is a transcription factor essential for gastrulation that is expressed 
throughout the primitive streak (Beddington et al. 1992, Inman & Downs 2006, 
Wilkinson et al. 1990, Willison 1990, Wilson & Beddington 1997, Wilson et al. 
1995). It is a target of Wnt signalling, and amongst its reported targets are Fgf and 
Wnt signalling components. It is thus likely that it is crucial in the stabilisation of the 
 




primitive streak signalling environment (Casey et al. 1998, Evans et al. 2012, Tada 
& Smith 2000, Yamaguchi et al. 1999). 
Eomes (Eomesodermin) is a transcription factor expressed in extraembryonic 
ectoderm throughout early pre-implantation development, and in the proximal 
posterior epiblast at the time of primitive streak specification (Ciruna & Rossant 
1999). It is required for the correct specification of the primitive streak and cell 
migration through it; Eomes-null cells fail to downregulate the epithelial marker E-
cadherin and are thus incapable of delaminating from the epiblast through the 
primitive streak (Arnold et al. 2008, Russ et al. 2000). 
Migration through the primitive streak is achieved by means of an epithelial-to-
mesenchymal transition (EMT). Cells in the epiblast, an E-cadherin-expressing 
epithelium, activate the expression of Snail, a transcription factor responsible for 
promoting the acquisition of mesenchymal migratory characteristics through the 
repression of Cdh1 expression and consequent loosening of cell-cell adhesions. Snail 
expression and EMT are dependent on the activity of Fgf8, which is expressed in the 
proximal posterior regions of the embryo and in the primitive streak (Carver et al. 
2001, Ciruna & Rossant 2001, Crossley & Martin 1995, Mahmood et al. 1995, Sun 
et al. 1999). 
As development progresses, the primitive streak elongates distally and reaches the 
distal tip of the embryo. Cells juxtaposed anteriorly to the primitive streak form a 
structure knows as the node, the mouse equivalent of Spemann’s organiser in 
Xenopus and Hensen’s node in the chick, which acts as a source of Nodal (Arnold & 
Robertson 2009, Beddington & Robertson 1999). The primitive streak is subject to a 
gradient of BMP4 from proximal to distal regions, a gradient of Nodal from distal to 
proximal regions, and Fgf8 expression throughout its length. The varying stimulation 
from these molecules and Wnt’s drives the specification of different mesodermal 
subtypes in cells that migrate at different positions along the streak. From proximal 
to distal, these are: extraembryonic mesoderm, lateral plate mesoderm, paraxial 
 




mesoderm, axial mesoderm. The cardiac mesoderm is specified at a similar level of 
the primitive streak to paraxial and lateral plate mesoderm, but migrates before these 
other subtypes. The cells that migrate through the anterior-most region of the 
primitive streak give rise to definitive endoderm, which intercalates and displaces the 
visceral endoderm. Not all visceral endoderm is displaced, as some has been 
suggested to contribute to the endodermal tissues of the embryo proper. High BMP 
signalling in the proximal regions of the embryo also gives rise to primordial germ 
cells (Arnold & Robertson 2009, Kinder et al. 1999, Kwon et al. 2008, Lawson 
1999, Lawson et al. 1999, Smith et al. 1994, Robb & Tam 2004, Tam & Loebel 
2007). 
As the embryo continues its expansion and somitogenesis is initiated, the node and 
the primitive streak become localised to the posterior-most regions of the embryo, 
extending the node-derived notochord in the process, and supplying mesodermal and 
endodermal cells to the extending caudal regions. The primitive streak is eventually 
referred to as the tail bud from E9.0-E9.5 (Arnold & Robertson 2009, Cambray & 
Wilson 2002, Ramkumar & Anderson 2011, Wilson & Beddington 1996). 
Intriguingly, it appears that the tail bud harbours a progenitor cell type capable of 
contributing to both mesoderm and neural lineages (Tzouanacou et al. 2009). 
 
1.2.1.4 Neural specification 
The induction of a neural fate in the anterior epiblast is achieved via AVE-mediated 
repression of BMP signals. BMP was identified as a repressor of neural fate in 
Xenopus laevis animal cap explants, which differentiate into the neural lineage when 
dissociated and cultured in the absence of signalling factors (Grunz & Tacke 1989, 
Wilson & Hemmati-Brivanlou 1995). This led to the formulation of a widely debated 
and disagreed upon hypothesis: the default model of neural specification. According 
to the hypothesis, in the absence of instructive or repressive signals, unspecified 
 




ectodermal cells will give rise to neural ectoderm. Support for the model is drawn by 
animal cap dissociation experiments in Xenopus and early experiments in axolotl, 
whereas criticism of the model stems primarily from work carried out in the chick 
embryo, which suggests a key role for Fgf signalling and an insufficient role for 
BMP inhibition in neural induction (De Robertis & Kuroda 2004, Hemmati-
Brivanlou & Melton 1997, Muñoz-Sanjuán & Brivanlou 2002, Stern 2006, Streit et 
al. 1998, Streit et al. 2000). In vitro experiments on differentiating mouse embryonic 
stem cells do not ultimately resolve this issue (Kunath et al. 2007, Stavridis et al. 
2007, Ying et al. 2003b, see Section 1.2.2 for a detailed discussion of in vitro data). 
Mouse is not as amenable a model organism for the study of lineage specification as 
the frog and the chick, and thus there are fewer data available which may shed light 
on this topic. What is certain is the involvement of BMP repression in neural 
induction. Mice lacking the Bmpr1 gene display premature induction of neural 
markers, not only anteriorly, but throughout the epiblast, and fail to upregulate 
markers of the primitive streak. Furthermore, the inhibition of Fgf signalling between 
E5.5 and E7.5 appears to promote the expression of the neural marker Hesx1 in 
cultured embryos, suggesting Fgf is not required, but rather plays a negative role on 
neural induction at the egg cylinder stage (Di-Gregorio et al. 2007). 
Further evidence implicates BMP signalling in the repression of neural fate in vivo. 
A similar set of experiments to those performed by Wilson & Hemmati-Brivanlou 
(1995) was recently carried out for mouse epiblasts. Explants of anterior and 
posterior epiblasts at E6.5, followed by 5 days of culture in serum-free N2B27 
medium in the presence or absence of BMP4, revealed that the untreated explants 
generated neural tissue, whereas the BMP4-treated explants gave rise to surface 
ectoderm, mesoderm and endoderm. At E7.0, untreated explants generated neural 
ectoderm, with posterior explants expressing lower levels of neural markers than 
anterior explants; BMP4 treatment of anterior explants gave rise to surface ectoderm 
and BMP4 treatment of posterior explants generated mesoderm and endoderm. At 
E7.5 BMP4 no longer inhibited neural marker expression in anterior explants, but it 
 




was capable of inducing mesodermal and endododermal markers in posterior 
explants (Li et al. 2013). These data have a number of implications: the neural 
differentiation of untreated explants in unsupplemented medium mimics the 
behaviour of Xenopus animal cap explants, and provides support for the default 
model; the anti-neural effect of BMP4 directly implicates it in the repression of 
neural induction until the stage at which cells have committed to the neural lineage 
(E7.5); the differential behaviour of explants following BMP4 treatment suggests 
that regional and temporal differences within the embryo affect the response of 
epiblast cells to BMP4. 
Whilst these observations lend support to the default model, it is impossible to 
ascertain whether instructive signals which may be necessary for neural induction, 
other than Fgf, are expressed in the Bmpr1 mutants or in the embryo explant cultures. 
One such signal may be represented by Igf (insulin-like growth factor), which is a 
neural inducer in Xenopus, and is expressed in gastrulation-stage embryos (Lee et al. 
1990, Pera et al. 2001, Pera et al. 2003, Telford et al. 1990). The N2B27 culture 
medium widely adopted for ES cell and EpiSC differentiation, and used by Li et al. 
(2013) for their explants cultures, contains insulin (Ying et al. 2003b). 
Nodal is also involved in the repression of neural fates, as demonstrated by the 
expansion of neural domains in Nodal-null embryos (Camus et al. 2006). Nodal 
expression is absent from Bmpr1-null embryos (Di-Gregorio et al. 2007), as may be 
expected due to the disruption of the positive regulatory loop involving Nodal, BMP 
and Wnt signals (see section 1.2.1.3). This may also suggest a requirement for low or 
absent Nodal signalling for neural induction. In keeping with this hypothesis, whilst 
the knockout of either of the Nodal antagonists Cer1 or Lefty1 does not result in a 
disruption in development, the knockout of both factors can lead to an anterior 
expansion of the domain of expression of primitive streak determinants (as well as 
the generation of multiple primitive streaks in a subset of mutants), and this 
 




phenotype can be partially rescued upon deletion of one Nodal allele (Perea-Gomez 
et al. 2002). 
 
1.2.2 Embryonic stem cell differentiation as a model for lineage specification 
The study of differentiating embryonic stem cells represents an extremely convenient 
experimental tool for the analysis of the molecular events that accompany lineage 
specification, for the reasons described in paragraph 1.1.3.3. Their usefulness, 
however, depends on their capability to replicate the exact molecular decisions that 
occur in vivo, and do so in an appropriate timescale. 
Ever since their isolation, it has been known that suspension culture of ES cells 
results in the formation of cystic embryoid bodies (EBs), hollow spherical cell 
aggregates containing cells from different germ layers (Doetschman et al. 1985, 
Martin 1981). In particular, the outside of the EBs is lined by endoderm, and the 
inside cells contain variable mixtures of mesoderm and ectoderm depending on the 
specific culture conditions. This structure is reminiscent of the endoderm lining the 
ectoderm and mesoderm in the post-implantation embryo and suggests that 
differentiating ES cells are capable of three-dimensional self-organisation. 
Furthermore, the sequence of gene activation over the timescale of differentiation 
experiments is the same as that seen in vivo, which implies that EB differentiation is 
a developmentally relevant ES cell differentiation system (Keller 2005). EBs present 
disadvantages however: they contain a mixture of different cell types, making the  
specification of one cell type impossible to study in isolation; they are three-
dimensional, making them less practical than two-dimensional cultures for imaging 
purposes; they are cultured in suspension, which is troublesome for live imaging. 
The differentiation of ES cells in adherent monolayers offers the solution to all of 
these problems. The culture of ES cells on feeder cells has been used to induce 
specification of different lineages (Kawasaki et al. 2000, Nakano et al. 1994), 
 




presumably due to the factors secreted by the different types of feeder cells used in 
the various protocols. This present a problem in itself, since it does not allow for the 
assessment of ES cell behaviour in a chemically defined context. This in turn means 
that drawing conclusions on the effects of soluble molecules of interest in the 
differentiation process is an imprecise process, as the molecules themselves or their 
inhibitors may already be secreted by the feeder layer. 
ES cells can however be differentiated on extracellular matrix in feeder-free culture 
(Coraux et al. 2003, Nishikawa et al. 1998). A widely adopted medium for ES cell 
differentiation was devised in 2003 by Smith and colleagues by combining N2 and 
B27-supplemented basal media, which had previously been used for serum-free 
culture of neural cells. They named the new culture medium N2B27 (Bottenstein & 
Sato 1979, Brewster et al. 1993, Ying et al. 2003a, Ying et al. 2003b). This medium 
was devised to support cell survival and proliferation without providing lineage-
specifying signals, although, as discussed in paragraph 1.2.1.4, it contains insulin, a 
protein related to Igf, which can promote neural fates in Xenopus. 
Culture of ES cells as an adherent monolayer plated on gelatine in N2B27 medium 
results in their conversion to the neural lineage (Pollard et al. 2006, Ying et al. 
2003a, Ying et al. 2003b). This suggests that in the absence of exogenous factors ES 
cells will specify neural ectoderm, thus providing apparent support to the default 
model of neural specification in the mouse. However, as discussed in paragraph 
1.1.4.4, ES cells secrete Fgf4, and Fgf activity is required during the early stages of 
neural induction, presumably to specify a post-implantation epiblast-like gene 
expression pattern (Burdon et al. 1999b, Kunath et al. 2007, Ma et al. 1992, Stavridis 
et al. 2007, Sterneckert et al. 2010). Consequently, whilst lack of exogenous signals 
will result in “default” neural specification, paracrine signalling appears to be 
essential in the first step of neural induction from ES cells, namely the exit from 
naïve pluripotency, as also noted by Smith and colleagues in the formulation of their 
“ground state” of ES cell self-renewal hypothesis (Ying et al. 2008). Importantly, ES 
cells differentiating in N2B27 appear to progress through the molecular transitions 
 




that occur in vivo, with initial expression of transcripts characteristic of pluripotent 
post-implantation epiblast followed by conversion to a neural ectoderm gene 
expression pattern, suggesting that N2B27 culture represents a developmentally 
relevant in vitro differentiation system (Aiba et al. 2006, Aiba et al. 2009, 
Sterneckert et al. 2010, Trott & Martinez Arias 2013). Furthermore, adherent 
monolayer differentiation of ES cells in N2B27 medium supplemented with specific 
molecules also allows to generate mesodermal, endodermal and epithelial cell types 
(Hansson et al. 2009, Malaguti et al. 2013, Ying et al. 2003a. The experiments 
carried out in Malaguti et al. 2013 were performed by Dr. Sally Lowell), and 
supplementation of the medium with factors that promote pluripotency allows for 
long-term maintenance of ES cells and EpiSCs (Brons et al. 2007, ten Berge et al. 
2011, Tesar et al. 2007, Wray et al. 2009, Ying et al. 2003a, Ying et al. 2008). This 
culture system is therefore an appropriate, powerful and convenient tool for the study 














1.3 The biology of Id1 
1.3.1 The helix-loop-helix family of transcriptional regulators 
1.3.1.1 Protein domains of basic helix-loop-helix factors 
The basic helix-loop-helix (bHLH) protein family was characterised as a set of 
transcriptional regulators sharing a structurally similar protein domain comprising a 
basic region adjacent to two α-helices separated by a loop region (Ellenberger et al. 
1994, Ferré-D’Amaré et al. 1993, Murre et al. 1989a, Villares & Cabrera 1987). This 
family is found in a variety of eukaryotic organisms, ranging from the yeast 
Saccharomyces cerevisiae to humans, and in the mouse it comprises over 100 genes, 
which are involved in a multiplicity of biological processes (Massari & Murre 2000, 
Skinner et al. 2010). There have been various phylogenetic classifications of bHLH 
proteins, based on sequence analysis, DNA binding properties, function and tissue 
specificity, and the proteins have been subdivided into 5, 6 or 7 subfamilies (Atchley 
& Fitch 1997, Ledent et al. 2002, Massari & Murre 2000, Stevens et al. 2008, 
Skinner et al. 2010). Some bHLH proteins contain domains shared with members of 
their subfamily: a leucine zipper DNA binding domain (shared by factors such as 
Myc, Max and Mxd1), a PAS dimerisation motif (shared by factors such as Ahr, 
Hif1a, Sim1), an Orange protein interaction domain (shared by factors such as Hes 
proteins, Hey proteins and Stra13), a WRPW motif involved in the repression of 
transcription (present in Hes proteins) (Blackwood & Eisenman 1991, Dawson et al. 
1995, Hooker & Hurlin 2006, Huang et al. 1993, Kewley et al. 2004, Prendergast et 
al. 1991, Sun et al. 2007). 
 
1.3.1.2 Interaction of bHLH dimers with DNA 
bHLH transcription factors contact DNA as dimers. The HLH domain mediates 
protein dimerisation, whereas the basic region is responsible for contacting the DNA 
 




at specific recognition sequences termed E-boxes, of sequence CANNTG (Figure 
1.3). Specific E-box sequences can be recognised by particular subsets of bHLH 
proteins, providing high target specificity for bHLH homo- or heterodimers 
(Ellenberger et al. 1994, Ephrussi et al. 1985, Jones 2004, Ruzinova & Benezra 
2003). In classical models of bHLH activity, tissue-specific bHLH factors 
heterodimerise with the ubiquitously expressed E proteins in order to contact the 
DNA (Murre et al. 1989b, Norton 2000). E proteins comprise E12, E47 (splice 
variants of the gene Tcf3, also referred to as E2A), E2-2 (encoded by Tcf4) and HEB 
(encoded by Tcf12) (Massari & Murre 2000). 
 
1.3.2 Id1: discovery and interactors 
1.3.2.1 Identification of Id proteins 
Id1 was identified in a screen for nucleotide sequences homologous to those 
encoding the second α-helix of the bHLH factors Myc, Myod and Myog. Weintraub 
and colleagues noticed that whilst the factor contained a helix-loop-helix domain, it 
lacked the basic region adjacent to it. They proposed that the protein may act as a 
dominant-negative heterodimerisation partner, and confirmed this hypothesis by 
demonstrating it could interact with E12, E47 and Myod, and inhibit their association 
with DNA. They therefore termed the protein Id, for “Inhibitor of DNA binding” 
(Benezra et al. 1990). 
Three more Id proteins have been discovered in the mouse: Id2, Id3 and Id4 (Christy 
et al. 1991, Riechmann et al. 1994, Sun et al. 1991). 
 
 





Figure 1.3 – Structure of a basic helix-loop-helix dimer in contact with DNA 
Crystal structure of the bHLH regions of a heterodimer of E47 (in cyan and blue) and 
Neurod1 (in purple and red) in contact with DNA (in pink and dark red). Three 
alternative views are shown; the orientation of arbitrary x, y and z axes is depicted to 
clarify the position of each view with respect to the others. 
The basic region of helix 1 (in red for Neurod1 and in blue for E47) contacts the 
major groove of DNA, with a glutamate and its neighbouring arginine residue 
recognising the cytosine and adenine nucleotides of the E-box. The remainder of 
helix 1, the loop and helix 2 (in purple for Neurod1 and in cyan for E47) mediate the 
dimerisation of the two proteins (Ellenberger et al. 1994, Longo et al. 2008). The 
image was generated using the Jmol Protein Explorer software with the crystal 
structure generated by Longo et al. (2008) (Protein Data Bank accession code: 











1.3.2.2 Id1 protein properties 
Id1 is encoded by a small locus containing 1160 nucleotides of exonic DNA. The 
locus encodes two splice isoforms, which encode proteins of 148 (Id1-001) and 168 
(Id1-002) amino acids, 41 of which constitute the HLH domain (Benezra et al. 1990, 
Hernandez et al. 1996, see Figure 3.1 for a diagrammatic view of the locus). The 
HLH domain of Id1 was shown to be necessary and almost sufficient for the 
repression of the DNA binding activity of E2A and Myod (Pesce & Benezra 1993). 
The remainder of the proteins contains no conserved protein domains but was found 
to contain a nuclear export signal (NES) and a nuclear localisation signal (NLS) 
(Makita et al. 2006, Trausch-Azar et al. 2004). Id1 is approximately 15kDa in size, 
and thus is able to freely diffuse through the nuclear pore (Mattaj & Englmeier 
1998). It is therefore likely that the intracellular localisation of Id1 is tightly 
regulated and of importance for its activity. Id1 can also be imported into the nucleus 
in complex with E12 and E47, and can mediate nuclear import of NLS-deficient E12 
and E47 proteins (Deed et al. 1996, Lingbeck et al. 2005). Co-transfection of Id1 
with E12 or E47 in HeLa cells increases the half-life of the protein from 0.9 hours 
(transfection of Id1 alone) to 10.3 hours (Id1+E12) or 9.5 hours (Id1+E47), 
suggesting E proteins can protect Id1 from the proteasome, which mediates its 
degradation (Bounpheng et al. 1999, Lingbeck et al. 2005). 
Id1 can be subject to post-translational modification. It has been shown to be 
phosphorylated in vitro by protein kinase A and protein kinase C. Id1 
phosphorylation did not impair its ability to inhibit the DNA binding of E47 (Nagata 
et al. 1995). 
 
1.3.2.3 Regulation of bHLH transcriptional activity  
Despite the ability of its HLH domain to mediate dimerisation, Id1 appears to be 
unable to homodimerise (Sun et al. 1991). It has been proposed this is the result of 
 




repulsion between the positively-charged arginine 68 residue on one Id1 monomer 
and arginine 96 on a second monomer, which would find themselves in close 
proximity in a homodimer (Wibley et al. 1996). Id2 shares its inability to 
homodimerise, whereas Id3 is capable of doing so (Sun et al. 1991, Wibley et al. 
1996). Id1 can interact with tissue-specific bHLH factors such as Myod, but appears 
to do so with low efficiency, whereas it has high propensity for interaction with E 
proteins (Benezra et al. 1990, Sun et al. 1991). It therefore appears that Id1 inhibits 
DNA binding primarily by sequestering E proteins and preventing their homo- or 
hetero-dimerisation with tissue-specific bHLH factors. A yeast two-hybrid screen 
performed in our laboratory to identify Id1 interactors in mouse ES cells identified 
E12 and E47 exclusively, providing support to this model of Id1 action (Davies et al. 
2013). bHLH factors that preferentially dimerise with factors other than E proteins, 
and that have weak affinity for Id’s, such as Myc (Loveys et al. 1996, Murre et al. 
1989b), would therefore be able to escape Id-mediated transcriptional regulation. 
Id proteins preferentially interact with specific E proteins: Id1 has a similar 
propensity for interaction with E12, E47 and E2-2 but lower propensity for 
interaction with HEB, Id2 favours interactions with E47 over the other factors, 
whereas Id3 displays reduced differences in its interaction preferences (Langlands et 
al. 1997). These results are supported by the observations that neonatal lethality in 














 mice (Barndt & Zhuang 1999, 
Yan et al. 1997). 
 
1.3.2.4 Interactions with non-bHLH proteins 
Id1 has been found to interact with proteins that lack a helix-loop-helix domain. It 
can interact with Psmd4, a component of the proteasome (also referred to as S5a). 
 




Psmd4 interacts with Id1 in a region N-terminal to the HLH domain and prevents Id1 
from heterodimerising with bHLH factors. It also diminishes its half-life (Anand et 
al. 1997). Id1 can interact with Pax2, Pax5 and Pax8, and inhibit their DNA binding 
and transcriptional activity. These proteins regulate the development of B-cells and 
kidney, so their inhibition by Id1 may play a role in the specification of these cell 
types (Roberts et al. 2001). Id1 can also interact with Ets family transcription factors. 
This protein family comprises many members involved in many biological processes, 
and it includes Fgf signalling mediators (Jedlicka & Gutierrez-Hartmann 2008). Id1 
has been shown to interact with Elk1 and Ets2 and to repress their transcriptional 
activity (Ohtani et al. 2001, Yates et al. 1999). Transcriptional activation of Cdkn2a 
(often referred to as INK4a or p16-INK4a) by Ets2 promotes cellular senescence, and 
Id1 can inhibit this process (Ohtani et al. 2001). Id1 can also interact and inhibit the 
activity of another factor involved in the activation of Cdkn2a, Dnajc2 (also referred 
to as MIDA1 and ZRF1) (Ribeiro et al. 2013, Shoji et al. 1995). The involvement of 
Id1 in the repression of Cdkn2a transcription through alternative pathways suggests 
the HLH factor may be crucial for the inhibition of premature cellular senescence. 
Other Id proteins interact with cell cycle components. Human ID2 can directly 
interact with the cell cycle regulator and tumour suppressor RB, and human ID2 and 
ID3 are phosphorylated by CDK2 (Deed et al. 1997, Iavarone et al. 1994). Human 
ID1 is not phosphorylated by CDK2 nor by CDK4 and does not interact with RB 
(Deed et al. 1997, Hara et al. 1996), suggesting that it might not be regulated by cell-
cycle components. 
 
1.3.2.5 Regulation of Id1 expression 
As discussed in paragraphs 1.1.4.2 and 1.1.4.3, Id1 is a positive target of BMP 
signalling and a negative target of Activin/Nodal/TGFβ signalling (Galvin et al. 
2010, Hollnagel et al. 1999, Katagiri et al. 2002, Korchynskyi & ten Dijke 2002, 
 




López-Rovira et al. 2002, Ogata et al. 1993). BMP activation of Smad1 and Smad5 
results in their interaction with Smad4 and direct binding of the Id1 promoter at two 
Smad Binding Elements and a GC-rich region, resulting in the induction of Id1 
transcription (Katagiri et al. 2002, Korchynskyi & ten Dijke 2002). Nanog can bind 
to Smad1 and repress the transcriptional activation of Id1 (Suzuki et al. 2006), and 
Id1 message is enriched in cells expressing low levels of a Nanog-GFP reporter 
(Galvin et al. 2010). 
In addition to the potential mechanisms for Activin/Nodal-mediated inhibition of 
BMP signalling described in paragraph 1.1.4.3, SMAD3, but not SMAD2, can 
directly bind the ID1 promoter in human cell lines in a region overlapping that bound 
by SMAD1. The repression of ID1 transcription is dependent on the interaction of 
SMAD3 with ATF3 (Kang et al. 2003). The interaction of both Smad2 and Smad3 
with the Id1 locus has been observed in mouse ES cells (Lee et al. 2011). 
Interestingly, TGFβ signalling can induce the expression of ID1 in human breast 
cancer cells, suggesting that SMAD3 may interact with cell-type specific factors 
promoting transcriptional activation of ID1 (Padua et al. 2008, Stankic et al. 2013). 
Id1 transcription is induced by serum as well as BMP4 (Barone et al. 1994, Benezra 
et al. 1990, Ying et al. 2003a). This induction was shown to be carried out by a 
protein complex including the zinc-finger protein Egr1, and an Egr1 binding site was 
identified on the Id1 promoter (Tournay & Benezra 1996). A recent publication has 
shown that Id1 induction in response to serum is dependent on active BMP 
signalling, Smad4 expression and a BMP response element on the Id1 promoter 
(Lewis & Prywes 2013). This suggests that Egr1 may be in complex with Smad 
proteins during the serum-induced activation of Id1 transcription. 
The Id1 promoter also contains a binding site for C/EBPβ, which drives Id1 
expression in pro-B-cells (Saisanit & Sun 1995, Saisanit & Sun 1997). 
 
 




1.3.3 The expression and function of Id1 in development 
1.3.3.1 Expression of Id genes in early development 
The expression of Id factors in pre-implantation development has not been assessed 
by means of in situ hybridisation or immunohistochemistry. The data available were 
generated in a single-cell quantitative real-time (qRT) PCR experiment on individual 
cells taken from the E3.5 and E4.5 inner cell masses and on single ES cells. Id1 was 
detected in 6 out of 14 cells from the E3.5 ICM, in 6 out of 10 cells from the E4.5 
ICM and in 10 out of 14 ES cells. In the E4.5 ICM, it is expressed in 3 out of 4 cells 
co-expressing Gata4 and Gata6, and in 3 out of 6 cells expressing Nanog, suggesting 
it is expressed both in the primitive endoderm and in the epiblast, although firm 
conclusions cannot be drawn from the analysis of so few cells (Tang et al. 2010). 
Phosphorylated Smad1 is heterogeneously distributed in the blastocyst, in line with 
this expression pattern for Id1 (James et al. 2005). Id2 was not detected at E3.5, and 
detected in 1 cell (expressing Gata4 and Gata6) at E4.5. It displays heterogeneous 
expression in ES cells. Id3 is expressed at similar levels in all cells of the E3.5 ICM, 
and is expressed in 8 out of 10 cells at E4.5. Its expression pattern in ES cells is more 
heterogeneous. Id4 was only detected in one E4.5 cell (expressing Nanog), and in 1 
ES cell (Tang et al. 2010). 
The data available for pre-gastrula and gastrula-stage embryos were generated in 
1992 and 1997 by in situ hybridisation of radioactively labelled probes (Jen et al. 
1997, Wang et al. 1992). The images are at low resolution, and it is somewhat hard 
to specifically identify which tissues have been hybridised and whether the 
hybridisation signal is above background levels. A recent publication has 
investigated the expression pattern of Id1 and Id2 at E6.5, E7.0 and E7.5, helping to 
shed some light on the expression pattern of these two genes (Li et al. 2013). 
At E5.5, Id1 is expressed in the proximal regions of the embryo and in the 
extraembryonic endoderm. It is unclear whether Id1 expression is detected in the 
epiblast or in the underlying visceral endoderm and overlying extraembryonic 
 




ectoderm. At E6.5 the expression pattern remains virtually identical. At E7.5 it is still 
expressed proximally, and is also detected in the allantois and in the chorion (Jen et 
al. 1997, Wang et al. 1992). The data by Li et al. (2013) show that at E6.5 Id1 
appears to be expressed both in the visceral endoderm and in the epiblast, but it is 
unclear whether this expression also extends to the extraembryonic ectoderm. At the 
early bud stage (using the embryo staging guidelines of Downs & Davies 1993) the 
expression of Id1 remains proximal and extends to the allantoic bud. At the headfold 
stage, Id1 is expressed in the cardiac crescent, in lateral mesoderm and in the 
chorion. 
At E6.5, Id2 is expressed in the extraembryonic ectoderm. At E7.5, it is expressed in 
the chorion. It is unclear whether it is also expressed in the epiblast (Jen et al. 1997). 
The data by Li et al. (2013) confirm the expression of Id2 in the extraembryonic 
ectoderm at E6.5. At the late bud stage, Id2 is expressed strongly in the chorion, but 
it also displays weaker expression in the proximal regions of the embryo. At the 
headfold stage, Id2 is expressed in the chorion and in the cardiac crescent. It can also 
be detected in the posterior of the embryo, but the published image does not clarify 
whether it is expressed along the primitive streak or whether the signal results from 
probe trapping. 
The in situ hybridisation images for Id3 and Id4 are too unclear to draw firm 
conclusions upon. The authors suggest Id3 is expressed throughout the epiblast and 
Id4 is not expressed (Jen et al. 1997). 
All four Id genes can be detected at later stages in a variety of cell types and tissues, 
derived from all three germ layers. The expression pattern of the genes is not 
identical, suggesting that their expression is differentially regulated, and that they 
may be involved in the regulation of different developmental processes. Id1 and Id3 
display the most overlapping expression patterns, whereas Id4 is primarily expressed 
in the neural lineage (Ellmeier & Weith 1995, Jen et al. 1996, Jen et al. 1997, Wang 
et al. 1992). 
 




1.3.3.2 Knockout of Id genes in vivo 
The knockout of Id1 has no effect on the viability of mice and results in no obvious 
phenotypic defect (Yan et al. 1997). Id2-null mice are indistinguishable from their 
littermates at birth, but a quarter of pups dies neonatally. The surviving mice exhibit 
retarded growth, lack lymph nodes and Peyer’s patches, and have a reduced number 
of natural killer cells (Yokota et al. 1999). Pregnant females also display defects in 
their mammary glands and are unable to lactate (Mori et al. 2000). The knockout of 
Id3 does not affect the viability of mice. Id3
-/-





 thymocytes, lower amounts of IgG1 and IgG2a in serum and lower B-cell 
proliferation than wild-type mice in response to treatment with an anti-mouse IgM 
antibody. The B-cell proliferation defect can be rescued by B-cell-specific 
overexpression of Id1 in Id3
-/-
 mice (Pan et al. 1999). Only 50% of Id4-null embryos 
survive until birth, and only 20% survive until aldulthood. The mutants display 
smaller brain sizes apparent from E11.5 due to premature terminal differentiation of 
progenitor cells (Bedford et al. 2005, Yun et al. 2004). 
Compound mutants for more than one Id gene have also been generated. Because of 
their overlapping expression pattern and of the ability of Id1 to rescue some of the 




 embryos were generated. The 
embryos exhibited angiogenic defects and smaller brain sizes from E10.5 and 
invariably died at E13.5, presumably because of cranial haemorrhaging from E12.5. 
A single intact allele of either Id1 or Id3 is sufficient for seemingly normal 
development and postnatal survival (Lyden et al. 1999). Knockout of any 4 out of 6 







, in which only one of the three genes is knocked out on both 
alleles. Lethality was due to defects in cardiogenesis from as early as E9.5. The 




 embryos appear to be due to impaired Igf1 and Wnt5a 










pups. This study did not report on whether any defects were observed in other tissues 
(Fraidenraich et al. 2004). 
 
1.3.3.3 Knockout of Id1 in ES cells 
The phenotype of Id1-null ES cells has also been investigated. These cells express 
lower levels of Nanog and Rex1 and higher levels of T. They have a reduced 
clonogenic potential, possibly as a result of the lower levels of Nanog. It is unclear 
whether Id1 has a direct effect on T expression, or whether the cells are simply 
adopting a gene expression pattern more similar to that of epiblast stem cells. 
Analysis of the microarray data comparing Id1
-/-
 ES cells to wild-type ES cells 
confirms that other post-implantation epiblast markers, such as Fgf5 and Otx2, are 
upregulated in the knockout cells (Romero-Lanman et al. 2011). 
 
1.3.3.4 Helix-loop-helix networks 
The development of many tissue types relies on a correct balance between the self-
renewal of stem and progenitor cells and the differentiation of these cells into the 
specific cell types required for the development and the homeostasis of the tissue in 
question. A commonly adopted mechanism for achieving this balance is the 
establishment of a cross-regulatory network of helix-loop-helix factors. This type of 
network is involved in a variety of developmental events, including myogenesis and 
neurogenesis (Massari & Murre 2000). I shall describe how an HLH network 
regulates neurogenesis in order to present the mechanisms underlying this type of 
transcriptional network. 
The undifferentiated status of neural stem cells and neural progenitor cells is 
maintained by two families that negatively regulate bHLH factor transcription: the Id 
protein family and the Hes protein family. 
 




As previously discussed, Id proteins inhibit the DNA binding and transcriptional 
activity of E proteins and of their heterodimerisation partners, which can induce cell 
differentiation. Id proteins play a crucial role in the maintenance of neural stem and 
progenitor cell multipotency, as exemplified by the reduced brain size and premature 




 embryos and in Id4
-/-
 embryos (Bedford et al. 
2005, Lyden et al. 1999, Yun et al. 2004). 
Hes proteins derive their name from their homology to the hairy and enhancer of 
split genes of Drosophila melanogaster. They are bHLH factors which also contain 
an Orange protein interaction domain and a WRPW C-terminal motif. They can 
achieve transcriptional repression in a number of ways: they can prevent DNA 
binding by E47 in a manner reminiscent of Id proteins; they can bind target DNA 
sequences (E-boxes or N-boxes for some Hes family members) and repress the 
transcription of pro-differentiation bHLH factors such as Ascl1 (also known as 
Mash1) through interaction with TLE corepressor factors; they can interact with pro-
differentiation factors already bound to DNA and inactivate transcription through 
association with TLE’s (Chen et al. 1997a, Dai et al. 2010, Giagtzoglou et al. 2003, 
Ross et al. 2003, Sasai et al. 1992). Furthermore, Hes family members can cross-
repress each other’s activity, and Hes factors can directly bind Id proteins (Bai et al. 
2007, Jhas et al. 2006, Jögi et al. 2002). Many Hes family members are Notch target 
genes, and can thus integrate cell-cell signalling with transcriptional activity 
(Ohtsuka et al. 1999, Sun et al. 2007). 
Neuronal specification occurs after the asymmetric division of an undifferentiated 
neural stem cell. One daughter cells remains undifferentiated and expresses Id and 
Hes proteins, and the other daughter cell loses expression of these factors and 
upregulates pro-differentiation bHLH factors, such as Ascl1 or Neurog2. These 
factors are capable of initiating neuronal differentiation and drive the formation of 
different neuronal subtypes (GABAergic and glutamatergic respectively). Neurog2 
activates the expression of Neurod1, a bHLH factor capable of inducing terminal 
neuronal differentiation (Ma et al. 1999). The asymmetricity of the division of the 
 




stem cell is reinforced through the activity of pro-neural genes, which induce the 
activity of the Notch ligand Delta, and drive the expression of Hes factors in the 
neighbouring sister cell (Bertrand et al. 2002). Self-renewal and differentiation 
decisions are sometimes enforced by stabilisation of oscillatory gene expression 
patterns. Hes1 and Ascl1 protein levels display oscillatory anti-phase behaviour in 
neural progenitor cells. If the oscillations in a cell terminate when Ascl1 levels are 
high and Hes1 levels are low, the cell can differentiate, if they terminate when Hes1 
levels are high and Ascl1 levels are low, the cell will retain multipotency (Imayoshi 
et al. 2013, Kageyama et al. 2007, Kageyama et al. 2008). bHLH factors also 
regulate astrocyte differentiation, through Hes activity, and oligodendrocyte 
differentiation, through Olig activity. Interestingly, Olig2 also displays oscillatory 
patterns in neural progenitor cells (Imayoshi et al. 2013). 
The oscillations in Hes protein expression are not limited to neural cells, and can be 
observed in ES cells. Differences in Hes1 expression affect the behaviour of ES cells 
during differentiation, with Hes1-high cells more prone to mesodermal fates and 
Hes1-low cells more prone to neural fates (Kobayashi et al. 2009, Zhou et al. 2013). 
Other HLH factors are also expressed in ES cells: Id proteins mediate the BMP-
induced maintenance of pluripotency, E proteins are expressed, and three pro-
differentiation factors expressed in LIF+FCS culture (Neurod1, Tcf15 and Twist1) 
have been found to interact with E12 and E47 and to promote the exit from a 
pluripotent state (Davies et al. 2013, Malaguti et al. 2013, Marchand et al. 2009, 
Ying et al. 2003a. The experiments on Twist1 in Malaguti et al. 2013 were 
performed by Dr. Paul Nistor). This suggests that a helix-loop-helix network may be 
involved in the regulation of ES cell pluripotency and differentiation. Notch may be 
involved in the regulation of this network, as it is known to affect the differentiation 
of ES cells, but it does not influence ES cell self-renewal, and it is not upstream of 
Hes1 activity or expression in this cell type (Kobayashi & Kageyama 2010, Lowell 
et al. 2006, Nemir et al. 2006, Schroeder et al. 2006). 
 




1.3.3.5 The roles of Id1 in ES cell self-renewal and differentiation 
Upon discovery of BMP signalling as the key component of serum for the 
maintenance of ES cell pluripotency, Id1 was identified as a key effector of this 
signalling pathway, and Id1 overexpression was found to be sufficient to sustain ES 
cell self-renewal in the presence of LIF (Ying et al. 2003a). Id1 appears to be 
dispensable for the maintenance of pluripotency in 2i culture, as it is expressed at 
extremely low levels (Marks et al. 2012), and its knockout does not result in overt 
differentiation in ES cell culture, although this could be due to the redundant 
expression of other Id family members (Romero-Lanman et al. 2011, see paragraph 
1.3.3.3). Its expression in LIF+FCS culture has only been investigated in the single-
cell qRT-PCR experiments described in paragraph 1.3.3.1, and appears to be 
heterogeneous (Tang et al. 2010). 
Id1 is rapidly downregulated at the onset of differentiation, both in N2B27 and in 
embryoid bodies (Aiba et al. 2006, Aiba et al. 2009, Romero-Lanman et al. 2011), 
an observation consistent with its role in the maintenance of ES cell self-renewal. 
Forced expression of Id1 inhibits cell differentiation towards the neural lineage and 
generates a mixture of morphologically diverse non-neural cells (Ying et al. 2003a). 
Despite its potent effect in the maintenance of pluripotency and in the inhibition of 
neural specification, very little is known of the expression pattern and of the roles of 
Id1 in pluripotent and differentiating cells. The work presented in this thesis aims to 
fill this void at least in part, in order to do justice to a small protein with enormous 








2.1.1 General reagents 
Product Vendor Catalogue 
number 
0.25% Trypsin EDTA, phenol red Gibco 25200-056 
1 kb DNA Ladder New England Biolabs N3232L 
1,4-Dithiothreitol (DTT) Roche 10197785103 
10 mM dNTP Mix Invitrogen 18427-013 
100 bp DNA Ladder New England Biolabs N3231L 
100mm TC-Treated Culture Dish Corning 430167 
2-Mercaptoethanol BDH 44143-3A 
75cm
2
 Rectangular Canted Neck Cell 
Culture Flask with Plug Seal Cap 
Corning 430720 
λ DNA-HindIII digest New England Biolabs N3012S 
Absolutely RNA Miniprep Kit Agilent Technologies 400800 
Accutase® solution Sigma A6964 
Acetic acid glacial AnalR Normapur® VWR 20104.334 
Amersham ECL Blocking Agent GE Healthcare RPN2125 
Amersham Hybond ECL 
Nitrocellulose Membrane 
GE Healthcare RPN203D 
Amersham Hyperfilm ECL 
(24x30cm) 
GE Healthcare 28-9068-40 
Amersham Rediprime II DNA 
Labeling System 
GE Healthcare RPN1633 
Ammonium chloride Acros Organics 423285000 
 




Ampicillin Calbiochem 171254 
Bacto™ Agar BD 214010 
BamHI-HF
®
 New England Biolabs R3136T 
Blasticidine S hydrochloride Sigma 15205-100MG 
Bovine Albumin Fraction V (7.5% 
solution) 
Gibco 15260-037 
Bovine Serum Albumin 100X 
(10mg/ml) 
NEB B9001S 
CellsDirect™ One-Step RT-PCR Kit Invitrogen 11753-100 
CHIR 99021 Axon 1386 
cOmplete ULTRA Tablets, EDTA-
Free, Glass Vials 
Roche 05892953001 
Containers, Polystyrene, 30ml 
Universal, Flow Seal Cap 
Sterilin 128A/FS 
Costar® 12 well clear TC-treated 
multiple well plates, individually 
wrapped, sterile 
Corning 3513 
Costar® 24 well clear TC-treated 
multiple well plates, individually 
wrapped, sterile 
Corning 3524 
Costar® 48 well clear TC-treated 
multiple well plates, individually 
wrapped, sterile 
Corning 3584 
Costar® 6 well clear TC-treated 
multiple well plates, individually 
wrapped, sterile 
Corning 3516 








CryoTube™ Vials Thermo Scientific 377224 
Deoxyribonucleic acid from herring 
sperm 
Sigma D7290-1ML 
DAPI in water at 10mg/mL Biotium 40043 
DMEM/F-12 Gibco 21331-020 
DNeasy® Blood and Tissue Kit Qiagen 69504 
Donkey serum Sigma D9663-10ML 
Dulbecco’s Phosphate Buffered Saline Sigma D8537 
Ethanol absolute AnalaR 
NORMAPUR® 
VWR 101074F 
Fibronectin, from bovine plasma Sigma F4759 
Foetal bovine serum, qualified, E.U.-
approved, South America origin 
Gibco 10270, batch 
40F0240K 
G418 sulphate PAA P27-011 
Gelatine from porcine skin Sigma G1890 
GenePulser®/MicroPulser™ 
electroporation cuvettes, 0.4cm gap 
Bio-Rad 165-2088 
Glasgow Minimum Essential Medium Sigma G5154 
Glycerol Fisher 56-81-5 
Glycine Sigma G8898-500G 
Illustra ProbeQuant G-50 Micro 
Columns 
GE Healthcare 28-9034-08 
Insulin from bovine pancreas Sigma I1882 
Isopropanol, 99.5%, for molecular 
biology, DNAse RNAse and Protease 
free 
Acros Organics 327272500 
Kanamycin Calbiochem 420311 
KasI New England Biolabs R0544S 
 




KnockOut™ Serum Replacement Gibco 10828-028 
KpnI New England Biolabs R0142S 
L-Glutamine 200mM (100X) Gibco 25030-024 
Laminin, 1mg/ml, from Engelbreth-
Holm-Swann murine sarcoma 
basement membrane 
Sigma L2020 
LB Broth, Miller (Luria-Bertani) BD 244620 
LDN 193189 Axon 1509 
Lightcycler® 480 Multiwell Plate 
384, white 
Roche 04729749001 
Lightcycler® 480 Probes Master Roche 04887301001 
Lightcycler® 480 SYBR Green I 
Master 
Roche 04707516001 
Lipofectamine™ 2000 Reagent Life Technologies 11668-027 
M-MLV Reverse Transcriptase Invitrogen 28025-013 
M2 medium Sigma M7167-100ML 
MEM NEAA Gibco 11140-035 
Methanol AnalaR Normapur® VWR 20847.240 
Millex®-GP syringe filter unit, 0.22 
µm, polyethersulfone, 33 mm, gamma 
sterilized 
Millipore SLGP033RS 
Neurobasal® medium Gibco 21103-049 
NotI-HF
®
 New England Biolabs R3189L 
NuPAGE® 4-12% Bis-Tris Gels, 1.0 
mm, 10 well 
Novex NP0321BOX 
NuPAGE® LDS Sample Buffer (4X) Novex NP0007 








NuPAGE® Transfer Buffer (20X) Novex NP0006 
Nylon membranes, positively charged Roche 11417240001 
Orange G Sigma O3756 
Orthoboric acid Fisher 10043-35-3 
Paraformaldehyde Sigma 158127-500G 
PD 0325901 Axon 1408 




PerfectHyb™ Plus Sigma H7033 
Petri dish, 140mm Sterilin 501V 
pGem®-T Easy Vector System I Promega A1360 
Phosphate buffered saline tablet Sigma P4417-100TAB 
Plasmid Maxi Kit Qiagen 12162 
Platinum® Pfx DNA Polymerase Invitrogen 11708-013 
Poly-L-ornithine solution Sigma P4957 
Progesterone Sigma P8783 
ProLong® Gold Antifade Reagent Molecular Probes P36930 
Propidium Iodide, 1mg/mL solution in 
water 
Biotium 40017 
Puromycin dihydrochloride from 
Streptomyces alboniger 
Sigma P8833 
Putrescine dihydrochloride Sigma P5780 
QIAprep Spin Miniprep Kit Qiagen 27104 
QIAquick Gel Extraction Kit Qiagen 28704 
Random Primers Invitrogen 48190-011 
rAPid Alkaline Phosphatase Roche 04898133001 
Recombinant human BMP-4 R&D 314-BP-010 
 










Restriction Endonuclease HindIII Roche 11274040001 
Restriction Endonuclease ScaI Roche 10775266001 
RIPA Buffer Sigma R0278-50ML 




SB431542 Abcam ab120163 
SeeBlue® Pre-Stained Standard Novex LC5625 
Sodium chloride Fisher S/3105/63 
Sodium dodecyl sulphate Sigma L3771-25G 
Sodium hydroxide Fisher S/4880/53 
Sodium selenite Sigma S5261 
Spermidine Sigma S2626 
Standard Petri Dish, 90mm, Single 
Vent, AS 
Sterilin 101R20 
Subcloning Efficiency™ DH5α™ 
Competent Cells 
Invitrogen 18265-017 
SuperSignal™ West Pico 
Chemiluminescent Substrate 
Thermo Scientific 34079 
SYBR® Safe DNA Gel Stain Invitrogen S33102 
T4 DNA Ligase New England Biolabs M0202L 
Taq DNA Polymerase Qiagen 201203 
Triton™ X-100 Sigma X100-100ML 
Tween® 20 Promega H5151 
 




Tris Base Fisher BP152-1 




XhoI New England Biolabs R0146S 
Zero Blunt® TOPO® PCR Cloning 






G:BOX F3 (Syngene) 
Gel tanks (Engineering & Design Plastics Ltd) 
Gene Pulser (Bio-Rad) 
IX51 inverted microscope (Olympus) with Retiga-2000R Fast 1394 camera 
(QImaging) 
LightCycler® 480 Instrument II (Roche) 
LSRFortessa (BD) 
NanoDrop ND-1000 Spectrophotometer (Thermo Scientific) 
NanoVue Plus Spectrophotometer (GE Healthcare) 
PowerPac™ Basic Power Supply (Bio-Rad) 
StereoZoom SMZ-U dissection microscope (Nikon) 
TCS SPE inverted confocal microscope (Leica) 
TProfessional Standard Thermocycler (Biometra) 









2.1.3 PCR primer sequences 
2.1.3.2 qRT-PCR primer sequences and UPL probe number 





























Hex CTACACGCACGCCCTACTC CAGAGGTCGCTGGAGGAA 50 
Id1 TCCTGCAGCATGTAATCGAC GGTCCCGACTTCAGACTCC 78 
Kdr CCCCAAATTCCATTATGACAA CGGCTCTTTCGCTTACTGTT 18 
Klf4 CGGGAAGGGAGAAGACACT GAGTTCCTCACGCCAACG 62 
Krt8 AGTTCGCCTCCTTCATTGAC GCTGCAACAGGCTCCACT 67 
 




Nanog CCTCCAGCAGATGCAAGAA GCTTGCACTTCATCCTTTGG 25 







Rex1 CAGCTCCTGCACACAGAAGA ACTGATCCGCAAACACCTG 16 
Snail GTCTGCACGACCTGTGGAA CAGGAGAATGGCTTCTCACC 71 











Wnt3a AATGGTCTCTCGGGAGTTTG CTTGAGGTGCATGTGACTGG 53 
Zeb1 GCCAGCAGTCATGATGAAAA TATCACAATACGGGCAGGTG 48 
Zeb2 CAAGAGGCGCAAACAAGC TGCGTCCACTACGTTGTCAT 79 













2.1.3.3 Other PCR primer sequences 




































































2.1.4.1 Primary Antibodies 






β-tubulin Sigma AA2 Mouse 1:4000 T8328 
Cdh1 Invitrogen ECCD-2 Rat 1:200 13-1900 
Cdh2 BD 32/N-cadherin Mouse 1:200 610920 
Esrrb Perseus 
Proteomics 
















Rabbit 1:1000 A11122 
Id1 Chemicon 7D4.2 Mouse 1:200 MAB4372 
Id1 Santa Cruz C-20 Rabbit 1:200 sc-488 
Klf4 R&D klf4aa11-483 Goat 1:200 AF3158 
Nanog eBiosciences eBIOMLC-51 Rat 1:200 14-5761-80 
Nkx2.5 Abcam Anti-Nkx2.5 Rabbit 1:200 ab35842 
Oct4 Santa Cruz C-10 Mouse 1:200 sc-5279 
T Santa Cruz C-19 Goat 1:200 sc-17745 
tagRFP Evrogen anti-tRFP Rabbit 1:1000 AB233 
Tcfap2a DSHB AP-2 alpha Mouse 1:10 3B5 
Tubb3 Covance Tuj1 Mouse 1:1500 MMS-435P 
 
 




2.1.4.2 Secondary antibodies 
Alexa Fluor® antibodies (Molecular Probes) conjugated to appropriate fluorophores 
were used as secondary antibodies for immunostaining experiments. 
Target species Raised in Fluorophore Catalogue number 
Chicken Goat FITC A16055 
Goat Donkey 568 A11057 
Goat Donkey 647 A21447 
Mouse Donkey 488 A21202 
Mouse Donkey 568 A10037 
Mouse Donkey 647 A31571 
Rabbit Donkey 488 A21206 
Rabbit Donkey 568 A10042 
Rat Donkey 488 A21208 
Rat Goat 568 A11077 
Rat Donkey 594 A21209 
 
For detection of primary antibodies in Western blots the following two secondary 
antibodies were used: ECL Mouse IgG, HRP-linked whole Ab (from sheep) (GE 
Healthcare, catalogue number NA931-1ML); ECL Rabbit IgG, HRP-linked whole 
Ab (from donkey) (GE Healthcare, catalogue number NA934-100UL). Both 













2.1.5 Formulation of solutions 
Denaturing solution: 87.66g/l sodium chloride, 20g/l sodium hydroxide in water. 
DNA loading dye: Orange G (Sigma) 0.25%, glycerol (Fisher) 30%, in water. 
Genomic DNA Lysis Buffer composition: Tris Base 100mM pH8.5, EDTA 5mM, 
NaCl 200mM, 0.2% SDS, in water. 
Lysogeny broth (LB): 2.5% LB powder (BD) in water. This formulation of LB 
contains 10g/l NaCl. This solution was prepared and autoclaved by the Institute 
Wash Staff. 
Neutralising solution: 116.8g/l sodium chloride, 121.1g/l Tris base, pH8.0 in water. 
N2 (homemade): 27.5ml DMEM/F12 (Gibco), 4ml sterile bovine serum albumin 
(75mg/ml in PBS, Gibco), 4ml insulin (25mg/ml in 0.01M HCl, Sigma), 4ml apo-
transferrin (100mg/ml in H2O, Sigma), 40µl sodium selenite (3mM in H2O, Sigma), 
400µl putrescine (160mg/ml in H2O, Sigma), 132µl progesterone (0.6mg//ml in 
ethanol, Sigma). This medium supplement was prepared in our Institute by the 
Transgenics Service. 
PBS (not for cell culture): 5 PBS tablets/l (Sigma) in water. 
SSC 20X solution: 175.2g/l NaCl, 88.2g/l Tris Base, pH7.4 in water. 
TAE: Tris Base (Fisher) 40mM, acetic acid 20mM, EDTA 1mM, pH 8.4, in water. 
TBE: Tris Base (Fisher) 22.5mM, orthoboric acid (Fisher) 22.5mM, EDTA 500µM 
pH 8.0, in water. 









2.2.1 DNA Methods 
2.2.1.1 DNA cloning methods 
2.2.1.1.1 Restriction enzyme digestion 
DNA digestions were performed by digesting 1-100 µg DNA with 5-100 units of the 
appropriate restriction enzymes, using the buffers and digestion conditions 
recommended by the enzyme manufacturers (New England Biolabs, Roche). 
Digestions were typically performed for 1-3 hours at 37ºC. 
 
2.2.1.1.2 Preparation of electrophoretic gels 
To generate electrophoretic gels, agarose was mixed with TBE and heated with a 
microwave until the agarose powder was fully melted. The solution was allowed to 
cool but not to solidify, and SYBR® Safe DNA Gel Stain (Invitrogen) was added at 
a 1:10000 dilution. The solution was mixed, poured into a gel mould and allowed to 
cool to room temperature and solidify. The concentration of agarose mixed with TBE 
varied from 0.8%-1.5% (weight/volume), depending on the size of the DNA 
fragments to be visualised. 
 
2.2.1.1.3 Gel electrophoresis 
The samples to be analysed were mixed with DNA loading dye (dye added at a 1:6 
dilution), loaded into a well of the prepared electrophoresis gel submerged in TBE, 
and subject to electrophoresis at 80-100V for 30-90 minutes, depending on the size 
of the DNA to be visualised. A DNA ladder was loaded next to the samples for size 
comparison (1 kb DNA Ladder or 100 bp DNA Ladder, New England Biolabs). 
 




After completion of the run, the gel was imaged under an ultraviolet transilluminator 
(G:BOX F3, Syngene) to verify the correct size of the DNA fragment. 
 
2.2.1.1.4 Purification of DNA from agarose gels 
If a DNA fragment was to be purified for further use, only one tenth of the restriction 
digestion reaction was run on an agarose gel for verification of the correct size under 
an ultraviolet transilluminator, as described above. Following this step, the remainder 
of the reaction was run on a separate agarose gel and briefly illuminated under an 
ultraviolet transilluminator. The DNA band of interest was excised from the gel 
using a sterile blade, and the gel fragment was transferred to a microcentrifuge tube. 
The length of the ultraviolet transillumination was kept to under 3 seconds to avoid 
the induction of mutations in the DNA sequence to be purified. The excised band 
was then purified using the QIAquick Gel Extraction Kit (Qiagen) following the 
manufacturer’s instructions. 
 
2.2.1.1.5 Quantification of DNA concentration 
The concentration of DNA in solution was measured using a NanoVue Plus 
Spectrophotometer (GE Healthcare) according to the manufacturer’s instructions. 
 
2.2.1.1.6 Dephosphorylation of linear DNA ends 
The 5’ phosphate groups of linear DNA were removed using rAPid Alkaline 
Phosphatase (Roche) according to the manufacturer’s instructions. Briefly, linear 
DNA was incubated in 1X rAPid Alkaline Phosphatase Buffer and 1U rAPid 
Alkaline Phosphatase for 10-30 minutes at 37ºC. The enzyme was then heat 
inactivated at 75ºC for 2 minutes. 
 




2.2.1.1.7 DNA fragment ligation 
Linear DNA fragments were ligated using T4 DNA Ligase (New England Biolabs). 
Ligation reactions were performed in a 10µl reaction volume containing 1X T4 DNA 
Ligase Reaction Buffer and 400U T4 DNA Ligase. A 3:1 molar ratio of insert:vector 
was used. Reactions were performed at 37ºC for 1 hour or at 4ºC overnight. 
 
2.2.1.1.8 Preparation of selective bacterial culture plates 
LB-agar was prepared by the Institute Wash Staff, by dissolving 1.5% Bacto™ Agar 
(BD) in LB. Ampicillin 1000X stocks were prepared by dissolving 100mg ampicillin 
powder (Calbiochem) in 1ml DNase/RNase-free water (Gibco) and filtering the 
solution through a 0.22µm filter (Millipore). Kanamycin 1000X stocks were 
prepared by dissolving 50mg kanamycin powder (Calbiochem) in 1ml 
DNase/RNase-free water (Gibco) and filtering the solution through a 0.22µm filter 
(Millipore). Antibiotic stock aliquots were kept at -20ºC, and upon thawing an 
aliquot was kept at 4ºC for no longer than 4 weeks. 
LB-agar was melted by microwaving the mixture and allowed to cool but not to 
solidify. The appropriate antibiotic was added at a 1:1000 dilution, and 15ml of LB-
agar/antibiotic mixture were pipetted into 90mm Standard Petri Dishes (Sterilin). The 
LB-agar was allowed to solidify at room temperature prior to use. Unused plates 
were conserved at 4ºC for no longer than 4 weeks. 
 
2.2.1.1.9 Plasmid transformation into DH5α bacteria 
Plasmids were transformed into chemically competent DH5α Escherichia coli 
(Invitrogen) according to the distributor’s instructions. Briefly, fewer than 200ng of 
DNA, in a solution of 10µl or less, were added to a tube containing 50µl of DH5α 
bacteria on ice. The mixture was incubated on ice for 30 minutes, heated to 42ºC for 
 




20 seconds in a water bath, then placed on ice for a further 2 minutes. 950µl of LB 
were added to the mixture, and the tube was incubated at 37ºC for 1 hour, shaking at 
225rpm. 100µl of the mixture were plated onto selective LB plates overnight at 37ºC. 
 
2.2.1.1.10 Plasmid purification from bacteria 
To purify 10-25µg of plasmid DNA, I picked one colony from the transformation 
plates into 5 ml LB, supplemented with the appropriate antibiotics, and incubated the 
liquid culture overnight at 37ºC, shaking at 225rpm. 
I then purified DNA using the QIAprep Spin Miniprep Kit (Qiagen), according to the 
manufacturer’s instructions. 
To purify 100-500µg of plasmid DNA, I picked one colony from the transformation 
plates into 1 ml LB, supplemented with the appropriate antibiotics, and incubated the 
liquid culture for 8 hours at 37ºC, shaking at 225rpm. I added 100-500µl of the 
culture to 100-500ml LB, supplemented with the appropriate antibiotics, and 
incubated the liquid culture overnight at 37ºC, shaking at 225rpm. 
I then purified DNA using the Qiagen Plasmid Maxi Kit, according to the 
manufacturer’s instructions. 
 
2.2.1.1.11 Plasmid sequencing 
Plasmid sequencing was performed by the GenePool service at The University of 
Edinburgh, making use of the BigDye® Terminator Cycle Sequencing technology 
(Invitrogen). I supplied the GenePool service with 6µl solutions containing 200-
500ng plasmid DNA and 1µl of a 3.2µM primer solution. Sequencing reads were 
analysed using the ApE software. 
 
 




2.2.1.2 PCR methods 
2.2.1.2.1 Taq PCR 
Taq DNA Polymerase was used to efficiently amplify DNA in those instances in 
which high fidelity of amplification was not required. 
PCR’s was performed according to the manufacturer’s instructions in a reaction 
volume of 50µl. The components of the reactions were as follows: 
Reagent Volume/reaction Final concentration 
10X PCR Buffer 5µl 1X 
25mM MgCl2 0-2µl 1.5-2.5mM 
dNTP mix (10mM each) 1µl 200µM each 
Forward primer (10µM) 2µl 400nM 
Reverse primer (10µM) 2µl 400nM 
Taq DNA polymerase 0.25-0.5µl 1.25-2.5 units/reaction 
Template DNA Variable Variable 
Water To 50µl - 
 
Thermal cycling was performed using a TProfessional Standard Thermocycler 
(Biometra), with the following cycle conditions: 
Step Temperature Duration (minutes:seconds) 
Denaturation 94ºC 03:00 
35 cycles of 
Denaturation 94ºC 01:00 
Annealing 55-58ºC 00:30 
Extension 72ºC 01:00 
(for amplicons longer than 1kb, 1 minute/kb) 
Following the 35 cycles 
Extension 72ºC 10:00 
 




Annealing temperatures were optimised for each primer pair; for the experiments 
reported in this thesis they lied within the range described above. 
 
2.2.1.2.2 Platinum® Pfx PCR 
Platinum® Pfx DNA Polymerase was used to amplify DNA in those instances in 
which high fidelity of amplification was required. 
PCR’s was performed according to the manufacturer’s instructions in a reaction 
volume of 50µl. The components of the reactions were as follows: 
Reagent Volume/reaction Final concentration 
10X Pfx Amplification Buffer 5µl 1X 
50mM MgSO4 1-2µl 1-2mM 
dNTP mix (10mM each) 1.5µl 300µM each 
Forward primer (10µM) 1.5µl 300nM 
Reverse primer (10µM) 1.5µl 300nM 
Platinum® Pfx DNA polymerase 0.4µl 1 unit/reaction 
Template DNA Variable Variable 












Thermal cycling was performed using a TProfessional Standard Thermocycler 
(Biometra), with the following cycle conditions: 
Step Temperature Duration (minutes:seconds) 
Denaturation 94ºC 05:00 
35 cycles of 
Denaturation 94ºC 00:15 
Annealing 55-58ºC 00:30 
Extension 68ºC 01:00 
(for amplicons longer than 1kb, 1 minute/kb) 
Following the 35 cycles 
Extension 68ºC 05:00 
 
Annealing temperatures were optimised for each primer pair; for the experiments 
reported in this thesis they lied within the range described above. 
 
2.2.1.2.3 Quantitative real-time PCR 
Quantitative real-time PCR was performed using the Roche LightCycler® 480 Real-
Time PCR System. This system makes use of Taq DNA polymerase to amplify short 
DNA amplicons, and uses fluorescent molecules to measure the number of DNA 
molecules present after each cycle of amplification. Whenever possible, I made use 
of the Universal ProbeLibrary (UPL) system, in which a short nucleic acid probe 
coupled to a fluorophore and a quencher specifically binds the DNA region to be 
amplified. Upon amplification of the DNA, the fluorophore is separated from the 
quencher and fluorescence can be detected by the LightCycler® 480 instrument. In 
alternative, I made use of the SYBR® Green I system, in which all DNA fluoresces 
upon binding the SYBR® Green I dye. Melting curves were analysed to ensure 
amplification of a single species of DNA. 
 




Primers used for qRT-PCR were designed using the online Roche Universal 
ProbeLibrary Assay Design Centre. The primer binding sequences were verified on 
the Ensembl online database to ensure the absence of single nucleotide 
polymorphisms. The primers were tested by performing Taq PCR on a cDNA sample 
and verifying the presence of a single amplicon on an electrophoretic gel. The 
amplicon generated by each primer pair was cloned into a pGem®-T Easy backbone 
(Promega), to be used as a serial dilution in qRT-PCR experiments. 
qRT-PCR experiments were carried out in 384-well plates, using a 10µl reaction 
volume. 
UPL reaction components: 
Reagent Volume/reaction Final concentration 
LightCycler® 480 Probes Master 5µl 1X 
Water 1.5µl - 
Forward primer (10µM) 0.45µl 450nM 
Reverse primer (10µM) 0.45µl 450nM 
Universal ProbeLibrary Probe (10µM) 0.1µl 100nM 
Template cDNA 2.5µl - 
 
UPL cycling conditions: 
Step Temperature Duration (minutes:seconds) 
Denaturation 95ºC 05:00 
45 cycles of 
Denaturation 95ºC 00:05 
Annealing 60ºC 00:10 
Extension 72ºC 00:01 
Following the 45 cycles 
Cooling 40ºC 00:10 
 




Fluorescence readings were taken after each extension step. 
SYBR® Green I reaction components: 
Reagent Volume/reaction Final concentration 
SYBR® Green I Master 5µl 1X 
Forward primer (10µM) 1µl 1µM 
Reverse primer (10µM) 1µl 1µM 
Template cDNA 3µl - 
 
SYBR® Green I cycling conditions: 
Step Temperature Duration (minutes:seconds) 
Denaturation 95ºC 05:00 
45 cycles of 
Denaturation 95ºC 00:05 
Annealing 58ºC 00:10 
Extension 72ºC 00:20 
Acquisition 81ºC 00:01 
Following the 45 cycles, a melting curve was generated in order to observe whether 
amplification of multiple DNA sequences had occurred. The machine settings were 
as follows. 




95ºC 4.8ºC/s 00:01 None 
65ºC 2.5ºC/s 00:10 None 
95ºC 0.11ºC/s  Continuous 
(5 acquisitions/ ºC) 
 




The number of molecules of the amplicon of interest in each reaction was calculated 
by the LightCycler® 480 Software, referring to a serial dilution of the pGem®-T 
Easy/amplicon plasmids described above, loaded in the same qRT-PCR plate at 
known concentrations (6 10-fold dilutions of plasmid at an initial copy number of 
10
8
/reaction). 3 replicate reactions were loaded on the qRT-PCR plates for each 
cDNA sample. To calculate the normalised expression value for a gene of interest for 
each biological sample, the average expression value of the gene of interest in the 3 
replicate reactions was divided by the average expression value of the housekeeping 
gene Tbp in 3 replicate reactions: 
If X1, X2, X3 are the expression values of 3 replicate reactions for gene X, and T1, T2, 
T3 are the expression values of 3 replicate reactions for Tbp, 
Gene expression value in sample = [(X1+X2+X3) / 3] / [(T1+T2+T3) / 3]. 
To calculate the biological average expression value for a gene of interest in 
biological replicate samples, the gene expression values in each sample, calculated as 
above, were averaged across biological replicates. 
 
2.2.1.2.4 Single-cell quantitative real-time PCR 
Single-cell quantitative real-time PCR was performed using the UPL system as 
described above, with some modifications. Experiments were carried out in 384-well 











Reagent Volume/reaction Final concentration 
LightCycler® 480 Probes Master 4µl 1X 
Water 1.2µl - 
Forward primer (10µM) 0.36µl 450nM 
Reverse primer (10µM) 0.36µl 450nM 
Universal ProbeLibrary Probe (10µM) 0.08µl 100nM 
Template cDNA 2µl - 
 
Cycling conditions: 
Step Temperature Duration (minutes:seconds) 
Heating 50ºC 02:00 
Denaturation 95ºC 10:00 
45 cycles of 
Denaturation 95ºC 00:15 
Annealing & Extension 60ºC 01:00 
Following the 45 cycles 
Cooling 40ºC 00:10 
 
Fluorescence readings were taken after each extension step. 
These cycling conditions were optimised for the LightCycler® 480 by Dr. Kumiko 
Iwabuchi, an expert in single-cell transcriptional analysis from Dr. Keisuke Kaji’s 
laboratory. 
The LightCycler® 480 Software was used to calculate the gene expression levels for 
each gene of interest based on a serial dilution of cDNA extracted from 32 cells and 
subject to pre-amplification alongside the analysed samples (10 2-fold serial 
dilutions). The Tbp level of the 1-cell equivalent of the serial dilution (i.e. the 1:32 
 




dilution of the 32-cell cDNA sample) was used to select single-cell samples to be 
analysed. Only cells with a Tbp expression value falling within a 0.5-1.5-fold range 
of this Tbp expression value were subject to qRT-PCR for a panel of genes of 
interest. 
2 replicate reactions were loaded on the qRT-PCR plates for each cDNA sample, in 
order to minimise the use of single-cell cDNA. Tbp-normalised gene expression 
values were calculated as described in the previous section (2.2.1.2.3). 
Spearman’s rank correlation coefficients for Tbp-normalised gene expression values 
were calculated with the R software, using the rcorr() function in the Hmisc package. 
This function also calculates the approximated asymptotic p-values for the 
correlations using the t-distribution. 
 
2.2.1.3 DNA isolation from mouse embryonic stem cells 
2.2.1.3.1 DNA isolation from 24-well plates 
Mouse ES cells were grown to confluency in 24-well plates. They were washed 
twice in PBS, then lysed in 500µl Genomic DNA Lysis Buffer supplemented with 
200µg/ml Proteinase K. The lysates were transferred to microcentrifuge tubes and 
incubated overnight at 55ºC shaking at 300rpm. The DNA was then precipitated by 
adding 1 volume of isopropanol (Acros Organics) and centrifuged. Excess salts were 
removed with two washes in 70% ethanol (VWR). The pellets were air-dried and 
resuspended in 500µl of water. 
 
2.2.1.3.2 DNA isolation from 6-well plates 
Mouse ES cells were grown to confluency in 6-well plates. Genomic DNA was then 
extracted using the Qiagen DNeasy® Blood and Tissue Kit, following the 
 




manufacturer’s instructions for animal blood or cultured cells. Following a first 
elution step, the eluate was passed through the column again to maximise DNA 
concentration and yield. 
 
2.2.1.4 Southern Blotting 
2.2.1.4.1 Genomic DNA digestion 
5µg of genomic DNA extracted from mouse ES cells were digested overnight at 
37ºC, in 100U of high-concentration restriction enzymes, in the appropriate digestion 
buffer, in the presence of 100µg/ml bovine serum albumin (New England Biolabs) 
and 2.5mM spermidine (Sigma). The DNA was then precipitated by adding 1 volume 
of isopropanol and centrifuged. Excess salts were removed with two 70% ethanol 
washes. The pellet was air-dried and resuspended in 20µl of water. 
 
2.2.1.4.2 Genomic DNA electrophoresis and denaturation 
The digested DNA was loaded on a 0.8% (w/v) agarose/TAE gel. λ DNA-HindIII 
digest (New England Biolabs) was loaded as a size marker. Electrophoresis was 
performed overnight at 10-25V, depending on the size of the electrophoretic gel and 
of the DNA fragments to be detected. The gel was stained with SYBR® Safe 
(Invitrogen) at a 1:10000 dilution in TAE for 15 minutes, then imaged under an 
ultraviolet transilluminator to verify the complete digestion of the DNA samples. The 
gel was then incubated in Denaturing Solution for 40 minutes on a rocking platform, 
rinsed with distilled water, and incubated in Neutralising Solution for 40 minutes on 








2.2.1.4.3 Transfer to nylon membrane 
DNA was then transferred onto a positively charged nylon membrane (Roche) 
making use of the transfer strategy depicted in Figure 2.1. 
The transfer was carried out for 48 hours, after which the nylon membrane was 
rinsed in 2X SSC and baked for 1 hour at 120ºC. 
 
 
Figure 2.1 – Southern blot transfer strategy 
Diagram of the strategy used to transfer DNA from an agarose gel to a nylon 
membrane for Southern blotting applications. A plastic tank was filled with 20X 
SSC. A glass plate (green) was placed upon the plastic tank. Filter paper (brown) was 
soaked in 20X SSC and wrapped around the glass pate, leaving the extremities of the 
paper bathed in 20X SSC, to enable the solution to maintain the paper wet by 
capillary action. The agarose gel containing the digested genomic DNA (pink) was 
placed on top of the filter paper, the nylon membrane (red) was pre-soaked in 20X 
SSC and rested on top of the gel. Four sheets of filter paper (brown) were soaked in 
20X SSC and placed on top of the nylon membrane. Absorbent tissue (grey) was 
placed on top of the filter paper. A second glass plate (green) was placed on top of 
the filter paper, and a weight (light blue) was balanced on top of the glass plate. 
 




2.2.1.4.4 Generation of probes for Southern blot 
The probes for Southern blotting were designed to be between 400-600 nucleotides 
in size and to be present in a single genomic location. The probes were generated by 
Taq PCR using wild-type E14tg2a ES cell genomic DNA as a template, purified by 
gel extraction, subcloned into a pGem®-T Easy backbone and sequenced. Probe 
fragments were generated by EcoRI digestion-mediated excision of the insert from 
the pGem®-T Easy backbone, followed by gel extraction. 
Probe labelling was carried out using the Amersham Rediprime II DNA Labeling 
System (GE Healthcare) according to the manufacturer’s instructions. Briefly, 25ng 
probe DNA were diluted in a total volume of 45µl of TE buffer in a screw cap tube. 
The tube was incubated at 100ºC for 5 minutes to denature the DNA, then placed on 
ice for 5 minutes. The DNA was then added to a reaction tube (containing dried 
dATP, dGTP, dTTP, random primers and exonuclease free Klenow enzyme), 
alongside 5µl [α-
32
P]dCTP (3000Ci/mmol). The reaction was incubated at 37ºC for 
10 minutes. In order to remove unincorporated nucleotides, the reaction contents 
were then added sequentially to two Illustra ProbeQuant G-50 Micro Columns (GE 
Healthcare) and centrifuged. The eluate was incubated at 100ºC for 5 minutes and 
chilled on ice for 5 minutes prior to hybridisation to the membrane. 
The same protocol was used to label a probe to detect the λ DNA-HindIII digest, 
using only 2µl [α-
32
P]dCTP (3000Ci/mmol), and 3µl of non-radioactive dCTP. 
 
2.2.1.4.5 Probe hybridisation to the membrane 
The baked membrane was rinsed with 2X SSC and placed into a glass hybridisation 
bottle. It was incubated with 20ml PerfectHyb™ Plus hybridisation buffer (Sigma) at 
65ºC for a minimum of 1 hour. 500µl sonicated herring sperm DNA (Sigma) were 
incubated at 100ºC for 5 minutes and cooled on ice for 5 minutes. They were added 
 




to the hybridisation bottle alongside the labelled probes of interest. The hybridisation 
was carried out overnight at 65ºC. 
 
2.2.1.4.6 Membrane washing and film exposure 
The hybridisation solution was removed and the membrane was washed twice for 15 
minutes in 2X SCC+0.1% SDS, and once for 30 minutes in 0.5X SSC+0.1% SDS. 
The membrane was wrapped in cling film and placed in a film developing cassette, 
where it was used to expose Amersham Hyperfilm ECL (GE Healthcare). Exposure 
time varied between 1-7 days at -80ºC. The film was developed in the dark using a 
film developer. 
 
2.2.2 RNA Methods 
2.2.2.1 Total RNA isolation 
Total RNA was extracted from cultured cells using the Absolutely RNA Miniprep 
Kit (Agilent Technologies), following the manufacturer’s instructions. 
The concentration of the isolated RNA was measured using a NanoVue Plus 
Spectrophotometer (GE Healthcare) according to the manufacturer’s instructions. 
 
2.2.2.2 cDNA synthesis 
First-strand cDNA synthesis was performed using M-MLV Reverse Transcriptase 
(Invitrogen), following the manufacturer’s instructions. Briefly, 1µg RNA was mixed 
with 1µl 10mM dNTP Mix (Invitrogen), 50ng Random Primers (Invitrogen) in a 
12µl reaction volume. The mixture was heated to 65ºC for 5 minutes and cooled on 
ice for 1 minute. 4µl 5X First-Strand Buffer, 2µl 0.1M DTT and 1µl RNaseOUT™ 
 




Recombinant Ribonuclease Inhibitor (40U/µl) (Invitrogen) were added. The mixture 
was incubated at 37ºC for 2 minutes. 1µl (200U) M-MLV Reverse Transcriptase was 
added, and the reaction was incubated at 25ºC for 10 minutes. Reverse transcription 
was performed at 37ºC for 50 minutes, and was followed by heat inactivation of the 
enzymes at 70ºC for 15 minutes. To digest the RNA template, 1µl (5U) RNase H 
(New England Biolabs) was added to the mixture, which was incubated at 37ºC for 
20 minutes. The cDNA was diluted 1:5 in DNase/RNase-free water (Gibco), and 
stored at -20ºC. 
 
2.2.2.3 cDNA generation from single cells 
RNA was extracted from single cells and reverse transcribed into cDNA using the 
CellsDirect™ One-Step RT-PCR Kit (Invitrogen), making use of the protocol 
described by Dalerba et al. (2011) with minor modifications. Each well of a 96-well 
PCR plate was preloaded on ice with 5µl 2X Reaction Mix, 0.2µl Superscript® III 
RT/Platinum® Taq Mix (with RNaseOUT™ Ribonuclease Inhibitor), 2.5µl primer 
mix (containing 200nM of each gene-specific primer to be used in later qRT-PCR 
experiments), 1.3µl DNase/RNase-free water (Gibco). Live single cells were sorted 
into separate wells of the PCR plate using a FACSAria cell sorter (BD Biosciences). 
32 cells were sorted into one well, to be used for the generation of qRT-PCR 
standard curves by serial dilution of the generated cDNA (see paragraph 2.2.1.2.4). 
The plate was placed in a TProfessional Standard Thermocycler (Biometra). RNA 
was reverse transcribed to cDNA and the cDNA was subject to 22 cycles of pre-
amplification of target amplicons (to ensure sufficient abundance of the amplicons of 
interest for qRT-PCR), as described by Dalerba et al. (2011). Briefly, the reactions 
were incubated at 50ºC for 15 minutes to lyse the cells and reverse transcribe the 
cDNA, the Superscript® III Reverse Transcriptase was inactivated and the 
Platinum® Taq was activated by heating the reactions to 95ºC, and pre-amplification 
 




was performed with cycles of 95ºC for 15 seconds and 60ºC for 4 minutes. The 
cDNA was diluted 1:5 with DNase/RNase-free water and stored at -20ºC 
 
2.2.3 Protein Methods 
2.2.3.1 Western Blotting 
2.2.3.1.1 Protein isolation from cultured cells 
Cultured cells were lysed in RIPA buffer (Sigma) supplemented with 0.5mM 
Pefabloc® SC (Sigma), 1mM DTT (Roche) and 1X Protease Inhibitor Cocktail 
(Roche cOmplete ULTRA Tablets). Cells were allowed to lyse on ice for 30 minutes 
before transferring the lysate to a microcentrifuge tube. 1µl (250U) Benzonase 
Nuclease (Sigma) was added to the tube and the solution was incubated at room 
temperature for 10 minutes. 
Protein concentration was estimated by measuring the absorbance of the sample at 
280nm with a NanoDrop ND-1000 spectrophotometer (Thermo Scientific). 
 
2.2.3.1.2 Sample preparation and gel loading 
The samples to be loaded on a Western blot gel were diluted in RIPA buffer to a 
uniform concentration. 25µl of protein sample were mixed with 12.5µl 4X NuPAGE 
LDS Sample Buffer (Novex) and with 12.5µl of a 1M DTT aqueous solution. The 
samples were boiled for 10 minutes and chilled on ice. 
A 10-well NuPAGE® 4-12% Bis-Tris Gel (Novex) was loaded in an XCell 
SureLock™ Mini-Cell electrophoresis tank (Novex), and submerged with 1X 
NuPAGE® MOPS SDS Running Buffer (Novex). 
10µl of each sample were loaded on to the gel alongside 10µl SeeBlue® Pre-Stained 
Standard (Novex). The gel was subject to electrophoresis at 200V for 50 minutes. 
 




2.2.3.1.3 Protein transfer to nitrocellulose membrane 
Transfer buffer was generated as an aqueous solution of 1X NuPAGE® Transfer 
Buffer (Novex) and 10% methanol (VWR). Amersham Hybond ECL Nitrocellulose 
Membrane (GE Healthcare) was cut to the size of the gel and soaked in transfer 
buffer for 10 minutes. Filter paper was cut to the size of the gel and soaked in 
transfer buffer for 10 minutes, alongside 4 blotting pads of the same size as the gel. 
The gel was removed from the plastic case it was lodged in and the protein transfer 
was set up in an XCell II™ Blot Module (Novex), following the manufacturer’s 
instructions. Briefly, the components for the transfer were assembled in the blotting 
module in the following order: 2 blotting pads, filter paper, gel, membrane, filter 
paper, 2 blotting pads. The transfer was carried out in the XCell SureLock™ Mini-
Cell tank in transfer buffer for 1 hour at 25V. 
 
2.2.3.1.4 Antibody staining 
The membrane was transferred to blocking solution, containing 5% (w/v) Amersham 
ECL Blocking Agent (GE Healthcare) and 0.1% Tween® 20 (Promega) in PBS. 
Blocking was carried out for 1 hour at room temperature on a rocking platform. The 
membrane was then incubated in primary antibody diluted in blocking solution for 1 
hour at room temperature on a rocking platform. The membrane was subject to three 
washes of 15 minutes in PBS+-0.1% Tween® 20 at room temperature on a rocking 
platform. Binding of the appropriate HRP-conjugated secondary antibody and 









2.2.3.1.5 Chemiluminescent film impression 
The membrane was placed on cling film. 1ml SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific) was added onto the membrane for 5 
minutes. The membrane was wrapped in cling film taking care to avoid the formation 
of air bubbles, and placed in a Western blot developing cassette. Amersham 
Hyperfilm ECL (GE Healthcare) was exposed to the chemiluminescent signals 
generated by the membrane for varying amounts of time, prior to film development. 
 
2.2.3.1.6 Membrane stripping 
If required, the primary and secondary antibodies were stripped from the membrane 
using a stripping buffer composed of 1.5% glycine (Sigma), 0.1% SDS (Sigma), 1% 
Tween® 20 (Promega) in water at pH 2.2. Stripping was performed at room 
temperature on a rocking platform for 10 minutes, and was followed by 2 washes in 
PBS and 2 washes in PBS+0.1% Tween® 20. Each wash was performed at room 
temperature on a rocking platform for 10 minutes. Further membrane labelling was 
performed as described in section 2.2.3.1.4. 
 
2.2.3.2 Immunofluorescence 
2.2.3.2.1 Sample fixation 
Cells cultured with the intent of imaging nuclear proteins at high magnification using 
the Leica TCS SPE inverted confocal microscope were fixed in PBS+4% PFA 
(Sigma)+0.1% Triton™ X-100 (Sigma) for 20 minutes at room temperature. The 
fixative was then neutralised with 50mM NH4Cl (Acros Organics) in PBS for 5 
minutes at room temperature, then subject to three 5-minute washes with PBS. 
 




Cells cultured for imaging with the widefield Olympus IX51 microscope were fixed 
in PBS+4% PFA for 20 minutes at room temperature, then subject to three 5-minute 
washes with PBS. 
Dissected embryos were fixed in PBS+4% PFA for 2 hours at room temperature. The 
fixative was then neutralised with 50mM NH4Cl in PBS for 20 minutes at room 
temperature. The embryos were then transferred to PBS. 
 
2.2.3.2.2 Antibody stain of cells 
Fixed cell samples were incubated in blocking solution for 30 minutes. Blocking 
solution consisted of PBS+3% donkey serum (Sigma)+0.1% Triton™ X-100. 
Primary antibodies were diluted in blocking solution and added to the cells for 1-3 
hours at room temperature or overnight at 4ºC. The samples were then subject to 
three 5-minute washes in PBS. Secondary antibodies were diluted 1:1000 in blocking 
solution and added to the cells for 1 hour at room temperature. The samples were 
subject to three 5-minute washes in PBS. 100ng/ml DAPI in PBS was added to the 
samples for 5 minutes. The samples were then subject to three 5-minute washes in 
PBS. 
When the staining was performed on cells cultured in wells, the samples were 
maintained in PBS prior to imaging. When the staining was performed on cells 
cultured on coverslips, the coverslips were mounted onto glass slides using a droplet 
of ProLong® Gold Antifade Reagent (Molecular Probes). The antifade reagent was 
allowed to cure for 48 hours at 4ºC, then the edges of the coverslips were sealed with 









2.2.3.2.3 Whole mount staining of mouse embryos 
The embryos were permeabilised in PBS+0.5% Triton™ X-100 for 1 hour at room 
temperature, after which they were transferred to blocking solution (same recipe as in 
paragraph 2.2.3.2.2) overnight at 4ºC. Primary antibodies were diluted in blocking 
solution and added to the embryos for 48 hours at 4ºC. The embryos were subject to 
five 10-minute washes in PBS+0.1% Triton™ X-100. Secondary antibodies were 
diluted 1:1000 in blocking solution and added to the embryos for 48 hours at 4ºC. 
When a DAPI stain was performed, DAPI was added to the secondary antibody stain 
solution at 100ng/ml. The embryos were subject to five 10-minute washes in 
PBS+0.1% Triton™ X-100. 
 
2.2.3.2.4 Staining of mouse embryo sections 
The slides containing the gelatine-mounted sections were immersed in PBS at 55ºC 
for 15 minutes to melt the gelatine. The slides were carefully dried with medical 
wipes, and circles were drawn around the sections with PAP pen. The sections were 
permeabilised in PBS+0.1% Triton™ X-100 for 10 minutes at room temperature, 
after which they were stained as described for cells in paragraph 2.2.3.2.2. Upon 
completion of staining, they were mounted using ProLong® Gold Antifade Reagent. 
The antifade reagent was allowed to cure for 48 hours at 4ºC, then the edges of the 
coverslips were sealed with transparent nail varnish. 
 
2.2.3.2.5 Imaging stained samples 
Cells and embryo sections were imaged using a widefield Olympus IX51 microscope 
with a QImaging Retiga-2000R Fast 1394 camera, or using a Leica TCS SPE 
inverted confocal microscope. The microscope used for each experiment is indicated 
in the relevant figure legend. 
 




Whole mount embryo stains were imaged using a Leica TCS SPE inverted confocal 
microscope. The embryos were imaged in a cell culture imaging chamber, 
submerged in PBS. 
Optimal exposure, gain and offset settings were empirically determined for each 
experiment. Pixel intensity in 8-bit images ranges between 0 and 255 (2
8
=256 
possible values). In order to adopt the appropriate settings, the sample with the 
highest expression of a specific factor of interest for each experiment was used to 
find the combination of gain and exposure that would result in pixel saturation at the 
highest intensity value (255). The negative control sample was then used with those 
gain and exposure settings to identify the offset setting that would result in pixel 
saturation at the lowest intensity value (0). This system ensures that only very few 
pixels in any given image are saturated at the lowest and highest fluorescent intensity 
values. 
When multiple fluorescent images were acquired for one field of view, the order of 
fluorophore acquisition was as follows: far red, red, green, blue, phase contrast. This 
was done to ensure minimal photobleaching of the sample. 
All images were acquired in 8-bit grayscale format. The coloured images presented 
in this thesis were generated by modifying the lookup table (LUT) associated with 
the pixel intensity values in Fiji (a distribution of ImageJ and Java enriched with 
multiple plugins) (Schindelin et al. 2012). For grayscale, the red, green and blue 
values associated with the 256 available pixel intensities are always equal (i.e. if a 
pixel has intensity 100, the red, green and blue values in the lookup table for that 
pixel will all be equal to 100). If, for example, an 8-bit grayscale image obtained 
from a green secondary antibody needs to be displayed in green, the red and blue 
values for each pixel intensity in the lookup table are set by Fiji to 0, so the displayed 
pixels range from 0 to 255 only in the green channel.  
 
 




2.2.3.2.6 Three-dimensional rendering of image stacks 
Images of embryos obtained as stacks of various focal plains were rendered in three 
dimensions using the 3D Viewer plugin in Fiji (Schmid et al. 2010). 
 
2.2.3.2.7 Nuclear segmentation for immunostaining quantification 
In order to perform nuclear immunostaining quantification, an automated software 
called Nucleus Editor (part of the Farsight Toolkit, available at http://www.farsight-
toolkit.org/) was used for nuclear segmentation. Nuclear segmentation is the name of 
the process by which the nuclei of all cells in an image are identified and given 
specific coordinates within the image (Lin et al. 2003). Nucleus Editor allows to 
adjust a variety of parameters to empirically determine the best segmentation values 
for nuclei in different images. For example, the nuclei of cells cultured in 2i are more 
spherical than the nuclei of cells within the post-implantation epiblast (three-
dimensional data not shown, for two-dimensional comparison see Figures 3.12 and 
5.2). It also provides the user with the possibility of manually editing segmented 
images to ensure the highest achievable accuracy of segmentation. This also gives 
the user the possibility to exclude dividing cells and cells not fully included in the 
field of view from further analysis. The result of a segmentation on the image of 
DAPI-stained nuclei of mouse embryonic stem cells is shown in Figure 2.2. 
 
 





Figure 2.2 – Nuclear segmentation of mouse embryonic stem cells 
a. E14tg2a mouse embryonic stem cells cultured in LIF+FCS, fixed and stained 
with DAPI. The image was acquired on a Leica TCS SPE confocal 
microscope. 
b. Segmentation result for the image in (a) using Nucleus Editor. The automated 
software result was manually edited to exclude dividing nuclei and nuclei not 
fully included in the field of view from the final segmentation result. Scale 
bar: 30µm. 
 
2.2.3.2.8 Nuclear immunostaining quantification using Multicell3D 
Having defined the spatial coordinates of each nucleus in a set of pictures of interest, 
I made use of a software to measure the average intensity of all pixels within each 
nucleus for every channel. This software, named Multicell3D, was developed by Dr. 
Guillaume Blin, a member of our laboratory, and has been successfully used for 
nuclear immunostaining quantification in cultured cells and in mouse embryos 
(Davies et al. 2013, Osorno et al. 2012). It confers every nucleus a unique identifier 
 




number and calculates a number of parameters for each nucleus. I made use of the 
average fluorescence intensity in each analysed channel, and of the volume of the 
nucleus. 
I will present two types of nuclear immunostaining quantification graph within this 
thesis: 
- A direct comparison of the average fluorescence intensity values (0-255) of 
two channels within single cells, by means of dot plots. 
- The analysis of the fluorescence distribution for a single channel across all 
analysed cells, by means of flow cytometry-like distribution plots. 
 
2.2.3.2.9 Average fluorescence intensity and integrated fluorescence intensity 
For flow cytometry-like distribution plots, I will present the intensity values for cells 
imaged in widefield or as a single confocal plan, and the integrated intensity values 
for cells imaged in 3D. The integrated intensity equals the fluorescence intensity 
multiplied by the nuclear volume, and provides an indication of the total amount of 
protein present within a nucleus. It therefore adjusts for nucleus size: 
Let nucleus x have a volume Vx = 100 pixels, and a number of molecules of a protein 
of interest Px = 100 molecules. Let each protein molecule have an average 
fluorescence intensity Ip = 1 AFU (arbitrary fluorescence unit)/molecule. The total 
fluorescence in nucleus x is: 
Fx= Px * Ip = 100 molecules * 1 AFU/molecule = 100 AFU. 
The average pixel fluorescence intensity in nucleus x is: 
Fpx = Fx / Vx = 100 AFU / 100 pixels = 1 AFU/pixel. 
The integrated fluorescence intensity in nucleus x is: 
 




IFx = Fpx * Vx = Fx / Vx * Vx = Fx = 100 AFU. 
The integrated fluorescence intensity is equal to the total fluorescence in nucleus x. 
It is therefore a representation of the total number of protein molecules in a nucleus, 
whereas the average fluorescence intensity is an indication of the local concentration 
of protein molecules in a nucleus. 
For comparison, let nucleus y have Vy = 50 pixels and Py = 100 molecules. The total 
intensity (and integrated fluorescence intensity) in nucleus y is: 
Fy = IFy = Py * Ip = 100 molecules * 1 AFU/molecule = 100 AFU. 
The average pixel fluorescence intensity in nucleus y is: 
Fpy = Fy / Vy = 100 AFU / 50 pixels = 2 AFU/pixel. 
Thus, nuclei x and y have the same integrated fluorescence intensity (number of 
protein molecules), but different average fluorescence intensity (concentration of 
protein molecules). 
As mentioned at the start of the paragraph, whenever nuclear volume measurements 
are available, by means of three-dimensional imaging, I will make use of the 
integrated intensity value for plotting distributions of a single factor. This will 
provide a better description of the amount of protein present in each analysed cell 











2.2.4 Cell culture 
2.2.4.1 Cell lines 
2.2.4.1.1 Wild-type embryonic stem cell lines 
Two wild-type embryonic stem cell lines were used in this study. 
E14tg2a ES cells are a clonal cell line derived from ES cells generated from 129/Ola 
blastocysts. They are hypoxanthine phosphoribosyltransferase deficient (Hooper et 
al. 1987). 
E14Ju09 ES cells are a clonal cell line derived by the Transgenics Unit in our 
Institute from ES cells obtained from chimaeric embryos generated with E14tg2a ES 
cells. They have a 129/Ola genetic background and are hypoxanthine 
phosphoribosyltransferase deficient. They have a high propensity for germline 
colonisation (observations made by the Transgenics Unit staff). 
 
2.2.4.1.2 Generation of transgenic Id1-overexpressing ES cells 
Id1 overexpressing ES cells were generated using an Id1 overexpression plasmid 
used by Ying et al. (2003a). The salient features of the plasmid are depicted in Figure 
2.3. The plasmid was linearised by digestion with ScaI and ethanol precipitated. Its 
concentration was quantified and 1µg was lipofected into 10
5
 E14tg2a ES cells. The 
cells were transferred to three 9cm dishes after 24 hours at 1/100, 1/10 and 8.9/10 
dilutions. 2µg/ml puromycin were added to the cells after a further 24 hours, and 
resistant clones were picked and expanded after 1 week of selection. 
 
 





Figure 2.3 – Id1 overexpression plasmid 
Structure of the plasmid used for the generation of Id1 overexpressing cells (plasmid 
code: AGS1356). The strong CAG promoter (Niwa et al. 1991) drives the expression 
of the Flag (MDYKDDDD)-tagged cDNA of Id1, which is followed by an internal 
ribosome entry site (IRES), a puromycin resistance gene (Pac), and a 
polyadenylation signal sequence (polyA). The Flag-Id1-IRES-Pac-polyA sequence is 
flanked by loxP sites in the same orientation, and followed by the cDNA of GFP and 
a second polyadenylation signal. The position of the ScaI restriction site used for the 
linearisation of the plasmid is indicated. 
 
2.2.4.1.3 Generation of Id1 reverted ES cells 
In order to excise the Flag-Id1-IRES-Pac-polyA sequence from the genome of clonal 
Id1 overexpressing ES cell lines, I lipofected 10
5 
cells with 3µg of a plasmid 
containing a CAG promoter driving expression of the Cre recombinase gene 
followed by an IRES  and a puromycin resistance gene (CAG-Cre-IRES-Pac, plasmid 
code: AGS844). The next day I plated the cells at clonal density (10 cells/cm
2
) in the 
absence of selection. After 1 week I observed the clones under the fluorescent 
microscope and I picked and expanded clones that were uniformly expressing GFP. 
 




2.2.4.1.4 Generation of empty vector control ES cells 
ES cells to be used as a control line for experiments involving the Id1 overexpressing 
cells were generated in parallel to these cell line to minimise variability. The cells 
were generated using an “empty vector” plasmid, the salient features of the plasmid 
are depicted in Figure 2.4. The plasmid was linearised by digestion with ScaI and 
ethanol precipitated. Its concentration was quantified and 1µg was lipofected into 10
5
 
E14tg2a ES cells. The cells were transferred to three 9cm dishes after 24 hours at 
1/100, 1/10 and 8.9/10 dilutions. 2µg/ml puromycin were added to the cells after a 













Figure 2.4 – Empty vector control plasmid 
Structure of the plasmid used for the generation of Id1 overexpressing cells (plasmid 
code: AGS564). The CAG promoter is directly followed by an internal ribosome 
entry site (IRES), a puromycin resistance gene (Pac), and a polyadenylation signal 
sequence (polyA). The position of the ScaI restriction site used for the linearisation of 
the plasmid is indicated. 
 




2.2.4.1.5 Generation of Id1-Venus reporter ES cells 
Id1-Venus reporter ES cells (named IdV) were generated using an updated version of 
the plasmid described by Nam & Benezra (2009), kindly gifted to our laboratory by 
Dr. Robert Benezra and Dr. Hyung-song Nam (Memorial Sloan-Kettering Cancer 
Center, New York, USA). The salient features of the plasmid are depicted in Figure 
2.5. 100µg of the plasmid were linearised by digestion with KpnI, ethanol 
precipitated and electroporated into 10
7
 E14Ju09 ES cells. 10
6
 cells were transferred 
to ten 9cm dishes immediately following electroporation. 300µg/ml G418 were 
added to the cells after 24 hours, and resistant clones were picked and expanded after 
10 days of selection. 
 
 
Figure 2.5 – Id1-Venus targeting plasmid 
Structure of the plasmid used for the generation of Id1-Venus reporter ES cells 
(plasmid code: pHN2). The Id1 open reading frame is followed by sequence coding 
for a flexible linker and Venus. This sequence is placed before the stop codon of Id1-
001. Venus is followed by the 3’UTR of Id1 and an excisable selection cassette. The 
cassette contains a Pgk promoter driving expression of Neo, a gene conferring 
resistance to G418, which is followed by a polyadenylation signal sequence. The 
Pgk-Neo-polyA sequence is flanked by Frt sites in the same orientation. The 5’ and 
3’ homology arms to the endogenous locus are 12479bp and 3630bp long. Outwith 
 




the regions of homology, an RNA polymerase II promoter fragment drives the 
expression of DTA, which encodes diphtheria toxin A, a toxic molecule that should 
kill cells which express this transgene following non-targeted integration events. The 
position of the KpnI restriction site used for the linearisation of the plasmid is 
indicated. 
 
2.2.4.1.6 Excision of the selection cassette from IdV ES cells 
In order to excise the Pgk-Neo-polyA sequence from the genome of IdV ES cells, I 
lipofected 10
5 
cells with 3µg of a plasmid containing a Pgk promoter driving 
expression of the FlpO recombinase gene. The next day I plated the cells at clonal 
density (10 cells/cm
2
) in the absence of selection. After 10 days I picked 96 colonies 
into a 96-well plate, replica plated them, and cultured one plate in the absence of 
G418 and the other plate in the presence of 300µg/ml G418. Only 1 colony displayed 
subsceptibility to G418, suggestive of excision of the selection cassette. I expanded 
that clonal ES cell line and named it IdV-SC. 
 
2.2.4.1.7 Generation of lineage labelled Id1-Venus reporter ES cells 
In order to genetically label IdV ES cells, I generated a plasmid encoding the red 
fluorescent protein mKate2 (Evrogen) fused to three SV40 nuclear localisation signal 
(NLS) sequences. mKate2 has minimal spectral overlap with Venus: the excitation 
and emission peaks of mKate2 are 589nm and 634nm, the excitation and emission 
peaks of Venus are 515nm and 528nm. The SV40 NLS sequences were used to 
ensure nuclear localisation of the protein to aid with cell detection in chimaeric 
embryos, whilst avoiding potential problems to due overexpression of mKate2-
tagged histone proteins as an alternative strategy for nuclear localisation of the 
fluorescent signal. 
 




In order to generate the overexpression plasmids, I amplified the open reading frame 
of mKate2 by overlapping extension PCR. A XhoI restriction site followed by a 
Kozak sequence were added at the 5’ end of mKate2, and a KasI restriction site was 
added at the 3’ end in place of the stop codon. The amplicon was cloned into a 
pCR®-Blunt II-TOPO backbone (Invitrogen) and sequence verified. The XhoI-
mKate2-KasI insert was purified by digestion of this intermediate plasmid with XhoI 
and KasI, followed by gel purification of this fragment. The opposite strands of three 
SV40 NLS sequences were synthesised as oligonucleotides, and were designed to 
leave overhangs on either end following their annealing. The overhang upstream of 
the NLS sequences corresponded to the overhang generated by the KasI restriction 
enzyme (5’-GCGC-3’), the overhang on the minus strand corresponded to that 
generated by the NotI restriction enzyme (5’-GGCC-3’). The final acceptor vector 
was digested with XhoI and NotI and the backbone fragment was gel extracted and 
purified. The backbone, mKate2 fragment and annealed NLS oligonucleotides were 
mixed at a 1:1:1 molar ratio and ligated with T4 DNA ligase. The assembled plasmid 
is depicted in Figure 2.6. 
The plasmid was linearised by digestion with ScaI and ethanol precipitated. Its 
concentration was quantified and 1µg was lipofected into 10
5
 IdV ES cells. The cells 
were transferred to three 9cm dishes after 24 hours at 1/100, 1/10 and 8.9/10 
dilutions. 2µg/ml puromycin were added to the cells after a further 24 hours, and 20 
resistant clones were picked and expanded after 1 week of selection. I screened the 
clones for maintenance nuclear mKate2 expression following 5 days of 
differentiation in culture medium containing FCS without LIF in the absence of 
selection. I generated frozen stocks of three clones with high transgene expression in 
all cells after differentiation, and used one of these for the experiments presented in 









Figure 2.6 – mKate2-NLS lineage labelling plasmid 
Structure of the plasmid used for the generation of lineage-labelled IdV ES cells 
(plasmid code: MMP077). The CAG promoter drives the expression of mKate2-
linker-NLS, which is followed by an internal ribosome entry site (IRES), a puromycin 
resistance gene (Pac), and a polyadenylation signal sequence (polyA). The position 
of the ScaI restriction site used for the linearisation of the plasmid and the positions 
of the restriction sites used for the generation of the plasmid are indicated (see main 
text). 
 
2.2.4.1.8 Generation of Id1-Venus Nanog-tagRFP double reporter ES cells 
In order to generate Id1-Venus Nanog-tagRFP ES cell lines, I made use of a 
construct generated and kindly gifted to me by Dr. Nicola Festuccia in Dr. Ian 
Chambers’s laboratory. The salient features of the plasmid are depicted in Figure 2.7. 
100µg of the plasmid were linearised by digestion with NotI, ethanol precipitated 
and electroporated into 10
7
 IdV ES cells. 10
6
 cells were transferred to ten 9cm dishes 
immediately following electroporation. 10µg/ml blasticidin S were added to the cells 
 








Figure 2.7 – Nanog-tagRFP targeting construct 
Structure of the plasmid used for the generation of Nanog-tagRFP reporter ES cells 
(plasmid name: pRescue_Nanog-RFP-IB). The 5’ homology arm (5840bp) is 
constituted by the four exons and 3 introns of the Nanog locus (as indicated in 
figure). The stop codon is replaced by the DNA encoding for a flexible linker, fused 
in frame to tagRFP. This sequence is followed by an IRES and Bls, a gene encoding 
for blasticidin S resistance. The IRES-Bls cassette is flanked by loxP sites. The 3’ 
homology arm (5331bp) contains the 3’ UTR of Nanog, including the endogenous 
polyadenylation signal sequence. The position of the NotI restriction site used for the 








2.2.4.2 Culture conditions 
All cell culture was performed on Corning cell culture plastics. 
 
2.2.4.2.1 LIF+FCS culture 
ES cells were propagated in LIF+FCS culture medium unless otherwise specified. 
This culture medium is similar to that used by Smith et al. (1988) upon 
characterisation of LIF as a crucial factor for the maintenance of pluripotency. Its 
composition is as follows: 
Component Volume Final concentration 
Glasgow Minimum Essential Medium 
(GMEM, Sigma) 
500ml  
Foetal Calf Serum (FCS, Gibco) 51ml 10% 
L-Glutamine/Sodium pyruvate solution 11ml L-Glutamine 2mM 
Sodium pyruvate 1mM 
Non-Essential Amino Acids (NEAA, 
Gibco) 
5.5ml 1X 
0.1M 2-mercaptoethanol 570µl 100nM 
LIF 570µl 100U/ml 
To passage ES cells cultured in LIF+FCS, Cell culture dishes were coated with 0.1% 
gelatine in PBS for 30 minutes prior to cell passaging. The medium was aspirated 
from the cells, sterile PBS (Sigma) was used to wash the cells once, and a 0.05% 
solution of trypsin EDTA (1:5 dilution of 0.25% trypsin EDTA, Gibco, in PBS) was 
added to the cultures. The cells were incubated at 37°C until detachment (typically 1-
3 minutes). 5-10 volumes of LIF+FCS medium were added to the cells to quench the 
action of trypsin EDTA. The cells were pelleted in a universal tube (Sterilin) at 300g 
for 3 minutes. The medium was aspirated, the cells were resuspended in fresh 
 




LIF+FCS medium and plated at the desired density on the prepared gelatinised 
dishes, after aspiration of the 0.1% gelatine solution. 
A standard haemocytometer was used to count cell numbers when required. 
 
2.2.4.2.2 N2B27 culture 
N2B27 culture for ES cell differentiation was performed as previously described 
(Pollard et al. 2006, Ying et al. 2003a, Ying et al. 2003b). 
Briefly, ES cells cultured in LIF+FCS were trypsinised, quenched, pelleted, 
resuspended in N2B27 medium, pelleted again, resuspended in N2B27 medium and 
plated at the desired concentration for differentiation. The composition of N2B27 
medium is as follows: 
Component Volume Final concentration 
DMEM/F12 (Gibco) 50ml  
Neurobasal (Gibco) 50ml  
L-Glutamine 1ml 2mM 
0.1M 2-mercaptoethanol 100µl 100nM 
N2 (homemade) 500µl  
B27 (Gibco) 1ml 0.5X 
 
2.2.4.2.3 2i and LIF+BMP4 culture 
2i and LIF+BMP4 culture was performed as previously described (Ying et al. 2003a, 
Ying et al. 2008). 2i and LIF+BMP4 are N2B27-based media. The composition of 
the N2B27 used for these cultures is identical to that used for differentiation, with the 
exception that the homemade N2 supplement is replaced by the N2 supplement 
produced by Gibco (500µl N2/100ml medium, final concentration 0.5X). 
 




To generate 2i medium, N2B27 was supplemented with 1µM PD0325901 and 3µM 
CHIR99021. 100U/ml LIF were added to make 2i+LIF medium. 
For the transfer of ES cells cultured in LIF+FCS to 2i culture medium, culture dishes 
were coated with poly-L-ornithine (Sigma) for 2 hours at room temperature. The 
poly-L-ornithine coating was removed and the dishes were then coated with laminin 
(Sigma) for 2 hours at room temperature. LIF+FCS cultures were trypsinised, 
quenched, pelleted, resuspended in N2B27, pelleted again, resuspended in 2i and 




. 2i cultures were 
passaged every three days. Cells were washed with DMEM/F12 and detached from 
the dish by incubating them in accutase (Sigma) at 37°C until detachment (typically 
3 minutes). They were quenched in N2B27, pelleted, resuspended in 2i and replated 





To generate LIF+BMP4 medium, N2B27 was supplemented with 100u/ml LIF and 
10ng/ml BMP4. 
For the transfer of ES cells cultured in LIF+FCS to LIF+BMP4 culture medium, 
culture dishes were coated with 0.1% gelatine for 30 minutes. LIF+FCS cultures 
were trypsinised, quenched, pelleted, resuspended in N2B27, pelleted again, 
resuspended in LIF+BMP4, counted and plated in LIF+BMP4 at the desired density. 
To passage LIF+BMP4 cultures, cells were washed with DMEM/F12 and detached 
from the dish by incubating them in accutase (Sigma) at 37°C until detachment 
(typically 3 minutes). They were quenched in N2B27, pelleted, resuspended in 
LIF+BMP4 and replated at the desired density. 
 
2.2.4.2.4 Epiblast stem cell culture 
Epiblast stem cell cultures were cultured as previously reported (Brons et al. 2007, 
Tesar et al. 2007) with minor modifications. The N2B27-based EpiSC culture 
medium composition was optimised in our Institute for EpiSC viability and 
 




proliferative capacity by Dr. Rodrigo Osorno and Dr. Anestis Tsakiridis in Dr. Ian 
Chambers and Dr. Val Wilson’s laboratories. Its composition is as follows. 
Component Volume Final concentration 
DMEM/F12 (Gibco) 50ml  
Neurobasal (Gibco) 50ml  
0.1M 2-mercaptoethanol 100µl 100nM 
L-Glutamine 1ml 2mM 
Non-Essential Amino Acids (Gibco) 1ml 1X 
N2 (Gibco) 500µl 0.5X 
B27 (Gibco) 2ml 1X 
Activin A, 10µg/ml in 0.1% BSA (R&D) 200µl 20ng/ml 
Fgf2, 10µg/ml in 0.1% BSA (R&D) 100µl 10ng/ml 
The EpiSC basal medium (modified N2B27) was prepared without addition of 
Activin A and Fgf2. These molecules were added to EpiSC basal medium at the 
concentrations described above immediately prior to use. 
EpiSCs were derived from ES cells following the protocol of Guo et al. (2009). A 
well of a 6-well plate was coated with 7.5ng/ml fibronectin in PBS for 1 hour. The 
fibronectin solution was removed and 3x10
4
 ES cells were plated onto the well in 
LIF+FCS. After 24 hours, the well was washed twice with PBS and EpiSC culture 
medium was added to the cells. The cells were allowed to reach high density before 
passaging. To passage the cells, they were washed in DMEM/F12 and incubated in 
accutase for 1-2 minutes at 37°C. The dish was forcefully slapped to induce cell 
detachment from the basal membrane without generating a single-cell suspension. 
N2B27 was used to quench the accutase, the cells were pelleted, resuspended in 
EpiSC culture medium and replated at high density in 1:2-1:4 dilutions. The EpiSCs 
were used for experimentation after 10 passages, to minimise the chances of leftover 
 




undifferentiated ES cell in the cultures, and before 20 passages, to decrease the 
likelihood of genetic or epigenetic abnormalities induced by extended passaging. 
 
2.2.4.2.5 Cell culture on coverslips 
Cells to be subject to confocal microscopy were cultured on confocal microscopy-
compatible plastic coverslips custom-made for the use of our laboratory by Ibidi. For 
each sample to be prepared, a coverslip was placed in a well of a 6-well plate and 
coated with the appropriate coating medium for a minimum of 1 hour prior to cell  
plating. 
 
2.2.4.2.6 Cell stimulation with exogenous molecules 
Cells stimulated with exogenous factors for flow cytometry or immunostaining 
analysis were treated as follows. 





the presence of the exogenous factors and cultured for 48 hours. 




. After 24 
hours, the culture medium was replaced with 2i supplemented with the exogenous 
factors, and the cells were cultured for a further 48 hours. For the R2i sample 
described in section 3.2.5.3, the medium was switched from 2i to R2i after 24 hours 
of plating, and the cells were cultured for a further 48 hours. 
For EpiSCs, the cells were plated in the presence of the exogenous factors at an 












 ES cells were plated in LIF+FCS and allowed to attach to a well of a 6-well plate 
(minimum 1 hour, generally  5-6 hours). 1-3µg of linear or circular plasmids were 
diluted in 100µl GMEM. 1-2µl Lipofectamine™ 2000 were diluted in 100µl GMEM 
and incubated for 5 minutes at room temperature. The diluted plasmid solution was 
gently added to the Lipofectamine 2000 solution and incubated for 20 minutes at 
room temperature. The Lipofectamine 2000/plasmid solution was then added to the 
ES cells in a drop-wise manner. The plate was gently rocked to spread the lipofection 
solution and incubated overnight at 37°C. Mock lipofections were performed by 
diluting 1-2µl Lipofectamine 2000 in 200µl GMEM and adding it to cells. Positive 
control lipofections were performed by lipofecting a fluorescent plasmid and 
screening for fluorescence under a fluorescent microscope 24 hours post-lipofection. 
 
2.2.4.3.2 Electroporation 
Prior to electroporation, thirteen 9cm dishes were gelatinised for 30 minutes at room 
temperature. The gelatine was removed, LIF+FCS medium was added to the dishes 
and they were transferred to a 37°C incubator for 1 hour. 9.2ml LIF+FCS medium 
were added to two universal tubes, which were transferred to a 37°C waterbath for 1 
hour. 100µg of the plasmid to be electroporated were linearised with the appropriate 
restriction enzyme, precipitated in 100% ethanol and washed once with 70% ethanol. 
For the second 70% ethanol wash, the microfuge tube in which the DNA was being 
precipitated was filled entirely with 70% ethanol to minimise the chance of bacterial 
carryover and spun again. The tube was then transferred to a cell culture hood, the 
ethanol removed and the pellet allowed to dry before resuspension in 100µl 
DNase/RNase-free distilled water (Gibco). 
 




ES cells to be electroporated were grown to confluency in two 75cm
2 
flasks. The 
cells were trypsinised, pelleted, resuspended in GMEM, pelleted and resuspended in 
700µl GMEM. The cells were counted and 10
7 
cells were added to a 4mm 
electroporation cuvette. The linearised plasmid in 100µl water was added to the cells 
and GMEM was added to a total volume of 800µl. The electroporation mixture was 
incubated at room temperature for 3 minutes, following which the cells were 
electroporated at 3µF (0.8kV). The 800µl containing electroporated cells were 
immediately transferred to a universal containing 9.2ml of pre-warmed LIF+FCS 
medium, and 1ml of this solution (10
6
 cells) was added to each of ten 9cm dishes. 
For the mock electroporation, 10
7 
cells were subject to the same electroporation 
procedure in the absence of plasmid DNA, transferred to the other universal 
containing 9.2ml of pre-warmed LIF+FCS, and 1ml of this solution was added to 
each of three 9cm dishes. Selective medium was added 24 hours after cell plating. 
 
2.2.4.4 Cryopreservation of cells 
2.2.4.4.1 Cell freezing 
To cryopreserve cells, they were subject to trypinisation/accutase treatment and 
pelleted following standard passaging routines. The supernatant was aspirated off 
and the cells were resuspended in FCS+10% dimethylsulphoxide (DMSO) 
(LIF+FCS cultures) or knockout serum replacement (KSR)+10% DMSO (N2B27-
based cultures). 1ml of FCS/KSR+DMSO was used for each aliquot to be frozen 
(usually 10
6
 cells were frozen per aliquot). Upon resuspension, each aliquot was 
transferred to a cryovial (Thermo Scientific) and immediately placed on dry ice. 
They were then transferred to -80°C freezers for temporary storage and liquid 
nitrogen tanks (-178°C) for long-term storage. 
 
 




2.2.4.4.2 Cell defrosting 
To defrost cells, 9ml LIF+FCS (for cells frozen from LIF+FCS) or N2B27 (for cells 
frozen from N2B27-based cultures) were added to a universal and incubated at 37°C. 
The aliquot containing the frozen cells was thawed at room temperature and 
immediately added to the pre-warmed medium. The cells were pelleted and the 
supernatant aspirated. The cells were then resuspended in the culture medium of 
choice and plated onto pre-coated plates or dishes. 
 
2.2.4.5 ES cell differentiation protocols 
2.2.4.5.1 N2B27 differentiation 
The preparation of ES cell samples for N2B27 neural adherent monolayer 
differentiation was performed as described in paragraph 2.2.4.2.2 and as previously 
reported (Pollard et al. 2006, Ying et al. 2003a, Ying et al. 2003b). The optimal 
plating density was empirically determined for each cell line to maximise cell 
survival and efficiency of differentiation. For the differentiation experiments using 
Id1 overexpressing and empty vector control ES cells, the densities were optimised 
to obtain similar cell numbers at the final timepoint of the differentiation experiments 
(day 5). Due to the continuous rapid proliferation rate of Id1 overexpressing ES cells 
during the first three days of differentiation, presumably due to their delayed exit 
from pluripotency, the plating densities were as follows: empty vector control, Id1 













 cells/9cm dish). Plating of the Id1 overexpressing ES cells at the 









2.2.4.5.2 Embryoid body differentiation 
ES cells were prepared for embryoid body (EB) differentiation by trypsinising, 
quenching and pelleting them as for routing passaging. They were then resuspended 
twice in LIF+FCS ES cell culture medium to which LIF had not been added (“-LIF 
medium”) and counted. Their density was adjusted to 25000 cells/ml –LIF medium. 
10ml PBS were added to a non-cell culture treated 140mm Petri dish (Sterilin). The 
lid of the dish was positioned so that its outside was in contact with the base plates of 
the cell culture hood. 100 droplets of 25µl of the cell suspension (625 cell/droplet) 
were pipetted onto the inside of the lid. The lid was turned over and closed over the 
PBS-filled bottom of the Petri dish, and carefully moved to a 37°C incubator. After 
three days, the PBS was removed from the Petri dish, the droplets were dropped onto 
the bottom of the Petri dish and 30ml –LIF medium were added to maintain the 
expanding EB’s in culture. To collect the EB’s for RNA extraction, the 30ml 
medium was transferred to a universal tube, the EB’s were pelleted by centrifugation 
at 300g for 3 minutes, the supernatant was carefully aspirated off, and the EB’s were 
lysed following the same protocol adopted for cell pellets. 
For the setup of EB differentiation from sorted cells, the cells in the sorted samples 
were pelleted, resuspended twice in –LIF medium supplemented with penicillin and 
streptomycin (Gibco) to prevent bacterial contamination deriving from the 
fluorescence activated cell sorter. The differentiation was then set up as described for 
trypsinised cells above, maintaining penicillin and streptomycin in the culture 
medium throughout the differentiation experiment. 
 
2.2.4.6 Flow cytometry and fluorescence activated cell sorting 
2.2.4.6.1 Sample preparation 
Cell samples were prepared for flow cytometry and fluorescence activated cell 
sorting by generating a single-cell suspension with standard passaging methods. 
 




Following trypsin/accutase treatment, quenching and pelleting, the cells were 
resuspended in PBS+10% FCS and immediately placed on ice in the dark. To 
remove dead cells from the flow cytometry analyses and the sorted samples, these 
resuspensions were supplemented with 100ng/ml DAPI or 1µg/ml propidium iodide. 
DAPI was used for samples analysed on the LSRFortessa (IVNR cells) or samples 
sorted on the FACSAria, propidium iodide was used for samples analysed on the 
FACSCalibur (flow cytometry experiments on IdV and IdV-SC cells), since this 
analyser lacks the laser/detector combination to detect DAPI. These fluorescent 
molecules cannot enter intact cells, but can penetrate dead cells with disrupted cell 
membranes and bind DNA, thus allowing to discriminate between live 
DAPI/propodium iodide-negative and dead DAPI/propidium iodide-positive cells 
during flow cytometry experiments. 
 
2.2.4.6.2 Sample analysis 
Flow cytometry experiments were performed as recommended by the manufacters of 
the analysers. The softwares used on the machines were CellQuest for the 
FACSCalibur and FACSDiva for the LSRFortessa. 10000-50000 cells were analysed 
for each sample. The FACSAria cell sorter was operated by the Flow Cytometry 
Staff in my presence, using the FACSDiva software. E14Ju09 ES cells were used as 
negative controls, and single-fluorophore controls were used whenever possible. 
 
2.2.4.6.3 Data analysis 
The data generated on the analysers and the sorter was exported as .fcs files. 
Analysis of the data was performed with the FlowJo software. Debris was excluded 
by gating using forward scatter and side scatter. Comparison of the amplitude and 
height of the side scatter signal was used to exclude doublets (two cells stuck 
 




together and simultaneously analysed). Dead cells were then excluded by gating for 
DAPI-negative or propidium iodide-negative cells. This data was then plotted to 
observe the expression pattern of the fluorescent proteins of interest. When 
generating overlay histograms, the same number of events were inputed for each 
separate sample. Gating to calculate percentages of positive and negative cells was 




2.2.5.1 Maintenance of mice 
Mice were housed and bred in the Animal Unit of the Centre for Regenerative 
Medicine, in accordance to the provisions of the Animals (Scientific Procedures) Act 
1986 and the 2010/63/EU Directive. 
 
2.2.5.2 Morula aggregation 
Morula aggregations were performed by the Transgenics Unit staff. ES cells used for 
morula aggregations were cultured in LIF+FCS prior to dissociation and aggregation 
into C57/BL6 host embryos. Embryos were cultured until the blastocyst stage and 
injected into the uterus of pseudopregnant females. 
 
2.2.5.3 Embryo dissections 
Female mice that were injected with chimaeric blastocysts were culled by cervical 
dislocation by the staff of the Animal Unit. The uterus was dissected from the mice, 
and embryos were dissected from the uterus in M2 culture medium (Sigma) at room 
 




temperature using forceps. The decidua and Reichert’s membrane were removed 
before the embryos were fixed as described in section 2.2.3.2.1. The dissections were 
performed under a StereoZoom SMZ-U dissection microscope (Nikon). 
 
2.2.5.4 Sectioning fixed embryos 
Fixed embryos were sectioned by the Histology Service of the institute. Embryos 
were embedded in gelatine, 7µm-thick sections were generated with a cryostat and 








The helix-loop-helix factor Id1 carries out a crucial role in the maintenance of 
embryonic stem cell pluripotency. ES cells are routinely cultured in medium 
containing LIF and foetal calf serum, and the key component of FCS for ES cell self-
renewal is BMP4, an extracellular signalling molecule which drives the transcription 
of Id1. Id1 overexpression can functionally substitute for BMP4/FCS to preserve the 
self-renewal capability of ES cells (Ying et al. 2003a). 
The expression of Id1 in pluripotent cultures has been studied at the population level. 
Id1 is expressed in ES cells cultured in LIF+FCS and rapidly downregulated at the 
onset of differentiation, both in neural adherent N2B27 differentiation and undirected 
embryoid body differentiation protocols; it is expressed at low levels in 2i culture 
(Aiba et al. 2009, Marks et al. 2012, Romero-Lanman et al. 2011, Ying et al. 2003a). 
The expression pattern of Id1 within pluripotent cultures at a higher resolution has 
been addressed as part of a single-cell qRT-PCR study, which revealed a 
heterogeneous expression pattern for the HLH factor both in ES cell cultures and in 
the inner cell mass of the blastocyst (Tang et al. 2010). 
The absence of comprehensive information on the expression pattern of Id1 at the 
protein level within single cells in culture led me to generate Id1-Venus fluorescent 
reporter ES cells. These cells were used to address the pattern of Id1 expression 
within pluripotent cultures at the single cell level by flow cytometry and imaging, to 
study its response to activation and inhibition of specific signalling pathways, and to 
investigate its relationship with other transcription factors involved in the 
maintenance of ES cell pluripotency. 
 
 





3.2.1 Id1-001 is the only expressed Id1 isoform in pluripotent and differentiated ES 
cells 
The Id1 locus encodes two splice variants of the gene, Id1-001 and Id1-002 
(Hernandez et al. 1996). These alternative transcripts are highly similar, and code for 
proteins which share 135 amino acids out of a total of 148 (Id1-001) or 168 (Id1-
002). The transcripts differ at their 3’ ends, Id1-001 contains an intron which is not 
spliced in Id1-002 (Figure 3.1a). 
I investigated which of these transcripts were expressed in ES cells and cells 
differentiated for 5 days in N2B27 medium in a neural adherent monolayer 
differentiation protocol (Ying et al. 2003a,b). I designed two sets of primers to 
amplify sequences contained in both transcripts or in Id1-002 only (Figure 3.1a). I 
could not design a set of primers specific to Id1-001 since its entire sequence is 
present in Id1-002 mRNA. I performed PCR’s on cDNA from ES cells cultured in 
LIF+FCS and ES cells cultured in N2B27 for 5 days, and observed that only Id1-001 
is expressed in these cultures (Figure 3.1b). 
 
3.2.2 The expression pattern of Id1 mRNA in pluripotent and differentiating 
cultures 
I set out to recapitulate published qRT-PCR and microarray results on the expression 
of Id1 mRNA in pluripotent cultures and differentiating cells. I performed qRT-PCR 
experiments on cDNA obtained from E14tg2a ES cells cultured in 2i, LIF+FCS or 
differentiated into EpiSCs (Figure 3.2a). Id1 is expressed at very low levels in 2i 
culture, at slightly higher levels in EpiSCs and at much higher levels in LIF+FCS. I 
then performed an adherent neural monolayer differentiation experiment by plating 
E14tg2a ES cells (cultured in LIF+FCS) in N2B27 for 5 days, extracting RNA at 
 




daily timepoints. I performed qRT-PCR experiments on these samples and observed 
that Id1 is sharply downregulated at the onset of differentiation, and its expression is 
progressively re-acquired during the course of the differentiation experiment (Figure 
3.2b), as had been previously observed in microarray experiments (Aiba et al. 2009). 
 
3.2.3 The quality of commercially available anti-Id1 antibodies is insufficient for 
reliable Id1 protein expression analysis 
In order to address the pattern of Id1 expression in culture at the protein level, I 
tested two commercially available anti-Id1 antibodies. The first antibody (Santa Cruz 
SC-488) had been used by Ying et al. (2003a) with promising results, the second 
(Chemicon 7D4.2) was tested for comparison. I performed Western blots on the 
lysate of E14tg2a ES cells cultured in LIF+FCS, and probed the membranes with the 
two antibodies (Figure 3.3). Neither of the antibodies resulted in the presence on the 
membranes of a single band of approximately 15 kDa, corresponding to Id1. The 
Santa Cruz antibody detected Id1, but also detected a further 9 non-specific bands. 
The Chemicon antibody resulted in a smear on the membrane. This confirmed a 
previous report which suggested the Santa Cruz SC-488 antibody was unsuitable for 
the specific detection of Id1 in mouse tissues (Perk et al. 2006). 
 
3.2.4 Generation of an Id1-Venus reporter ES cell line 
The lack of a commercially available high quality specific anti-Id1 antibody raised 
the problem of how to address the expression of Id1 protein in pluripotent cultures at 
single-cell resolution. When faced with the same issue, Perk et al. (2006) opted for 
the generation of anti-Id1 antibodies. Whilst this strategy offers the advantage of 
being able to study the expression of Id1 in all cells and tissues of interest, the 
successful generation of a specific antibody is by no means certain. I selected an 
 




alternative strategy, with a higher likelihood of success and other benefits: the 
generation of an Id1 fluorescent reporter ES cell line. The advantages of a 
fluorescent reporter line are manifold: not only can the expression of Id1 be studied 
by imaging and Western blotting, it can also be studied by flow cytometry, and live 
cells can be sorted into separate populations based on expression of the fluorescent 
reporter protein. This cannot be done with antibody staining, since Id1 is an 
intracellular protein and permeabilisation of live cells for immunostaining prior to 
flow cytometry would result in their death. 
 
3.2.4.1 Selection of a reporter system 
I decided to generate a fusion of Id1 with Venus, a yellow fluorescent protein with 
the appealing properties of being bright and fast-folding (Nagai et al. 2002, Shaner et 
al. 2005), and thus coupling ease of detection with minimal likelihood of disruption 
of the properties of wild-type Id1. The use of a fusion protein offers advantages over 
systems that rely on gene replacement, on insertion of an internal ribosomal entry 
site followed by the fluorescent protein sequence downstream of the gene of interest, 
or on 2A peptide-fluorescent protein fusions. The replacement of one of the alleles of 
a gene of interest with a fluorescent protein may result in the loss of potential 
regulatory sequences within the gene body, resulting in a misregulation of the 
transcription of the reporter allele. It can also lead to haploinsufficiency phenotypes. 
Whilst this is unlikely to be the case for Id1, since its knockout has no phenotype in 
vivo (Fraidenraich et al. 2004, Lyden et al. 1999), the observation that its knockout 
does have a phenotype in ES cells (Romero-Lanman et al. 2011) means subtle 
haploinsufficiency phenotypes have the potential to arise under specific culture 
conditions. Internal ribosome entry sites cannot guarantee equimolar expression of 
the mRNAs of the fluorescent protein and of the gene of interest. Conventional 
IRES’s can lead to lower expression of the transcript downstream of the IRES (Chan 
et al. 2011), which could result in undetectable fluorescent protein expression in a 
 




cell that is expressing the gene of interest. The gtx-IRES transcriptional amplification 
system results in higher expression of the transcript downstream of the IRES 
(Canham et al. 2010, Chappell et al. 2000). If the transcriptional amplification is not 
constant amongst all cells in culture, differences in fluorescent protein expression 
levels could arise in cells expressing the same amount of gene of interest mRNA. 
Fusion of the protein of interest to a fluorescent protein via a 2A peptide allows 
equimolar expression of the two proteins with minimal disruption to the function of 
the protein of interest. 2A peptides, in fact, lead to the co-translational separation of 
the two linked proteins, so that expression of each molecule of a protein of interest 
leads to expression of a molecule of fluorescent protein (Donnelly et al. 2001, 
Palmenberg et al. 1992, Ryan et al. 1991). This system should allow for accurate 
reporting of the expression of the gene of interest, but does not allow to study the 
subcellular localisation of the protein of interest, and, if the stability of the 
fluorescent protein and the protein of interest vary greatly, could result in persistence 
of fluorescence after loss of expression of the protein of interest. The use of fusion 
proteins is also subject to disadvantages: the fusion protein may be defective in cell 
localisation or in protein activity, and the fluorescent protein may affect protein 
stability, but it guarantees the presence of the protein of interest whenever 
fluorescence is detected. Importantly, in the case of Id1, an Id1-Venus fusion protein 
has already been generated and shown to accurately report Id1 expression within the 
nervous system, without causing any phenotype in the reporter mouse harbouring 
two copies of the reporter construct targeted into both endogenous Id1 loci (Nam & 
Benezra 2009). 
 
3.2.4.2 Id1-Venus targeting strategy 
To generate Id1-Venus reporter ES cells, I made use of an updated version of the 
targeting construct used by Nam & Benezra (2009), kindly gifted to our laboratory 
by Dr. Robert Benezra and Dr. Hyung-song Nam (Memorial Sloan-Kettering Cancer 
 




Center, New York, USA). This targeting vector contains a 5’ targeting arm with 
12479bp of homology to the wild-type Id1 locus (including Id1 itself), the sequence 
encoding a flexible linker and Venus fused to the 3’ end of Id1-001 upstream of the 
stop codon, a further 874bp of homologous DNA containing the polyadenylation site 
for the transcript, an Frt-flanked Flp-excisable selection cassette containing a Pgk 
promoter driving transcription of the selectable marker Neo, a 3630bp-long 3’ 
homology arm, and an RNAPII promoter fragment driving expression of the toxic 
molecule DTA outwith the regions of homology, to promote the death of cells 
harbouring random integrations of the construct (Figure 3.4b). Correct targeting of 
this construct to the Id1 locus would result in the replacement of the endogenous Id1 
sequence (Figure 3.4a) with the Id1-Venus fusion followed by the selection cassette 
(Figure 3.4c). Episomal transfection of a plasmid containing a Pgk promoter driving 
expression of FlpO recombinase would then result in recombination of the two Frt 
sites and loss of the selection cassette (Figure 3.4d). For more information refer to 
section 2.2.4.1.5 of the Materials and Methods chapter. 
 
3.2.4.3 Generation of Id1-Venus reporter ES cells 
I electroporated the linearised targeting construct into E14Ju09 ES cells. These ES 
cells were derived in our Institute from E14tg2a chimaeric embryos and share the 
same genotype of E14tg2a ES cells. They were selected for use due to their high rate 
of germline transmission and chimaeric contribution, as determined by our Institute’s 
Transgenics Service staff. Electroporated cells were cultured in the presence of 
300µg/ml G418 for 10 days before clones were picked into 96-well plates. Genomic 
DNA was extracted from each of the clones undergoing expansion. I performed 
Southern blots on the genomic DNA samples digested with HindIII using the probe 
designed by Nam & Benezra (2009) for identification of correctly targeted clones 
(Figure 3.5a). I identified three clonal ES cell lines with the correct targeting event 
(clones 47, 72 and 77). The ~6kb band corresponding to the targeted allele band in 
 




the blots appeared to be weaker than the ~12kb wild-type band for clones 72 and 77. 
I re-extracted genomic DNA from the three clones and the parental E14Ju09 ES cells 
and repeated the Southern blots, probing the membrane with the same “targeting” 
probe as in Figure 3.5a as well as with a probe to detect spurious integrations of the 
construct (Figure 3.5b, probe binding location depicted in Figure 3.4). All three 
clones had appropriately sized wild-type and targeted bands, but the targeted band 
for clones 72 and 77 appeared to be weaker than the wild-type band again. Clone 77 
also had an extra construct integration event. I therefore elected to use clone 47 for 
future experiments, and I re-named this clonal ES cell line IdV, for Id1-Venus. 
 
3.2.4.4 Verification of Venus expression in the reporter cells 
I proceeded to test whether the Venus fluorescence was detectable from the fusion 
protein by performing flow cytometry and immunostaining of ES cells cultured in 
LIF+FCS. Flow cytometry revealed that Venus fluorescence can be detected in this 
cell line, and that it is distributed normally, with the majority of cells expressing the 
fluorescent protein (Figure 3.5c). I then stained IdV ES cells using a polyclonal anti-
GFP antibody (A111222, Molecular Probes) capable of detecting the Venus epitope, 
and counterstained cell nuclei using DAPI. This revealed a heterogeneous expression 
pattern for Id1-Venus within ES cell colonies (Figure 3.5d). I made use of a nuclear 
immunostaining quantification software named MultiCell3D, developed by Dr. 
Guillaume Blin, a member of our laboratory, to measure the Venus fluorescence 
intensity within the each nucleus of over 900 IdV and over 1000 E14Ju09 ES cells 
(more information on MultiCell3D can be found in section 2.2.3.2.8 of the Materials 
and Methods chapter). A logarithm-scale plot of the intensity distribution of the 
nuclear Venus signals revealed a fluorescence distribution nearly identical to that 
observed in the flow cytometry experiment (Figure 3.5d), giving further credit to the 
flow cytometry result and confirming the validity of the nuclear immunostaining 
quantification technique for analysis of protein expression at the single cell level. 
 




3.2.4.5 Venus expression reports Id1 expression 
In order to verify whether Venus fluorescence correctly reported expression of Id1, I 
performed fluorescence-activated cell sorting of the 20% of cells expressing the 
highest and the 20% of cells expressing the lowest Venus fluorescence in a LIF+FCS 
ES cell culture. RNA was collected from the sorted samples and the starting culture 
and reverse transcribed to cDNA. qRT-PCR experiments were performed on the 
three samples to measure the expression level of Id1, Venus and the housekeeping 
gene Tbp, used to normalise the levels of Id1 and Venus transcripts (Figure 3.6). Both 
Id1 and Venus were expressed at the highest level in the Venus-high population, at an 
intermediate level in unsorted cells, and at the lowest level in the Venus-low sample. 
This suggests the expression of Venus in the reporter cells is accurately reporting the 
expression of Id1. 
 
3.2.4.6 Excision of the selection cassette from IdV ES cells 
I then set out to excise the selection cassette from the IdV ES cells. I lipofected the 
cells with a plasmid encoding FlpO recombinase, plated the cells at clonal density 
and allowed them to form colonies. I picked 96 colonies into a 96-well plate, replica 
plated them, and cultured one plate in the absence of G418 and the other plate in the 
presence of 300µg/ml G418. Only 1 colony displayed subsceptibility to G418, 
suggestive of excision of the selection cassette. Genomic DNA was extracted and 
digested with HindIII, and a Southern blot was performed with this genomic DNA 
alongside that of E14Ju09 and IdV ES cells (Figure 3.7a). The Southern blot 
confirmed the removal of the selection cassette. I named this cell line IdV-SC for 
IdV minus Selection Cassette. For more information refer to sections 2.2.4.1.6 of the 








3.2.4.7 Comparison of Venus fluorescence in IdV and IdV-SC ES cells 
I next set out to compare the expression level of Venus between IdV and IdV-SC ES 
cells. I decided not to perform this comparison between cells cultured in LIF+FCS 
because these culture conditions can contain different ratios of cells in different self-
renewal states (naïve pluripotency, primed pluripotency and differentiation) between 
parallel cultures, and this property could in turn influence the number of Id1-Venus 
expressing cells and the intensity of Id1-Venus expression in those cells. I therefore 
decided to culture the two ES cell lines in 2i, a defined culture medium which 
homogenises cell potency and gene expression (Ying et al. 2008, Nichols et al. 
2009), and supplemented this medium with 10ng/ml of the Id1 inducer BMP4 and 
with 10µM SB431542, a small-molecule inhibitor of Activin/Nodal signalling, 
shown to induce Id1 expression in ES cells cultured in LIF+FCS (Galvin et al. 2010). 
I performed flow cytometry analysis of the two cell lines alongside E14Ju09 non-
fluorescent control ES cells, and observed that Id1-Venus was expressed in 
2i+BMP4+SB431542 at similar levels between IdV and IdV-SC cells, suggesting 
either cell line is fit for Id1-Venus expression analysis in ES cells (Figure 3.7b). 
The IdV ES cells offer the possibility of applying G418 selection during routine cell 
passaging, thus ensuring that the transgene is not lost by mitotic recombination 
(Stern 1936) or that the locus is not epigenetically silenced. The IdV-SC ES cells 
have the advantage of lacking exogenous DNA downstream of the Id1 locus (with 
the exception of an Frt site), thus ensuring that no regulatory DNA sequence is 
disrupted. Serum-free culture results in greater susceptibility of cells to antibiotic 
selection, and to prevent excessive cell death I avoided applying the selective 
medium in these conditions. I consequently performed all experiments in serum-free 
medium with IdV-SC ES cells, and I will present flow cytometry data for LIF+FCS 
culture performed with the same cell line for coherence. Most of these data were 
generated in parallel with IdV ES cells, and the cell lines displayed the same 
behaviour. Their identical response to BMP4 stimulation and inhibition is illustrated 
 




as an example in Figure 3.7c (see the next paragraph for further details on the BMP4 
response of Id1-Venus reporter cells). 
 
3.2.5 Analysis of Id1-Venus expression in pluripotent cultures by flow cytometry 
3.2.5.1 Id1 is induced by BMP4 and repressed by Activin A in LIF+FCS culture 
Id1 has been shown to respond to treatment with BMP4 and the Activin/Nodal 
inhibitor SB431542 in LIF+FCS culture of ES cells at the transcript level (Galvin et 
al. 2010). I set out to investigate the response of Id1 protein to BMP4 and 
Activin/Nodal stimulation and inhibition at the single cell level by performing flow 
cytometry analyses of IdV ES cells cultured in LIF+FCS and treated with agonists 
and antagonists of the BMP and Activin A signalling pathways for 48 hours. I 
selected this experimental strategy to understand how ES cells in LIF+FCS culture 
conditions would respond to alterations in these signalling pathways over a time 
window that would allow them to comprehensively alter their gene expression, 
without conceding a long enough time frame for the cells to overtly differentiate. The 
observed changes in Id1-Venus expression should therefore represent a mid-term 
reaction to exogenous stimuli at steady state, rather than the intrinsic capability of an 
ES cell culture to respond to said stimuli after starvation in the absence of any other 
instructive signal. 
Firstly, I assessed the Id1-Venus response to BMP signalling stimulation and 
inhibition. To stimulate BMP signalling, I made use of recombinant BMP4 at a 
concentration of 10ng/ml, the concentration used by Ying et al. (2003) to maintain 
ES cell self-renewal in LIF+BMP4 culture. To inhibit BMP signalling, I cultured 
cells in the presence of 100nM LDN-193189, a small-molecule compound which at 
this concentration selectively inhibits phosphorylation of Smad1/5/8 without 
affecting phosphorylation of Smad2 in mouse pulmonary artery smooth muscle cells 
cultured in the presence of FCS (Yu et al. 2008). The compound is also routinely 
 




used at this concentration to inhibit BMP signalling in the neural induction of human 
pluripotent stem cells (Chambers et al. 2012). 
I performed flow cytometry on untreated, BMP4-stimulated and LDN-193189-
treated LIF+FCS cultures of IdV-SC ES cells, alongside E14Ju09 parental non-
fluorescent control ES cells (Figure 3.8a. This is the same experimental setup as in 
Figure 3.7c; the data are displayed for ease of comparison with the rest of the figure). 
I observed that, as expected, Id1-Venus fluorescence was increased upon BMP4 
treatment and was decreased upon LDN-193189 treatment. This suggests that whilst 
there is BMP in FCS, it is not at a concentration which would saturate BMP 
receptors, or BMP4 addition to LIF+FCS culture would have no effect. It is 
interesting to note that LDN-193189 treatment decreased Id1-Venus expression but 
did not abolish it, suggesting that either the LDN-193189 dosage was not sufficient 
to fully suppress BMP signalling, or that factors other than Smad1/5/8 were 
promoting Id1-Venus expression (see paragraph 1.3.2.5 for a description of non-
Smad Id1 inducers). Increasing the concentration of LDN-193189 would likely result 
in non-specific inhibition of Activin/Nodal receptors (Yu et al. 2008), thus the 
question remains unanswered. 
I then proceeded to investigate the effects of Activin A stimulation and inhibition on 
expression of Id1-Venus in LIF+FCS culture. Activin A stimulates the 
phosphorylation of Smad2/3, which can act antagonistically to the BMP-induced 
phosphorylation of Smad1/5/8 (Candia et al. 1997, Yamamoto et al. 2009), and it is 
therefore perhaps unsurprising that Activin/Nodal inhibition can induce Id1 at the 
transcript level (Galvin et al. 2010). To stimulate Activin/Nodal signalling, I made 
use of recombinant Activin A at a concentration of 20ng/ml, the concentration used 
to culture Activin/Nodal-dependent epiblast stem cells (Brons et al. 2007, Tesar et al. 
2007). To inhibit Activin/Nodal signalling, I used 10µM SB431542, a small 
molecule compound that at this concentration selectively inhibits phosphorylation of 
Smad2 without affecting the phosphorylation of Smad1 in a variety of cell types 
cultured in FCS (Inman et al. 2002). The compound is also routinely used at this 
 




concentration to inhibit Activin/Nodal signalling in the neural induction of human 
pluripotent stem cells (Chambers et al. 2009, Chambers et al. 2012). 
I performed flow cytometry on untreated, Activin A-stimulated and SB431542-
treated LIF+FCS cultures of IdV-SC ES cells, alongside E14Ju09 parental non-
fluorescent control ES cells (Figure 3.8b). I observed that, as expected, Id1-Venus 
fluorescence was increased upon SB431542 treatment. Activin A stimulation of ES 
cells decreased Id1-Venus fluorescence, but not by a large amount. This suggests that 
FCS contains a high amount of Activin/Nodal signalling agonists, which almost 
saturate Activin/Nodal receptors. It would appear that Activin/Nodal inhibition is the 
key limiting step for Id1-Venus expression in LIF+FCS culture: when gating the 
flow cytometry plot so that fewer than 1% of E14Ju09 ES cells result Venus-
positive, approximately 90% of SB431542-treated IdV-SC ES cells express Id1-
Venus, compared to approximately 65% of untreated ES cells (gate not shown, 
average of three experiments). 
I then tested the effects of administering combinations of agonists and antagonists of 
Activin/Nodal and BMP signalling (Figure 3.8c,d). Activin A reduced Id1-Venus 
expression in BMP4-treated cells, but did not further decrease Id1-Venus expression 
in LDN-193189-treated cells, confirming the near-saturating levels of Activin/Nodal 
agonists in FCS. SB431542 treatment potentiated the BMP4-driven Id1-Venus 
induction, and overcame LDN-193189 inhibition to drive similar levels of Id1-Venus 
expression to LIF+FCS culture. 
It would therefore appear that there is a high level of Activin/Nodal signalling in 
LIF+FCS culture. Inhibition of this with SB431542 results in a strong increase in 
fluorescence that cannot be suppressed by BMP inhibition. It is also interesting to 
note that LDN-193189-mediated BMP inhibition leads to a reduction in Id1-Venus 
fluorescence that is not affected by further administration of Activin A, which 
suggests a basal level of Id1-Venus expression may be intrinsic to LIF+FCS culture, 
 




or that other Activin A inhibition-resistant factors contribute to Id1-Venus 
expression. 
In summary, the expression of Id1-Venus at the protein level in LIF+FCS culture is 
positively regulated by BMP4 and negatively regulated by Activin/Nodal signalling. 
 
3.2.5.2 The expression of Id1-Venus in different ES cell culture systems 
ES cells can be maintained in a self-renewing state using different combinations of 
molecules supplemented to basal culture media. I set out to investigate the changes in 
expression of Id1-Venus in four ES cell culture media. Alongside the canonical 
LIF+FCS culture, I tested Id1-Venus expression in three N2B27-based media: 
LIF+BMP4, in which the self-renewal-stimulating activity of serum is directly 
supplanted by that of BMP4 (concentration: 10ng/ml) (Ying et al. 2003a); 2i, in 
which two small molecule inhibitors of Mek (PD0325901, concentration: 1µM) and 
of GSK3β (CHIR99021, concentration: 3µM) shield cells from autocrine signals that 
would drive their differentiation, without the need for supplementation with further 
extracellular signals (Ying et al. 2008); and 2i+LIF, in which LIF stimulation 
strengthens the maintenance of self-renewal induced by 2i. 
I  performed flow cytometry on IdV-SC ES cells cultured in each of these four 
conditions for a minimum of three passages, alongside non-fluorescent control 
parental E14Ju09 ES cells cultured in LIF+FCS (Figure 3.9a). Id1-Venus was not 
expressed in 2i nor in 2i+LIF, and was expressed at similar levels in LIF+FCS and 
LIF+BMP4. The lack of fluorescence in 2i and 2i+LIF confirms the transcript level 
data in Figure 3.2a. The observation that replacement of FCS with BMP4 results in 
similar Id1-Venus expression strengthens the argument that BMP is the crucial 
component of FCS for Id1 expression in ES cell culture (Ying et al. 2003a). 
 
 




3.2.5.3 Activin/Nodal inhibition and BMP4 stimulation are essential for Id1-Venus 
expression in 2i culture 
In order to understand whether the signals that regulate Id1 expression in LIF+FCS 
play a similar role in 2i culture, I performed flow cytometry on IdV-SC cells cultured 
in 2i and supplemented with LIF, 20ng/ml Activin A, 10ng/ml Fgf2 or 100nM LDN-
193189 for 48 hours (Figure 3.9b). I included Fgf2 amongst the test conditions to 
address whether it could induce Id1-Venus expression via Mek-independent 
pathways. The adopted concentration of Fgf2 is the concentration used to maintain 
pluripotency in EpiSC culture (Osorno et al. 2012). Supplementation of 2i medium 
with either of these molecules had no effect on Id1-Venus expression, which was 
unsurprising since the reporter is not expressed in 2i. This also suggests that Fgf2 
cannot induce Id1-Venus expression in the presence of PD0325901. 
I then tested the effects of adding 10ng/ml BMP4 and 10µM SB431542 to 2i cultures 
for 48 hours (Figure 3.9c,e). BMP4 stimulation drastically increased the expression 
of Id1-Venus, but the expression of the reporter was fully silenced upon 
simultaneous addition of BMP4 and Activin A (the histogram for the 
2i+BMP4+Activin A sample overlaps that of 2i alone and is hidden by it). SB431542 
promoted a mild increase in fluorescence, that was suppressed upon simultaneous 
addition of SB431542 and LDN-193189 (the histogram for the 2i+SB431542+LDN-
193189 sample overlaps that of 2i alone and is hidden by it). The combination of 
BMP4 and SB431542 resulted in the expression of Id1-Venus to levels similar to 
those of LIF+FCS culture. 
I also compared the expression levels of the reporter cells cultured in 2i+SB431542 
or in R2i, a culture medium alternative to 2i that also promotes ground state 
pluripotency, the composition of which is N2B27+1µM PD0352901+10µM 
SB431542 (Figure 3.9d) (Hassani et al. 2012, Hassani et al. 2013). The expression 
levels of Id1-Venus in the two media are similar, suggesting that inhibition of 
GSK3β by CHIR99021 does not affect the levels of Id1-Venus. 
 




The combination of these data suggests that the expression of Id1-Venus in 2i culture 
is dependent on simultaneous activation of BMP and inactivation of Activin/Nodal 
signalling, as exemplified by the lack of Venus fluorescence in 2i+BMP+Activin A 
and 2i+LDN-193189+SB431542. The levels of BMP in 2i culture appear to be lower 
than those of Activin/Nodal agonists, since Id1-Venus displays a stronger induction 
upon BMP4 addition than SB431542 addition (assuming Id1-Venus is induced and 
repressed equally by equimolar amounts of BMP and Activin/Nodal agonists). 
 
3.2.5.4 Id1 expression in LIF+FCS is inhibited by Mek inhibition independently of 
BMP and Activin/Nodal 
I proceeded to test the effects of the inhibitors used in 2i culture on Id1-Venus 
expression in LIF+FCS. I cultured IdV-SC ES cells in LIF+FCS supplemented for 48 
hours with 1µM of the Mek inhibitor PD0325901, 3µM of the GSK3β inhibitor 
CHIR99021, a combination of both inhibitors or with 10ng/ml Fgf2, to address 
whether Fgf stimulation had an opposite effect to Mek inhibition. This concentration 
of Fgf2 is the concentration used to maintain pluripotency in EpiSC culture (Osorno 
et al. 2012). I performed flow cytometry on the cells alongside an unsupplemented 
LIF+FCS culture and a non-fluorescent parental E14Ju09 ES cell control (Figure 
3.10a). Inhibition of Mek resulted in a marked reduction of Id1-Venus expression, to 
a level lower than that seen with LDN-193189. Addition of Fgf2 to the culture did 
not increase Venus fluorescence (the histogram for the LIF+FCS+Fgf2 sample 
overlaps that of LIF+FCS alone and is hidden by it), suggesting that either Fgf’s (or 
other Mek agonists) are present in FCS to a high amount, or that Mek inhibition 
downregulates Id1-Venus expression via an indirect mechanism. Inhibition of 
GSK3β resulted in a slight downregulation of Id1-Venus. Simultaneous inhibition of 
GSK3β and Mek reduced the expression level of Id1-Venus to a similar level to that 
seen for Mek inhibition alone. 
 




I then tested whether the Mek inhibition-driven downregulation of Id1-Venus could 
be rescued by addition of BMP4 (Figure 3.10b). Addition of BMP4 to PD0325901-
treated cells promoted expression of Id1-Venus to levels lower than LIF+FCS, a 
similar result to that seen for 2i+BMP4 (Figure 3.9c). This suggests that the 
mechanism of inhibition of Id1-Venus expression by PD0325901 has a more 
pronounced effect on Id1-Venus expression than BMP4 stimulation. 
Next, I asked whether the combination of Mek inhibition, BMP inhibition and 
Activin/Nodal stimulation could abolish Id1-Venus expression in LIF+FCS culture 
(Figure 3.10c). The combination of PD0325901 with Activin A, LDN-193189 or 
both further downregulated the expression of Id1-Venus compared to either of the 
molecules alone (refer to Figure 3.8 for the effects of Activin A and LDN-193189 in 
isolation or in combination), but could not fully suppress Id1-Venus fluorescence. 
Fewer than 5% of the cells expressed the reporter, and in these cells the levels of Id1-
Venus were very low, suggesting that the combination of these factors has a 
profound inhibitory effect on Id1-Venus expression. 
These observations suggests that the process of Mek inhibition is a major regulator of 
Id1 expression in addition to BMP and Activin/Nodal. The observation that the 
combination of Mek inhibition with either BMP inhibition or Activin A stimulation 
resulted in the downregulation of Id1-Venus compared to either of these treatments 
in isolation implies that Mek inhibition negatively regulates Id1 expression through a 
mechanism that is likely to be independent of BMP and Activin/Nodal. This 
conclusion is compounded by the observation that BMP stimulation of PD0325901-
treated cells can rescue Id1-Venus expression in part both in LIF+FCS and in 2i. 
Furthermore, it appears that Id1 expression can be drastically reduced but not fully 
abolished in LIF+FCS. This is suggestive of the presence of one or more factors that 
can positively regulate Id1 expression independently of the effects of BMP, Activin 
A and Mek. 
 
 




3.2.5.5 Id1 is induced by BMP4 and repressed by Activin A in epiblast stem cell 
culture 
Having characterised the expression pattern of Id1-Venus in ES cells, I wished to 
study its expression and its response to exogenous signals in EpiSCs. I therefore 
derived EpiSCs from IdV-SC ES cells by plating ES cells in EpiSC culture medium 
(N2B27+10ng/ml Fgf2+20ng/ml Activin A) and passaging them at high density for 
10 passages to ensure that the great majority (if not the totality) of cells in the culture 
have exited naïve pluripotency. This derivation method was originally described by 
Guo et al. (2009) and is routinely adopted by various research groups in our Institute 
(Osorno & Chambers 2011, Osorno et al. 2012). 
In first place I assessed the effect of withdrawing Fgf2 or Activin A from EpiSC 
culture medium on the expression of Id1-Venus. To ensure suppression of autocrine 
signals, I added 10µM SB431542 to the cells which I cultured in the absence of 
Activin A, and 1µM PD0325901 to the cells which I cultured in the absence of Fgf2. 
I cultured EpiSCs in these conditions for 48 hours and assessed their expression of 
Id1-Venus by flow cytometry (Figure 3.11a). EpiSCs express reduced levels of Id1-
Venus compared to ES cells, but the expression of the reporter is not abolished, in 
accordance with the transcript-level data presented in Figure 3.2a. 
Immunofluorescence analysis of EpiSCs reveals that Id1-Venus is expressed in the 
Oct4-expressing pluripotent compartment, as well as in Oct4-negative cells (Figure 
3.11d). Culture of EpiSCs in the absence of Fgf2 and the presence of PD0325901 
results in a slight downregulation of Id1-Venus. Removal of Activin A and addition 
of SB431542, on the other hand, drives the upregulation of Id1-Venus. This suggests 
that in EpiSC culture the expression of Id1 is dampened by Activin A, and that Fgf2 
only plays a minor role in the promotion of Id1 expression. 
I next investigated the response of EpiSCs to BMP stimulation and inhibition, by 
culturing EpiSCs in 10ng/ml BMP4 or 100nM LDN-193189 for 48 hours (Figure 
3.11b,d). Treatment of EpiSCs with LDN-193189 did not alter the expression of Id1-
 




Venus, suggesting that BMP signalling is low in EpiSC cultures or that its effectors 
are inhibited. Culture of EpiSCs in the presence of BMP4 resulted in a surprising 
bimodal expression pattern: a proportion of the cells responded by upregulating Id1-
Venus to levels similar to those seen in LIF+FCS culture, whilst the remainder of the 
cells appeared refractory to BMP4 stimulation and retained an expression pattern 
similar to that of non-stimulated EpiSCs. The proportion of the cells that respond or 
do not respond to BMP varies between experiments, potentially as a result of slightly 
different cell densities. This suggests that one or more factors present in EpiSC 
cultures can desensitise cells from BMP stimulation. 
I proceeded to test whether one of such factors may be Activin A by removing it 
from the EpiSC culture medium and by suppressing paracrine Activin/Nodal 
signalling with 10µM SB431542, whilst adding 10ng/ml BMP4 to the culture 
medium (Figure 3.11c). This resulted in the loss of bimodal Id1-Venus expression, 
with cells now expressing the reporter in a normal distribution, suggesting that 
Activin A may be responsible for the inhibition of the BMP4 response. Surprisingly, 
however, cultures treated with BMP4+SB431542 expressed lower average levels of 
Id1-Venus than cultures treated with SB431542 alone. This may be due to the fact 
that EpiSCs rely on Activin A for self-renewal, and are thus likely to have initiated 
differentiation after 48 hours in its absence. The cell type generated by 
BMP4+SB431542 stimulation may express other factors that may negatively 
regulate the expression of Id1-Venus. Stimulation of EpiSC cultures for a shorter 
time may aid in the study of the effects of these molecules within cells which have 
not lost their pluripotent identity. 
In summary, epiblast stem cells express low levels of Id1 and have inactive BMP 
signalling. BMP stimulation results in upregulation of Id1-Venus in a subset of cells 








3.2.6 Analysis of Id1-Venus expression in pluripotent cultures by nuclear 
immunostaining quantification 
Having studied the expression pattern of Id1-Venus in ES cell cultures by flow 
cytometry, I set out to investigate its expression pattern and its relationship with 
pluripotency factors by immunostaining. This technique allows one to observe a 
freeze-frame image of the state of cells within a culture, and to study the expression 
of multiple proteins of interest simultaneously within each individual cell. By 
measuring the fluorescence intensity for each protein of interest within each imaged 
nucleus with the MultiCell3D software (Chapter 2 section 2.2.3.2.8), it is also 
possible to obtain quantitative expression data at the single cell level. 
I therefore decided to recapitulate some of the expression data I generated by flow 
cytometry making use of immunostaining to study the expression pattern of Id1-
Venus and of the pluripotency factors Nanog and Oct4. Given that Id1 is expressed 
heterogeneously, I wished to investigate whether this factor is specifically associated 
with either naïve (Nanog-high) or primed (Nanog-low) subpopulations of ES cells, or 
with spontaneously differentiated cells (Oct4-negative). I performed immunostains 
on cells cultured in 2i, LIF+FCS, LIF+FCS+BMP4 (10ng/ml), LIF+FCS+LDN-
193189 (100nM) or LIF+FCS+PD0325901 (1µM) (Figure 3.12a). I observed that, in 
accordance with the flow cytometry data, Id1-Venus was not expressed in 2i, was 
expressed at low levels in the presence of LDN-193189 or PD0325901, and was 
expressed at higher levels in LIF+FCS and LIF+FCS+BMP4. Nanog was expressed 
uniformly at high levels in 2i, and slightly less homogeneously but still at high levels 
in the presence of PD0325901. It was expressed at a lower level and more 
heterogeneously in the other culture conditions. Oct4 was expressed at similar levels 
in a rather uniform manner in all culture conditions (Figure 3.12). This acts as a 
control confirming that differences in expression of Id1-Venus and Nanog are not 
artefacts resulting from differences in size or shape of cells in the different 
conditions. 
 




The agreement of these data with the findings of the flow cytometry experiments 
validate this quantitative immunostaining approach. 
I performed pairwise comparisons of gene expression within single cells by 
generating dot plots plotting the expression level of one factor over another within 
each nucleus (Figure 3.13). I observed that in all of the conditions, only very few (if 
any) cells were co-expressing high levels of Id1-Venus and high levels of Nanog. It 
appears that cells that are expressing high levels of one of the two factors will 
express intermediate or low levels of the other. This observation is in accordance 
with a previous report that Nanog negatively regulates the expression of Id1 (Suzuki 
et al. 2006). The negative relationship between the two factors had not previously 
been described at the single-cell level. The relationship between Id1-Venus and Oct4 
appears to be different. High levels of Id1-Venus are often associated with high or 
intermediate levels of Oct4, with very few cells expressing high levels of Id1-Venus 
and low levels of Oct4. A similar, yet even more striking, distribution is observed 
when plotting the levels of Nanog and Oct4. No cells appear to express high levels of 
Nanog and low levels of Oct4, with a visually evident maximum Nanog:Oct4 ratio 
being present in each of the plots. In 2i, the variability of Oct4 for each specific 
Nanog intensity is decreased, so that all cells lie in a line close to the maximum 
Nanog:Oct4 ratio described above. This effect has previously been described by 
Muñoz Descalzo et al. (2012) using a different nuclear immunostaining 
quantification software. This confirms the replicability of the result and the validity 
of MultiCell3D as an analysis platform. It is interesting to note that cells cultured in 
LIF+FCS+PD0325901 appear to tend to the maximum Nanog:Oct4 ratio more than 
cells cultured in the other LIF+FCS-based conditions, suggesting this culture 
condition may contain a higher number of cells in a naïve pluripotent state, as may 
be expected from the high levels of Nanog seen in the presence of PD0325901. 
 




In conclusion, Id1-Venus and Nanog appear to be in a negative relationship, as high 
expression of both factors within the same cell was rarely observed in any of the 
analysed conditions. 
 
3.2.7 Investigation of the relationship between Id1 and Nanog through the 
generation of an Id1-Venus Nanog-tagRFP double reporter ES cell line 
3.2.7.1 Generation of Id1-Venus Nanog-tagRFP reporter ES cells 
In order to further investigate the relationship between Id1 and Nanog, I decided to 
target one Nanog allele in IdV ES cells to generate a double fluorescent reporter ES 
cell line. I made use of a construct generated and kindly gifted to me by Dr. Nicola 
Festuccia in Dr. Ian Chambers’s laboratory. Targeting of this construct to the Nanog 
locus results in the insertion of DNA encoding a flexible linker and the red 
fluorescent protein tagRFP at the 3’ end of the Nanog open reading frame, prior to 
the stop codon, resulting in the production of a Nanog-tagRFP fusion protein. This 
sequence is followed by an IRES and Bls, a gene conferring resistance to blasticidin 
S (Figure 3.14a-c). The targeting construct is promoterless, the transcribed region of 
the Nanog locus constitutes the entire 5’ homology arm, the 3’ untranslated region 
and the 4315 nucleotides of DNA downstream of that constitute the 3’ homology 
arm. Random integration of the construct should therefore be unlikely to confer 
resistance to blasticidin S, as the expression of Bls is dependent on integration 
downstream of a promoter. For more information refer to section 2.2.4.1.8 of the 
Materials and Methods chapter. 
I electroporated 100µg of the linearised targeting construct into 10
7
 IdV ES cells. 
After 10 days of selection with 10µg/ml blasticidin S, only 9 colonies had grown. I 
picked and expanded the clones, and performed Southern blots on BamHI-digested 
genomic DNA extracted from the 9 cell lines, using the targeting probe depicted in 
Figure 3.14. All 9 samples displayed the correct banding pattern (data not shown). I 
 




repeated the DNA isolation, digestion and Southern blotting for 3 of the clones. I 
confirmed the correct targeting of the construct to one allele of Nanog, and verified 
that the construct had not randomly integrated in other regions of the genome for any 
of the clones (Figure 3.14d). These double reporter ES cell lines were named IVNR, 
for Id1-Venus Nanog-tagRFP. 
 
3.2.7.2 Verification of tagRFP expression in the reporter cells 
I proceeded to test whether the tagRFP and Venus fluorescence were detectable in 
the three IVNR clones, and if the fluorescence levels were consistent with the 
expected behaviour of Nanog and Id1 proteins in various culture conditions. I 
cultured the three IVNR clones in LIF+FCS, LIF+FCS+10µg/ml blasticidin S (in 
order to select for Nanog-tagRFP-IRES-Bls expression from the targeted Nanog 
locus), 2i or N2B27 for 48 hours, then analysed the expression of Venus and tagRFP 
by flow cytometry  (Figure 3.15). The 2i samples had been cultured in 2i medium for 
4 passages prior to the setup of the experiment. The fluorescence distribution of Id1-
Venus met expectations: expression of the factor was at its maximum in LIF+FCS, 
decreased in N2B27 and was detected at low levels in very few cells in 2i, for all of 
the three clones. Addition of blasticidin S to LIF+FCS culture also decreased Id1-
Venus expression, an observation which fits with blasticidin S-mediated selection of 
Nanog-tagRFP-expressing cells, and with the negative input of Nanog on Id1 
expression (Suzuki et al. 2006). 
Nanog-tagRFP expression was extremely low. Less than 10% of IVNR ES cells 
cultured in LIF+FCS expressed tagRFP, with the percentage increasing only 
marginally upon addition of blasticidin S. 2i culture, which results in uniform Nanog 
expression (Figure 3.12a, Ying et al. 2008), led to a slight increase in tagRFP 
expression, but did not result in uniform expression of the fluorescent reporter, with 
40-70% of cells still within the tagRFP-negative gate in the three IVNR clonal lines. 
This suggests that whilst the three cell lines express Nanog-tagRFP in accordance 
 




with their culture conditions, the fluorescence generated by the fusion protein is too 
low to be detected with the BD LSRFortessa analyser used for this experiment (the 
only analyser in the Institute capable of detecting tagRFP). The same observations 
were made by Dr. Nicola Festuccia upon generation of Nanog-RFP reporter cell lines 
from wild-type ES cells. 
In order to verify that the weak expression of tagRFP truly recapitulated the 
expression of Nanog, I randomly selected IVNR clone 2 ES cells and immunostained 
them using anti-tagRFP and anti-Nanog antibodies in LIF+FCS culture (Figure 
3.16a). I performed nuclear immunostaining quantification on the samples, and 
observed a positive correlation between Nanog and tagRFP expression (Pearson 
product-moment correlation coefficient: 0.8629) (Figure 3.16b). This confirms that 
tagRFP fluorescence accurately reports the expression of Nanog. Having verified this 
for IVNR clone 2, I used this clone for further experiments. 
 
3.2.7.3 Attempted purification of populations based on fluorescent protein expression 
I then tested whether fluorescence activated cell sorting of ES cells based on 
expression of Venus and tagRFP could result in the isolation of enriched populations 
expressing a selected combination of the two proteins. I cultured IVNR ES cells in 
LIF+FCS and sorted them into four populations based on Venus and tagRFP 
expression (Figure 3.17a). I immediately analysed the sorted samples on the BD 
LSRFortessa analyser (Figure 3.17b). Whilst separation based on Venus expression 
worked with considerable success, separation based on tagRFP expression did not. 
The vast majority of cells from the tagRFP-negative sorted samples lacked 
expression of tagRFP, but only a minor fraction of cells from the tagRFP-positive 
sorted samples were expressing the red fluorescent protein, although the proportion 
of tagRFP-expressing cells was increased in these populations compared to unsorted 
cells (data not shown, Figure 3.15). Thus, it would appear that sorting based on 
 




tagRFP expression succeeds in isolating a Nanog-tagRFP-negative population (with 
more than 98% purity), but does not succeed in purifying a Nanog-tagRFP-positive 
population. It can however generate a Nanog-tagRFP enriched population (24% 
tagRFP-positive cells after sorting, compared to 4.5% tag-RFP positive cells in the 
unsorted sample. These numbers and the previous one for the tagRFP-negative 
population represent the average of the Venus-high and Venus-low samples). 
 
3.2.7.4 Venus and tagRFP report Id1 and Nanog expression 
I repeated the experiment described in the previous paragraph and extracted RNA 
from the four sorted populations as well as an unsorted control. I reverse transcribed 
the RNA and performed qRT-PCR experiments on the samples (Figure 3.18). Id1 
expression was enriched in the Venus-positive tagRFP-negative (V+R-) and Venus-
positive tagRFP-positive (V+R+) samples. Nanog expression was enriched in the 
Venus-negative tagRFP-positive (V-R+) and the V+R+ samples. The expression of 
both factors was low in the double negative samples (V-R-) (Figure 3.18a). This 
suggests that the two fluorescent proteins report the expression of Id1 and Nanog, 
and confirms tagRFP-based sorting is capable of enriching the proportion of Nanog-
tagRFP-expressing cells within a sample. The expression of the Nanog target Esrrb 
reflected the expression of Nanog, whereas that of the general pluripotency marker 
Oct4 was similar across all sorted populations (Figure 3.18b). The expression of the 
primed pluripotency markers Fgf5 and T (but not that of Otx2) was enriched in the 
V-R- sample, suggestive of a possible differentiation-primed state within cells not 
expressing neither Id1 nor Nanog in LIF+FCS culture (Figure 3.18c,d). The pro-
differentiation factor Tcf15 was lower in the R+ samples, consistent with its negative 
relationship with Nanog (Figure 3.18c,d) (Davies et al. 2013). Neither Hex nor Sox1 
displayed enrichment in any of the samples, suggesting that neither of these four 
subpopulations is primed for primitive endoderm or neural commitment (Figure 
3.18d). In conclusion, sorting of IVNR cells based on expression of Id1-Venus and 
 




Nanog-tagRFP results in the isolation of cell populations displaying differential 
expression of pluripotency and differentiation markers. 
 
3.2.7.5 Levels of Nanog, but not of Id1, in ES cell cultures influence the kinetics of 
EB differentiation 
Having established that the four populations sorted from IVNR ES cells were 
characterised by different gene expression patterns, I tested whether they showed 
functional differences in their ability to undergo differentiation. 
I repeated the sorting experiments and generated embryoid bodies (in the presence of 
FCS and in the absence of LIF) from each of the four sorted samples as well as from 
an unsorted control culture. I extracted RNA after 3 and 5 days of differentiation, 
reverse transcribed it, and performed RT-qPCR experiments to measure the 
expression levels of markers of various lineages (Figure 3.19). I confirmed that the 
sorted populations were correctly reporting expression levels of Id1 and Nanog in the 
starting populations (Figure 3.19a). Both the tagRFP-positive samples (Venus-
positive and Venus-negative) displayed a delayed exit from pluripotency, as 
indicated by higher expression of Cdh1, Fgf5, Nanog, Oct4, and the lower expression 
of the differentiation marker Cdh2 after 3 days of differentiation, compared to the 
two tagRFP-negative populations (Figure 3.19a,b,f). The EBs contained little or no 
neural ectoderm, as indicated by the low levels of Ascl1 (commonly referred to as 
Mash1) and Sox1 (Figure 3.19c). The four populations upregulated the endodermal 
marker Gata6 and the pro-EMT factors Zeb1 and Zeb2 with the same kinetics 
(Figure 3.19d,f). The delayed exit from pluripotency was evident when observing 
differentiation towards the mesodermal lineage. The tagRFP-positive populations 
expressed higher levels of the primitive streak marker T and lower levels of the 
differentiated mesoderm marker Kdr (also commonly referred to as Flk1) on the third 
 




day of differentiation (Figure 3.19e), but both markers were expressed at similar 
levels between the samples after 5 days of differentiation. 
Therefore, it appears that different expression levels of Id1 in LIF+FCS culture are 
not associated with differences in the kinetics of ES cell differentiation towards 
mesendodermal lineages in FCS-containing medium. High expression of Nanog, on 
the other hand, is associated with a slower exit from the pluripotent state. 
 
3.3 Discussion 
3.3.1 Flow cytometric analysis of Id1 expression in ES cell cultures 
The generation of an Id1-Venus reporter ES cell line provided me with a useful tool 
to address the expression pattern of Id1 in pluripotent cultures at the protein level and 
at single-cell resolution. 
I made use of this cell line to confirm published RNA expression data which 
suggested a heterogeneous expression pattern in LIF+FCS cultures (Tang et al. 
2010), and observed that Id1-Venus fluorescence exhibits what appears to be a 
normal distribution, with some cells displaying high fluorescence and some not 
expressing the reporter allele (Figure 3.5c,d). The distribution of Id1-Venus 
fluorescence therefore suggests a continuous spectrum of Id1 protein levels within 
ES cells, as opposed to tightly regulated specific levels of expression. 
 
3.3.1.1 The response of Id1-Venus to BMP stimulation and inhibition in LIF+FCS 
I investigated the effect of agonists and antagonists of common signalling pathways 
on the expression of Id1-Venus. Id1 is a well-established target of BMP signalling in 
a variety of organisms and cell types, including mouse ES cells (Hollnagel et al. 
1999, Katagiri et al. 1994, Ogata et al. 1993, Ying et al. 2003a). It is therefore 
 




unsurprising that Id1-Venus fluorescence was increased upon BMP4 stimulation and 
decreased upon BMP inhibition of LIF+FCS cultures (Figures 3.7c, 3.8a). The latter 
observation confirms that BMPs are present in FCS: if this were not the case, then 
Id1-Venus fluorescence would be unaffected by BMP inhibition. The former 
observation suggests that the BMP levels in FCS are not sufficient to saturate BMP 
receptors, because if this were not the case then BMP4 stimulation would not 
increase Id1-Venus fluorescence. The approximate combined concentration of 
BMP4, BMP6 and BMP9 in FCS was reported to range between 11 and 25 ng/ml 
(equating to 1.1-2.5 ng/ml in culture medium containing 10% FCS), depending on 
the supplier and batch of FCS (Herrera & Inman 2009). It is therefore conceivable 
that supplementation with 10ng/ml BMP4 could result in receptor saturation, but 
addition of BMP4 at higher concentrations is required to test this hypothesis. BMP 
inhibition by treatment of ES cells with 100nM LDN-193189 did not result in 
abolition of Id1-Venus expression. It is unclear whether this is due to incomplete 
inhibition of BMP signalling or whether other factors are responsible for Id1 
expression in LIF+FCS culture. Whilst increased LDN-193189 concentrations result 
in unspecific inhibition of Smad2 phosphorylation, implying the question above 
cannot be answered by increasing the concentration of this inhibitor, a Western blot 
against phosphorylated Smad’s may clarify whether 100nM LDN-193189 can 
effectively inhibit Smad1/5/8 phosphorylation. The possibility that other factors are 
inducing Id1 expression will be discussed later in this chapter. 
 
3.3.1.2 The response of Id1-Venus to Activin/Nodal stimulation and inhibition in 
LIF+FCS 
Id1 has been reported to be a negative target of Activin/Nodal signalling in mouse 
embryonic stem cells (Galvin et al. 2010). I therefore set out to investigate how the 
supplementation of LIF+FCS culture medium with recombinant Activin A or with 
the Activin/Nodal signalling inhibitor SB431542 would affect Id1-Venus expression. 
 




I observed that addition of Activin A to LIF+FCS had little effect on Id1-Venus 
fluorescence, but that administration of SB431542 dramatically increased Id1-Venus 
expression (Figure 3.8b). This suggests that Activin/Nodal signalling agonists are 
present at near-saturating levels in LIF+FCS culture, confirming previously reported 
observations (Ogawa et al. 2007). It also implies that Activin/Nodal signalling has a 
profound inhibitory effect on Id1-Venus expression. 
 
3.3.1.3 The integration of multiple signals regulates Id1 expression in ES cell 
cultures 
I analysed the expression of Id1-Venus in various ES cell culture conditions (Figure 
3.9a). I observed that Id1-Venus expression is similar in LIF+FCS and 
N2B27+LIF+BMP4, which suggests the balance of BMP’s and Activin/Nodal 
agonists is similar in the two culture conditions. ES cells cultured in LIF+FCS and 
LIF+KSR secrete Activin/Nodal agonists (Ogawa et al. 2007), so it is possible that 
the same is true for ES cells cultured in LIF+BMP4. I also observed that Id1-Venus 
is not expressed in 2i nor in 2i+LIF, in keeping with published RNA-Seq data 
suggesting low expression in 2i (Marks et al. 2012). This is an interesting 
observation in the light of the persistence of Id1-Venus fluorescence in LIF+FCS 
cultures treated with the BMP inhibitor LDN-193189 and with Activin A (Figure 
3.8). There are various possible explanations to this difference in basal expression. 
The first is that 2i cultures could be devoid of BMP signals, whereas 100nM LDN-
193189 may not be sufficient to inhibit all of the BMP in LIF+FCS. 2i cultures do 
appear to have low amounts of BMP, as judged by the strong induction of 
fluorescence which followed BMP4 administration to 2i cultures (Figure 3.9c,e). 
A second possibility is that Mek and/or GSK3β inhibition could be responsible for a 
decrease in Id1-Venus fluorescence. This also appears to be the case, since both 
PD0325901 and CHIR99021 administration to LIF+FCS culture resulted in Id1-
Venus downregulation, and simultaneous administration of PD0352901, Activin A 
 




and LDN-193189 to LIF+FCS cultures caused a further downregulation of Id1-
Venus expression (Figure 3.10a,c). 
A third explanation could be that factors expressed in 2i culture may be responsible 
for the repression of Id1 expression. Nanog is uniformly expressed in 2i (Figure 
3.12a, Ying et al. 2008), and it can repress Id1 transcription (Suzuki et al. 2006), 
suggesting this explanation may also be true. 
Finally, it is also conceivable that factors expressed in LIF+FCS but not in 2i could 
be responsible for the transcription of Id1. 
The combination of these data and considerations leads to the formulation of a model 
whereby Id1 expression in LIF+FCS is promoted by BMP agonists, present at levels 
below receptor saturation, and inhibited by Activin/Nodal agonists, present at levels 
close to receptor saturation, resulting in heterogeneous Id1-Venus expression. 
Treatment of cells with LDN-193189 reduces Id1-Venus expression, but does not 
abolish it, due to the positive input of one or more unidentified factors. Treatment of 
cells with Activin A does not affect the expression of Id1-Venus greatly, since 
Activin/Nodal agonists are present in culture at near-saturating levels. Treatment of 
cells with a Mek inhibitor drives the downregulation of Id1-Venus, possibly through 
the action of Nanog, and simultaneous inhibition of Mek and BMP signalling drives 
most, but not all, cells to lose expression of Id1-Venus. The residual expression may 
be due to incomplete Mek and BMP inhibition or to the positive input of one or more 
unidentified factors. Fgf2 does not induce expression of Id1-Venus, suggesting it is 
either found in serum at saturating levels, or that it does not promote Id1 
transcription (Figure 3.20a). 
In 2i culture, levels of neither BMP nor Activin/Nodal agonists are saturating, whilst 
Mek and GSK3β inhibition are fully repressing the expression of Id1-Venus, 
possibly through the action of Nanog. The induction of Id1-Venus expression 
depends on simultaneous BMP stimulation and Activin/Nodal inhibition, as the 
repressive action of Mek inhibition will overcome the positive effect of BMP4 if 
Activin A is added to the culture at saturating levels, and it will overcome the 
 




positive effect of SB431542-mediated Activin/Nodal signalling inhibition if BMP 
signalling is inhibited with LDN-193189. The complete silencing of Id1-Venus 
expression in 2i may be due to the lack of the unidentified factors promoting Id1 
expression mentioned above for LIF+FCS culture, or to the uniform and high 
expression of Nanog, which can exert a negative effect on Id1 transcription (Figure 
3.20b). 
 
3.3.1.4 The expression of Id1-Venus in epiblast stem cells 
Id1-Venus is expressed at low levels in epiblast stem cells, due to the repressive 
action of the Activin A present in the culture medium and to the presence of low 
levels of BMP agonists, as confirmed by the lack of Id1-Venus downregulation in the 
cultures upon LDN-193189 treatment (Figure 3.11b). The expression of Id1-Venus 
in EpiSC cultures must therefore result from the positive influence of other factors. 
Removal of Fgf2 from EpiSC culture medium does not result in a marked 
downregulation of Id1-Venus (Figure 3.11a), suggesting that if it does induce the 
expression of Id1-Venus, it is not the sole factor to do so (Figure 3.20c). 
BMP4 stimulation of EpiSCs results in a bimodal expression pattern, with a 
proportion of the cells unable to respond to BMP. The removal of Activin A from the 
culture medium coupled to Activin/Nodal inhibition resulted in the restoration of a 
normally-distributed expression pattern, but not all the cells express Id1-Venus, 
implying that other negative regulators of Id1 transcription exist in these cultures 
(Figure 3.11b-d). It is also possible that EpiSCs express variable levels of BMP 
receptors, and that some cells fail to respond to BMP stimulation by expressing Id1-








3.3.2 Negative relationship between Id1-Venus and Nanog in ES cell cultures 
3.3.2.1 Nuclear immunostaining quantification of ES cell cultures 
In order to address the relationship between Id1-Venus and the pluripotency factors 
Nanog and Oct4, I performed immunostains of ES cells cultured in various 
conditions and quantified the immunofluorescent signal for each of the factors in the 
nuclei of each of the imaged cells (Figure 3.12). The expression pattern of Id1-Venus 
reflected that seen in flow cytometry analyses, displaying a response to BMP 
stimulation and inhibition, and low expression in 2i and LIF+FCS+PD0325901 
(Figure 3.12b). This confirms the validity of immunostaining quantification as a 
technique for analysing protein expression at the single cell level. 
Comparison of the expression level of pairs of factors within single cells indicated 
that cells expressing high levels of Id1-Venus tend to express Oct4, suggesting they 
are not differentiated cells within cultures, but also tend to express low or 
intermediate levels of Nanog. There appears to be a negative relationship between 
the two factors, with very few cells expressing high levels of both. This could be 
explained by the observation that Id1 is a negative transcriptional target of Nanog 
(Suzuki et al. 2006), although the negative relationship between the two factors had 
not been previously characterised at the single cell level. The negative effect of 
Nanog on Id1 may explain why the HLH factor displays a certain heterogeneity of 
expression within monolayer cultures uniformly exposed to FCS. 
I was also able to confirm a previous report on the relationship between Nanog and 
Oct4 in LIF+FCS and 2i cultures (Muñoz Descalzo et al. 2012), and to extend its 
findings to BMP4-, LDN-193189- and PD0325901-treated LIF+FCS cultures. ES 
cells appear to be incapable of expressing high levels of Nanog without expressing 
high levels of Oct4. There is a maximum Nanog:Oct4 ratio of fluorescent intensity 
which cannot be surpassed. This is clearly visible on the dot plots in Figure 3.13a as 
the limit before the empty triangle of space in the bottom right regions of the plots. In 
2i culture, the Nanog:Oct4 ratio in all cells tends to this maximum ratio, so that while 
 




levels of the factors in individual cells will vary, the expression ratio of the two 
proteins will remain relatively constant. I observed that in LIF+FCS cultures treated 
with PD0325901 the cells appeared to have less variability in Oct4 expression and to 
tend to the maximum Nanog:Oct4 ratio, suggesting this culture system is more 
similar to 2i than the other tested LIF+FCS-based cultures. 
 
3.3.2.2 Issues with the generation of an Id1-Venus Nanog-tagRFP double reporter 
ES cell line 
To further characterise the relationship between Id1 and Nanog, I generated Id1-
Venus Nanog-tagRFP double reporter ES cells. Flow cytometry analysis revealed 
that the tagRFP fluorescence was too low for accurate detection with a BD 
LSRFortessa analyser, the only analyser in our Institute with the correct laser-
detector combination for detection of tagRFP fluorescence. Even in 2i culture, where 
Nanog is expressed uniformly (Figure 3.12, Ying et al. 2008), tagRFP was 
undetectable in approximately half of the cells in the culture (Figure 3.15). This 
observation prevented an in-depth flow cytometric study of the expression pattern of 
Id1-Venus and Nanog-tagRFP in response to perturbation of signalling pathways in 
culture, since the data collected for Nanog-tagRFP would not be reflective of the true 
expression of Nanog. In addition, purification of Nanog-tagRFP-positive populations 
proved impossible (Figure 3.17). 
 
3.3.2.3 Differences in gene expression in Id1-Venus Nanog-tagRFP sorted 
populations 
Whilst not fluorescing at a sufficient intensity to capture the full range of Nanog 
expression, tagRFP did at least report high levels of Nanog, as seen by the shift 
towards positivity observed in 2i culture compared to N2B27 culture (Figure 3.15), 
 




by the correlation of Nanog and tagRFP immunostaining signals (Figure 3.16), and 
by the enrichment for Nanog message in tagRFP-positive sorted cells (Figure 3.18a, 
Figure 3.19a). Interestingly, Id1-Venus-negative Nanog-tagRFP-negative cells 
displayed higher levels of the primed pluripotency markers Fgf5 and T, lower levels 
of the naïve pluripotency marker Esrrb and similar levels of Oct4 compared to the 
other sorted populations (Figure 3.18). This may suggest that these cells, unshielded 
from neural commitment due to the lack of Id1, and not constrained in a pluripotent 
state due to the lack of Nanog, may represent a cell type in a differentiation-
favourable state. Undirected embryoid body differentiation of the sorted populations 
did not reveal accelerated kinetics of differentiation for this population compared to 
Id1-Venus-positive Nanog-tagRFP-negative cells (Figure 3.19). Perhaps this is not 
surprising, given that the EB differentiation protocol used in these experiments 
primarily induced mesendodermal differentiation, which is not strongly suppressed 
by Id1. Furthermore, it is possible that the serum present in the differentiation 
medium rapidly upregulated Id1 in the Nanog-tagRFP-negative Id1-Venus-negative 
subpopulation. A serum-free neural induction experiment may reveal differences in 
differentiation kinetics between these populations, given that Id1 gain-of function has 
a powerful inhibitory effect on neural differentiation (Ying et al. 2003a). Analysis of 
earlier timepoints may also be required to observe differences in the rate of exit from 
pluripotency. 
 
3.3.2.4 Significance of the negative relationship between Id1 and Nanog 
Nanog negatively regulates the transcription of Id1 (Suzuki et al. 2006), and I have 
shown that the two factors display a negative relationship at the protein level. It is 
however unclear why the pluripotency factor Nanog would negatively regulate the 
inhibitor of differentiation Id1. The data I have generated is not sufficient to move us 
past the realm of speculation. 
 




One possibility is that Id1 may be capable of inducing primitive endoderm 
differentiation of ES cells, and that Nanog is repressing this effect. Nanog is in fact 
expressed in an exclusive pattern with the primitive endoderm specifier Gata6 in the 
inner cell mass (Chazaud et al. 2006) and displays a negative relationship with 
primitive endoderm inducers in ES cell cultures (Singh et al. 2007). Id1 expression 
was found to be associated with a primitive endoderm-like population of ES cells 
characterised by expression of Hex (Canham et al. 2010), although Hex is not 
enriched in Id1-Venus-positive cells (Figure 3.18d). 
Alternatively, Nanog may be acting as a guardian of pluripotency by repressing the 
transcription of the neural inhibitor Id1, thus allowing ES cells to differentiate into 
any germ layer without the anti-neural bias which may be introduced by Id1 
expression. 
A third possibility is that the negative relationship between the factors is required 
later in development, and its existence in pluripotent cultures is merely a by-product 
of later developmental events. Nanog and Id1 expression overlap in the proximal 
posterior regions of the gastrulating mouse embryo (Jen et al. 1997, Morkel et al. 
2003, Osorno et al. 2012). Id1 repression by Nanog may be required at this time and 
location for the correct sequence of events to take place for the correct migration of 
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Figure 3.1 – Id1 isoforms and their expression 
a. Structure of the Id1 locus illustrating the DNA regions encoding two 
alternative mRNA isoforms. 
Black boxes: coding region, white boxes: untranslated regions, diagonal lines: 
intronic DNA, straight lines: untranscribed intergenic DNA, arrows: primer 
pairs (numbered 1 and 2) used to detect both transcripts (1) or Id1-002 only 
(2). 
b. PCR performed using the primer pairs depicted in (a) to detect total Id1 
transcript (1) or Id1-002 specifically (2). 
Template DNA was cDNA from ES cells cultured in LIF+FCS (“ES cells”), 
cDNA from ES cells cultured in N2B27 for 5 days (“N2B27 d5”), a plasmid 
containing the entire Id1 locus (“+ve ctrl”) or water (“-ve ctrl”). 
































Figure 3.2 – Id1 expression in pluripotency and differentiation 
a. Id1 mRNA levels in 2i+LIF, LIF+FCS and EpiSCs. Error bars: standard 
deviation of two biological replicates. 
b. Id1 mRNA levels at daily timepoints of neural adherent monolayer 
differentiation of ES cells. ES cells cultured in LIF+FCS (Day 0) were replated 
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Figure 3.3 – Poor quality of anti-Id1 antibodies 
Western Blots on protein lysate from ES cells cultured in LIF+FCS, probing with 
two different commercially available anti-Id1 antibodies: SC-488 (Santa Cruz) and 
7D4.2 (Chemicon). The expected molecular weight of Id1 (approximately 15 kDa) is 



































a – Wild-type locus 
b – Targeting construct 
c – Targeted locus 
d – Targeted locus, Pgk-Neo removed 
158 
 
Figure 3.4 – Id1 reporter targeting strategy 
a. Wild-type Id1 locus. 
Single horizontal lines: intergenic DNA, medium-sized white boxes: 
homology regions with targeting vector, big white boxes: untranslated 
regions, black boxes: coding regions, parallel diagonal lines: sequence of 
homology region not displayed, green box: Southern blot multiple integration 
probe, blue box: Southern blot targeting probe. 
b. Targeting vector containing a flexible linker followed by the Venus cDNA 
(yellow box) fused in frame with the 3’ end of Id1. 
Red triangles: Frt sites, grey box: Pgk-Neo selection cassette, purple box: 
DTA negative selection marker outwith homology regions. 
c. Id1 locus following a correct targeting event. 
d. Removal of the Pgk-Neo selection cassette following transfection with a 
plasmid encoding FlpO. 
The sizes of bands detected on Southern blot membranes following genomic DNA 

















     Targeting probe     Multiple integration probe 
       wt 47 72 77   wt 47 72 77 


























Figure 3.5 – Screening and identification of an Id1-Venus reporter ES cell clone 
a. Southern blot using the targeting probe depicted in Fig.3.4a. The λ DNA 
HindIII digest (NEB) was loaded to the left of the samples as a size marker. 
Three clones with the correct banding pattern were identified (clones 47, 72, 
77). Black arrow: wild-type band (~12kb), blue arrow: targeted band (~6kb). 
b. Repeat of the Southern blot on the parental cell line and the three targeted 
clones using the targeting probe and a multiple integration probe. The λ DNA 
HindIII digest (NEB) was loaded to the left of the samples as a size marker. 
Green arrow: correct targeting event (~7kb), red arrow: aberrant targeting 
event (~9kb). 
Clone 72 has a more intense wild-type band than targeted band, clone 77 has 
a second integration event, clone 47 has the correct banding pattern. 
c. Flow cytometric analysis of the parental ES cell line and the Id1-Venus 
reporter ES cell line (IdV clone 47) cultured in LIF+FCS. This experiment 
was repeated 3 times; the median Venus fluorescence intensities for the 
biological replicates of the IdV sample have a standard deviation of 
approximately 15%. 
d. Quantification of nuclear Venus signal of parental and IdV ES cells cultured 
in LIF+FCS and stained with a polyclonal anti-GFP antibody capable of 
recognising the Venus epitope. The signal from over 900 nuclei was scored 
for each cell line using the Multicell3D software. An image of a 
representative IdV ES cell colony stained with the anti-GFP antibody and 
imaged on a Leica TCS SPE inverted confocal microscope is included to 































Figure 3.6 – Venus expression recapitulates Id1 expression 
Levels of Id1 and Venus transcript in IdV ES cells cultured in LIF+FCS and sorted 
by fluorescence-activated cell sorting into Venus-high (“V-hi”) and Venus-low (“V-
lo”) populations. The 20% of live cells displaying the highest or lowest Venus 
fluorescence were sorted to generate the two populations. RNA was extracted from 
these samples as well as the starting unsorted population (“Unsorted”) and qRT-PCR 
was performed on reverse transcribed cDNA. Transcript levels were normalised to 
the levels of Tbp. No error bars are displayed as there was only one biological 

































































Figure 3.7 – Id1 expression is unaffected by the Pgk-Neo cassette 
a. Southern blot using the targeting probe depicted in Fig.3.4a on genomic DNA 
from wild-type ES cells, IdV cells and an IdV clone transfected with a 
plasmid encoding FlpO which had become subsceptible to G418, suggestive 
of excision of the Pgk-Neo cassette. 
Black arrow: wild-type band (~12kb), light blue arrow: targeted band (~6kb), 
red arrow: targeted band without the selection cassette (~4kb). 
The G418-subsceptible clone appears to have lost the selection cassette. It 
was renamed IdV-SC. 
b. Flow cytometric analysis of wild-type, IdV and IdV-SC cells. 
The cells were cultured in 2i+10µM SB431542+10ng/ml BMP4 to minimise 
variations in Id1 expression due to different levels of differentiation in 
LIF+FCS parallel cultures. Parental non-fluorescent cells are included as a 
control. This experiment was repeated 3 times; the median Venus 
fluorescence intensities for the biological replicates of the IdV and IdV-SC 
samples have a standard deviation of less than 5%. 
c. Flow cytometric analysis of IdV and IdV-SC ES cells cultured in LIF+FCS 
and stimulated for 48 hours with 10ng/ml BMP4 or 100nM LDN-193189 
(LDN, a small-molecule BMP signalling inhibitor). Parental non-fluorescent 
cells are included as a control. The experiment was repeated 3 times. The 
median Venus fluorescence intensity values for the biological replicates of 
each of the IdV samples (LIF+FCS, LIF+FCS+BMP4, LIF+FCS+LDN-
193189) have a standard deviation of less than 15%; the median Venus 
fluorescence intensity values for the biological replicates of each of the    
IdV-SC samples have a standard deviation of less than 5%. In all replicate 
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Figure 3.8 – Id1-Venus response to BMP and Activin A stimulation and 
inhibition in LIF+FCS culture 
Flow cytometric analysis of IdV-SC ES cells cultured in LIF+FCS and stimulated 
with agonists and antagonists of the BMP4 and Activin/Nodal signalling pathways 
for 48 hours. Parental non-fluorescent cells are included as a control. 
a. Id1-Venus response to addition of 10ng/ml BMP4 or 100nM LDN-193189 
(LDN, a small-molecule BMP signalling inhibitor). 
b. Id1-Venus response to addition of 20ng/ml Activin A (ActA) or 10µM 
SB431542 (SB43, a small molecule Activin/Nodal signalling inhibitor). 
c. Effect of Activin A or SB431542 administration to BMP4- or LDN-193189-
treated ES cells on Id1-Venus expression. 
d. Effect of BMP4 or LDN-193189 administration to Activin A- or SB431542-
treated ES cells on Id1-Venus expression. 
The experiments were repeated 3 times. The median Venus fluorescence intensity 
values for the biological replicates of each of the samples have a standard 
deviation of less than 20%. In all replicate experiments the data follow the same 












     a – ES cell culture     b – 2i culture 
 
     c – BMP/Activin crosstalk in 2i 
 





























Figure 3.9 – Id1-Venus expression in ES cell cultures and 2i 
a.-d. Flow cytometric analysis of IdV-SC ES cells cultured as described below. 
Parental non-fluorescent cells are included as a negative control. 
a. Id1-Venus expression in four alternative ES cell culture conditions: 
LIF+FCS, N2B27+LIF+BMP4, 2i and 2i+LIF. Cells were cultured in 
N2B27+LIF+BMP4, in 2i and 2i+LIF for a minimum of 3 passages before 
performing the flow cytometry experiment. 
b. Id1-Venus expression in 2i culture in response to the addition of LIF, 
20ng/ml Activin A (ActA), 10ng/ml Fgf2 or 100nM LDN-193189 (LDN) for 
48 hours. The LIF+FCS sample is included as a reference for Id1-Venus 
expression. 
c. Id1-Venus expression in 2i culture in response to the addition of 20ng/ml 
Activin A (ActA), 10ng/ml BMP4, 100nM LDN-193189 (LDN), 10µM 
SB431542 (SB43) or a combination of these for 48 hours. The LIF+FCS 
sample is included as a reference for Id1-Venus expression. 
d. Id1-Venus expression in 2i culture following the addition of 10µM SB431542 
for 48 hours or following a change of medium to R2i 
(N2B27+SB431542+PD0325901) for 48 hours. The LIF+FCS sample is 
included as a reference for Id1-Venus expression. 
The experiments were repeated 3 times. The median Venus fluorescence 
intensity values for the biological replicates of each of the samples have a 
standard deviation of less than 15%. In all replicate experiments the data 
follow the same trend as those displayed in figure. 
e. ES cells cultured in 2i in the presence or absence of 10ng/ml BMP4 (48 hour 
stimulation). The samples were fixed and immunostained with anti-GFP and anti-
Oct4 antibodies. The cells were imaged on a Leica TCS SPE inverted confocal 





   a – Fgf/CHIR response  b – BMP/PD03 crosstalk 
 











Figure 3.10 – Id1-Venus response to perturbations of GSK3β, Fgf/Mek, 
Activin/Nodal and BMP signalling in LIF+FCS culture 
Flow cytometric analysis of IdV-SC ES cells cultured in LIF+FCS and stimulated 
with the factors described below for 48 hours. Parental non-fluorescent cells are 
included as a control. 
a. Id1-Venus expression in response to treatment with the inhibitors used in 2i. 
LIF+FCS cultures were supplemented with 10ng/ml Fgf2, 3µM CHIR99021 
(CHIR, a GSK3β inhibitor), 1µM PD0325901 (PD03, a Mek inhibitor), or a 
combination of these. 
b. Id1-Venus expression following stimulation with 10ng/ml BMP4, 1µM 
PD0325901 (PD03), or both. 
c. Id1-Venus expression following stimulation with 20ng/ml Activin A, 100nM 
LDN-193189 (LDN), 1µM PD0325901 (PD03), or combinations of these 
molecules. 
The experiments were repeated 3 times. The median Venus fluorescence intensity 
values for the biological replicates of each of the samples have a standard deviation 
of less than 20%. In all replicate experiments the data follow the same trend as those 












a – Removal of Fgf2/ActA  b – Response to BMP 
   
c – Combination of BMP and SB43 
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Figure 3.11 –  Id1-Venus expression in epiblast stem cells 
a.-c. Flow cytometric analysis of Id1-Venus expression in IdV-SC EpiSCs derived 
from ES cell cultures and cultured for 48 hours as described below. Parental 
non-fluorescent cells and IdV-SC ES cells cultured in LIF+FCS are included 
as a reference. 
a. EpiSCs cultured in N2B27 supplemented with 20ng/ml Activin A and 
10ng/ml Fgf2 (EpiSCs), in N2B27 supplemented with 20ng/ml Activin A and 
1µM PD0325901 (EpiSCs-Fgf2+PD03), in N2B27 supplemented with 
10ng/ml Fgf2 and 10µM SB431542 (EpiSCs-ActA+SB43). 
b. Response of EpiSCs to addition of 10ng/ml BMP4 or 100nM LDN-193189 
(LDN). 
c. Response of EpiSCs to simultaneous stimulation of BMP4 and inhibition of 
Activin/Nodal signalling. EpiSCs were cultured as described above and in 
N2B27 supplemented with 10ng/ml Fgf2, 10ng/ml BMP4 and 10µM 
SB431542 (EpiSCs-ActA+SB43+BMP4). 
The experiments were repeated 3 times. The median Venus fluorescence intensity 
values for the biological replicates of each of the samples have a standard 
deviation of less than 15%, with the exception of the samples supplemented with 
BMP4 and SB431542, for which the standard deviation is approximately 25%, 
potentially as a result of varying cell density and/or of the onset of differentiation 
(see main text). In all replicate experiments the data follow the same trend as 
those displayed in figure. 
d. EpiSCs cultured in the presence of 10ng/ml BMP4, 100nM LDN-193189 (LDN) 
or in the absence of both molecules for 48 hours, fixed and immunostained with 
anti-GFP and anti-Oct4 antibodies. The cells were imaged on a Leica TCS SPE 
















































































Figure 3.12 – Immunostaining quantification of Id1, Nanog and Oct4 in 
LIF+FCS 
Response of IdV ES cells to BMP4 stimulation, BMP inhibition and Mek inhibition 
in LIF+FCS culture. IdV ES cells cultured in 2i were analysed as a negative control 
for Id1-Venus expression and as a positive control for Nanog expression. 
a. IdV ES cells cultured in 2i, in LIF+FCS, in LIF+FCS with addition of 
10ng/ml BMP4, 100nM LDN-193189 (LDN, BMP inhibitor) or 1µM 
PD0325901 (PD03, Mek inhibitor) as indicated in figure, immunostained for 
GFP, Nanog, Oct4 and counterstained with DAPI. The cells were imaged on 
a Leica TCS SPE inverted confocal microscope. Scale bar: 30 µm. 
b. Immunostaining quantification for Id1-Venus, Nanog and Oct4 in all culture 
conditions in (a). A minimum of 400 nuclei were scored for each of the 
LIF+FCS-based culture conditions, and over 200 nuclei were scored for 2i. A 
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Figure 3.13 – Immunostaining quantification of Id1, Nanog and Oct4 in 
LIF+FCS (2) 
a. Dot plots indicating the relationship between Id1-Venus, Nanog and Oct4 in 
the samples shown in Fig 3.12. A minimum of 400 nuclei were scored for 
each of the LIF+FCS-based culture conditions, and over 200 nuclei were 
scored for 2i. A minimum of five fields of view was used for each condition. 
b. Zoom in on the Id1-Venus over Nanog plots shown in (a). Note that the axes 


























































































a – Wild-type locus 
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Figure 3.14 – Generation of an Id1-Venus Nanog-tagRFP double reporter ES 
cell line 
a-c Nanog-tagRFP targeting strategy. The sizes of bands detected on Southern 
blot membranes following genomic DNA digestion with BamHI are indicated 
for the various alleles. 
a. Wild-type Nanog locus. Single horizontal lines: intergenic DNA, medium-
sized white boxes: homology regions with targeting vector, big white boxes: 
untranslated regions, black boxes: coding regions, green box: Southern blot 
multiple integration probe, dark red box: Southern blot targeting probe. 
b. Targeting vector containing a flexible linker followed by the tagRFP cDNA 
(red box) fused in frame with the 3’ end of Nanog. 
Blue triangles: loxP sites, brown box: internal ribosome entry site, yellow 
box: Bls (blasticidin S resistance gene). 
c. Nanog locus following a correct targeting event. 
d. Southern blots on wild-type, IdV and three blasticidin-resistant clones, using 
the targeting probe and the multiple integration probe depicted in (a). The λ 
DNA HindIII digest (New England Biolabs) was loaded to the left of the 
samples as a size marker. 
Black arrow: wild-type band (~7kb), dark red arrow: targeted band (~8kb), 
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Figure 3.15 – Flow cytometric analysis of IVNR cells 
Density plots generated by flow cytometric analysis of the levels of Venus and 
tagRFP in three IVNR clones cultured in LIF+FCS, LIF+FCS+10µg/ml blasticidin S 
(to select for expression from the Nanog-tagRFP locus), 2i or N2B27 for 48 hours, 
alongside a non-fluorescent control (E14Ju09). Density ranges from red (highest) to 
blue (lowest). Percentages of cells within each of the quadrants drawn in the figure 
are displayed within the density plots. The experiment was performed once for all 
clones and conditions. 
A diagrammatic representation of the fluorescent protein transcripts present in IVNR 
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Figure 3.16 – tagRFP accurately reports Nanog expression in IVNR ES cells 
a. IVNR clone 2 ES cells cultured in LIF+FCS, fixed and immunostained with anti-
Nanog and anti-tagRFP antibodies. Nuclei were counterstained with DAPI. The 
cells were imaged on an Olympus IX51 microscope. Scale bar: 100µm. 
b. Nuclear immunostaining quantification of the cells in (a) alongside a parental 
(E14Ju09) control stained with an anti-tagRFP primary antibody and with 
secondary antibodies against both anti-Nanog and anti-tagRFP (“Negative 






























Figure 3.17 – tagRFP-based sorting does not purify the tagRFP-positive 
population 
a. Fluorescence-activated cell sorting of IVNR clone 2 ES cells cultured in 
LIF+FCS, based on expression of Venus and tagRFP as illustrated in figure. 
E14Ju09 ES cells were used as a negative control. 
The sorting was performed on a BD FACSAria sorter. 
b. Flow cytometric analysis of the sorted cells immediately after sorting. V: 
Venus, R: tagRFP, -: negative, +: positive. 
The analysis was performed on a BD LSRFortessa analyser, hence the gates 
are not in the same place on the graphs as the data generated by the BD 
FACSAria sorter in (a). The gates are positioned similarly to those in (a) with 
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Figure 3.18 – tagRFP and Venus accurately report Nanog and Id1 expression 
qRT-PCR on IVNR clone 2 ES cells cultured in LIF+FCS sorted based on Venus and 
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Figure 3.19 – Expression of Nanog, but not of Id1, affects kinetics of EB 
differentiation 
qRT-PCR on IVNR clone 2 ES cells cultured in LIF+FCS, sorted based on Venus 
and tagRFP expression as illustrated in Fig.3.17a and differentiated into embryoid 
bodies in GMEM+10% FCS. V: Venus, R: tagRFP, -: negative, +: positive. 




























Figure 3.20 – Regulation of Id1 expression in pluripotent cells 
Diagramatic representation of the signalling pathways shown in this Chapter to 
regulate the expression of Id1 in ES cells and epiblast stem cells. 
a. In LIF+FCS culture, BMP and Activin/Nodal signalling agonists are present 
in the culture medium. BMP promotes Id1 expression, Activin/Nodal agonists 
inhibit it. Mek and GSK3β also positively regulate Id1 expression. The 
combinatorial effect of these pathways results in heterogeneous Id1 
expression within the culture. 
b. In 2i culture, Mek and GSK3β inhibition have a profound inhibitory effect on 
Id1 expression, and BMP signals are low or absent from the culture medium. 
Id1 is therefore not expressed in these culture conditions. 
c. In epiblast stem cell culture, exogenous Fgf2 and Activin A are present in the 
culture medium. Fgf2 does not affect Id1 expression, Activin A represses Id1. 
BMP signals are low or absent from the culture medium. The factor(s) that 
drive low levels of Id1 expression in a small subset of cells are currently 
unknown. 




The effects of Id1 overexpression in the differentiation 




Id1 is a key downstream effector of BMP4 signalling in the maintenance of ES cell 
pluripotency and in the modulation of ES cell differentiation. The overexpression of 
the helix-loop-helix factor can sustain ES cell self-renewal in combination with LIF, 
and can recapitulate the block on the neural differentiation of ES cells imposed by 
BMP4 stimulation (Finley et al. 1999, Hollnagel et al. 1999, Ying et al. 2003a, 
Zhang et al. 2010). 
BMP4 is required for mesoderm formation in vivo, with mutants either failing to 
express the primitive streak determinant T or exhibiting mesodermal defects until 
E9.5 when they invariably die (Winnier et al. 1995). It is therefore not surprising that 
serum and BMP4 have been employed in the differentiation of ES cells towards 
mesodermal lineages (Keller et al. 1993, Johansson & Wiles 1995, Nishikawa et al. 
1998, Park et al. 2004). 
However, BMP4 has also been used to generate endoderm and surface ectoderm 
from mouse ES cells (Coraux et al. 2003, Gouon-Evans et al. 2006), and to derive 
trophoblast from human ES cells (Sudheer et al. 2012), raising the question of what 
its precise role may be, and to which, if any, of these cell types is Id1 directing 
differentiation towards. 
ES cells cultured in an adherent monolayer in the absence of LIF and the presence of 
BMP4 generate a mixture of two cell types: colonies of densely packed cells 
expressing Oct4, and flat epithelial sheets with “big flat cells” co-expressing Cdh1 
and Tcfap2a (also known as AP-2α), a combination of markers that characterises 
surface ectoderm and trophoblast (Arkell & Beddington 1997, Mitchell et al. 1991) 





(Figure 4.1). It would therefore appear that even in the simplest of BMP4 stimulation 
experiments a complex phenotype arises. 
I set out to characterise the effect of Id1 overexpression on ES cell differentiation 
towards the neural lineage in greater detail. I aimed to discover whether the Id1-
imposed inhibition of neural specification was due to a delay in the exit from 
pluripotency, a switch in differentiation trajectory, or both; to assess to what 
differentiated cell type seen in BMP4-treated cultures Id1 was directing 
differentiation towards, if any; to understand whether the presence of Id1 in wild-




4.2.1 Generation and validation of Id1 overexpressing ES cell lines 
4.2.1.1 Generation of Id1 overexpressing ES cell lines 
In order to assess the effect of Id1 overexpression in differentiation, I transfected 
E14tg2a ES cells with the Id1 overexpression plasmid used by Ying et al. (2003a). 
This plasmid, diagrammatically depicted in Figure 4.2a, contains the strong CAG 
promoter (Niwa et al. 1991) driving the expression of the Flag-tagged cDNA of Id1, 
which is followed by an internal ribosome entry site (IRES), a puromycin resistance 
gene (Pac), and a polyadenylation signal sequence (pA). The Flag-Id1-IRES-Pac-pA 
sequence is flanked by loxP sites in the same orientation, and followed by the cDNA 
of GFP and a second polyadenylation signal. This allows for the Cre recombinase-
mediated excision of the Id1 transgene from the genome of ES cells and expression 
of GFP in its place. I also transfected E14tg2a ES cells with a plasmid containing the 
CAG promoter driving expression of Pac to generate an “empty vector” control cell 
line (for more information refer to sections 2.2.4.1.2 and 2.2..4.1.4 of the Materials 





and Methods chapter). I selected for stable transfectants by culturing the transfected 
cells in 2µg/ml puromycin and expanded clonal cell lines. 
I performed a qRT-PCR analysis of RNA samples extracted from a clonal empty 
vector control cell line and three Id1 overexpressing clones cultured in LIF+FCS 
(Figure 4.2b). All three lines expressed higher levels of Id1 than the control ES cells, 
ranging between 20- and 65-fold higher expression. I then assessed expression at the 
protein level by performing Western blots on the protein lysate of the same samples 
cultured in LIF+FCS and in N2B27 for 5 days (Figure 4.2c,d). Probing the Western 
blot membrane with anti-Id1 antibody (Santa Cruz SC-488) revealed that Id1 protein 
was overexpressed in both ES cells and cells that had undergone neural 
differentiation. The wild-type and Flag-tagged exogenous proteins are 
distinguishable due to the increased size of the exogenous protein. It appears that Id1 
expression is lost from all cell lines upon differentiation: the endogenous protein can 
no longer be detected in any of the cell lines, and the transgenic protein is 
downregulated in both clones 7 and 11, and possibly in clone 4, which was already 
expressing low levels of the transgene in LIF+FCS culture. 
 
4.2.1.2 The Id1 overexpressing ES cell lines lack a functional Flag epitope 
I performed a Western blot using the lysates described above and probed the 
membrane with an anti-Flag antibody (Figure 4.2d). Surprisingly, none of the clones 
produced detectable bands, unlike a positive control lysate of wild-type ES cells 
transfected with a plasmid encoding Flag-Neurod1. Immunostaining of fixed ES 
cells from the same cell lines also resulted in no Flag signal being detected (data not 
shown). 
I re-sequenced the plasmid used to make the cell lines (Figure 4.3a). Alignment of 
the sequencing read to the sequence of endogenous Id1 revealed that the final lysine 
residue on the Flag epitope was also the second residue of wild-type Id1 (Figure 
4.3b,c). It is therefore possible that the biochemical and structural properties of the 





transgenic protein mask the Flag epitope making it impossible to detect by Western 
blot and immunofluorescence. It is worth noting that Ying et al. (2003a) observed a 
protein band of the same size to that detected in Figure 4.2c when performing 
Western blots with anti-Id1 antibody, but that they did not perform Flag 
immunoblots or immunostains. Hence, it is possible that the cell lines they used also 
lacked a detectable Flag epitope. 
 
4.2.1.3 Excision of the Id1-IRES-Pac-pA cassette by Cre-mediated recombination 
I generated a “rescued” cell line by transfecting one Id1-overexpressing clone (clone 
7) with a circular plasmid containing a CAG promoter driving expression of a Cre 
recombinase gene. I plated the cells at clonal density, then screened the plate by 
fluorescence microscopy to pick and expand clones expressing GFP in place of Id1 
(for more information refer to section 2.2.4.1.3 of the Materials and Methods 
chapter). I verified loss of Id1 expression and overexpression of GFP by qRT-PCR 
(Figure 4.4a, data not shown). These clones will be referred to henceforth as “Id1 
reverted”. These lines serve as a control to ensure that any Id1 overexpression 
phenotype can be directly attributed to the Id1 transgene and not to a secondary 
genetic change. 
 
4.2.1.4 Functional validation of Id1 overexpressing cell lines 
In order to verify the functional competence of the Id1 transgene within these cell 
lines, I set up adherent monolayer neural differentiation experiments in N2B27 
culture medium to verify the capability of Id1 to inhibit this process, as described in 
Ying et al. (2003a). I made use of the empty vector control clone, Id1 overexpressing 
clones 7 and 11, and one Id1 reverted clone. 
I performed qRT-PCR on RNA samples collected daily from ES cells cultured in 
N2B27 for 5 days, and on the starting population sample of ES cells cultured in 





LIF+FCS (Figure 4.4a, data not shown for clone 11 since it behaved as clone 7). The 
Id1 overexpressing clones expressed higher levels of Id1 transcript than the control 
clones, and displayed severely dampened upregulation of the neural marker Sox1, 
which was highly upregulated in the empty vector control and the Id1 reverted cells. 
The amount of Id1 transcript was reduced (approximately 4-fold) after just 24 hours 
in serum-free N2B27 medium. This transgene downregulation was common to the 
two tested clones and a third Id1 overexpressing clonal ES cell line generated using a 
different plasmid (plasmid structure: CAG-Id1-IRES-Pac, data not shown) and is 
therefore unlikely to be a clone- or plasmid-specific phenotype. 
I then repeated the experiment and fixed the samples at day 5 of differentiation. I 
stained the cells with an antibody against the neuronal marker Tubb3 and imaged 
them to detect expression of Tubb3 and of GFP (Figure 4.4b, data not shown for 
clone 11 since it behaved as clone 7). The empty vector and Id1 reverted control cell 
lines displayed widespread expression of Tubb3, which was not detectable in Id1 
overexpressing cells. The Id1 reverted control was uniformly GFP-positive, 
indicating successful excision of the Id1 transgene. 
Id1 overexpression therefore inhibits neural differentiation, as expected, confirming 
that the Id1 transgene is functional in these cell lines. 
 
4.2.2 Id1 overexpression does not prevent the loss of naïve pluripotency markers 
Having illustrated the functional capability of the cell lines to reproduce the 
previously reported inhibition of neural differentiation, I set out to characterise the 
kinetics of the differentiation process. 
I set up an adherent neural monolayer differentiation experiment by plating empty 
vector control or Id1 overexpressing ES cells cultured in LIF+FCS in N2B27 for 3 
days. I extracted RNA from the starting population and at daily timepoints during 
differentiation, and performed qRT-PCR analysis of the samples for Id1 and markers 





of naïve pluripotency (Figure 4.5). I confirmed Id1 was overexpressed in the test 
samples compared to control, and recapitulated the downregulation of Id1 transcript 
after just 24 hours in serum-free N2B27 medium observed in Figure 4.4a (Figure 
4.5a). Esrrb, Klf4, Rex1 and Nanog were all downregulated to basal levels of 
expression within 24 hours of cell culture in N2B27, with comparable kinetics 
between control and Id1 overexpressing cells (Figure 4.5b). I stained empty vector 
control and Id1 overexpressing ES cells cultured in LIF+BMP4 or in N2B27 for 2 
days with antibodies against Esrrb and Klf4. The expression of both markers was lost 
after 48 hours of culture in N2B27 (Figure 4.6a). Their downregulation was 
confirmed by quantification of the nuclear immunostaining signal intensity of a 
minimum of 130 nuclei for each of the four samples (Figure 4.6b). 
I have confirmed the findings presented in this section using an independently-
generated line of ES cells that I engineered to allow doxycycline-inducible 
expression of an Id1 transgene. These data are not presented in this thesis, but can be 
found in our recent publication (Malaguti et al. 2013). 
We can therefore conclude that Id1 overexpression in neural adherent monolayer 
differentiation does not affect the downregulation of naïve pluripotency markers on 
the timescale I have adopted for my experiments. 
 
4.2.3 Id1 overexpression delays the exit from a pluripotent epiblast-like state whilst 
promoting a proximal posterior epiblast identity 
Having established Id1 overexpression does not delay the exit from naïve 
pluripotency, I set out to investigate whether it affected gene expression during early 
timepoints of neural differentiation, or whether it played its role in the inhibition of 
neural specification at a later stage. 
I used the RNA samples described in section 4.2.2 to investigate the expression of 
markers of various lineages during the first three days of neural adherent monolayer 





differentiation (Figure 4.7). Whilst Id1 did not affect the kinetics of downregulation 
of naïve pluripotency markers (Figure 4.5b), it delayed the downregulation of Oct4 
and Cdh1, factors expressed in both pre-implantation and post-implantation 
pluripotent epiblast. It also delayed the downregulation of the post-implantation 
pluripotent epiblast markers Fgf5 and Otx2 (Figure 4.7a). This evidence points 
towards a delay in the exit from a post-implantation state of pluripotency. This was 
corroborated by a delay in the upregulation of Zeb1 and Zeb2, transcription factors 
capable of driving the epithelial-to-mesenchymal transition and forcing cells to exit 
the pluripotent state, and of Cdh2, which encodes a transmembrane protein expressed 
in cells that have undergone EMT (Figure 4.7c). Interestingly, whilst delaying the 
loss of markers of pluripotent epiblast, Id1 overexpression also induced the 
expression of T, Gsc and Eomes, markers of proximal posterior epiblast/primitive 
streak, and inhibited the upregulation of neural markers Sox1 and Zfp521 (Figure 
4.7b,c). This suggests a multifaceted role for Id1: on one hand it delays the exit from 
a post-implantation epiblast-like pluripotent state, on the other it provides the 
differentiating cells with a regionally specified identity, that of proximal posterior 
epiblast. In that respect it is interesting to note that Nanog is re-upregulated in Id1 
overexpressing cells at day 3 of differentiation (Figure 4.5b). Nanog is a marker of 
the naïve pluripotency state, its overexpression can sustain LIF-independent ES cell 
self-renewal, and it is a key determinant of the epiblast in the inner cell mass of the 
blastocyst (Chambers et al. 2003, Chambers et al. 2007, Mitsui et al. 2003, Silva et 
al. 2009). However, it is also expressed in the posterior half of the E6.5 epiblast 
(Morkel et al. 2003, Osorno et al. 2012). Thus, its downregulation and consequent 
upregulation in Id1 overexpressing cells would add further weight to the conclusion 
that Id1 is promoting a pluripotent proximal posterior epiblast cell type. 
I assessed the expression of some of these markers during this differentiation process 
at the protein level by performing immunofluorescence staining of empty vector 
control and Id1 overexpressing ES cells cultured in LIF+FCS or differentiated for 1, 
2 or 3 days in N2B27. Control cells replace Cdh1 with Cdh2 at their cell membranes 





starting at day 2 of differentiation. Id1 overexpressing cells, on the other hand, 
maintain expression of Cdh1 and do not upregulate Cdh2 within the timeframe of 
this experiment (Figure 4.8a). Control cells gradually downregulate Oct4, with cells 
expressing low levels of the protein at day 3. They do not visibly upregulate T 
protein. Id1 overexpressing cells, instead, retain Oct4 expression and upregulate T on 
the third day of differentiation (Figure 4.8b). I performed immunostaining 
quantification of the nuclear fluorescence signal of empty vector control and Id1 
overexpressing cells cultured in LIF+FCS or in N2B27 for 3 days and stained with 
antibodies against Oct4 and T. Whilst the factors display a similar expression pattern 
in LIF+FCS culture, there is a very clear difference in their expression after 3 days of 
differentiation. Approximately 40% of control cells express Oct4, with 6% of these 
co-expressing T. Approximately 75% of Id1 overexpressing cells express Oct4, with 
45% of these co-expressing T. For both cell lines, less than 2% of cells express T 
without co-expressing Oct4. Oct4 is downregulated as epiblast cells become 
mesodermal. This suggests that the T-positive cells that are being generated in this 
culture system represent the Oct4-positive T-positive cells present in the epiblast 
rather than an Oct4-negative early mesodermal cell type (Rivea-Pérez & Magnuson 
2005). 
I have also confirmed the findings presented in this section, for a subset of the 
markers described, in independently-generated ES cells that allow for doxycycline-
inducible expression of an Id1 transgene (Malaguti et al. 2013). 
We can therefore conclude that, based on detailed marker analysis at the transcript 
and at the protein level, Id1 overexpression can inhibit neural differentiation by 
delaying the exit from a pluripotent post-implantation epiblast-like state and by 









4.2.4 Id1 overexpression ultimately favours mesodermal differentiation 
4.2.4.1 Id1 overexpression cannot prevent the exit from a pluripotent epiblast-like 
state 
In order to understand into what lineage Id1 overexpressing cells eventually 
differentiate into, I set up a neural adherent monolayer differentiation of empty 
vector control and Id1 overexpressing ES cells in N2B27 medium. This experiment 
is similar to the one described above, but the gene expression of the cells was 
characterised at later points in time. I collected RNA from the starting populations of 
ES cells cultured in LIF+FCS and from cells cultured in N2B27 for 3, 4 or 5 days, 
and performed qRT-PCR analysis for a range of markers of different germ layers 
(Figure 4.9). I confirmed Id1 was overexpressed in the test samples, and noticed once 
more that the transgene was downregulated after differentiation (Figure 4.9a). The 
naïve pluripotency marker Esrrb was downregulated in both control and Id1 
overexpressing cells after 3 days of differentiation (Figure 4.9b), as expected from 
the results presented in the previous section. Control cells exhibited very little 
detectable expression of the pluripotent post-implantation epiblast markers Oct4, 
Cdh1 and Fgf5 on the third day of differentiation, whereas the three factors were still 
readily detectable in Id1 overexpressing cells. These epiblast markers were 
ultimately downregulated, however, after 4 days of culture in N2B27 (Figure 4.9c). 
Immunostaining of empty vector control and Id1 overexpressing cells at day 3 and 
day 5 of N2B27 differentiation confirmed at the protein level that Id1 overexpression 
can maintain Cdh1 and Oct4 expression until day 3 but not until day 5 of 
differentiation (Figure 4.10). Id1 overexpressing cells upregulated proximal posterior 
epiblast markers T, Eomes and Gsc on day 3 of differentiation, and these were also 
downregulated subsequently (Figure 4.9d). Immunostaining of empty vector control 
and Id1 overexpressing cells at day 3 and day 5 of N2B27 differentiation confirmed 
at the protein level that Id1 overexpression can maintain Cdh1 and T expression until 
day 3 but not until day 5 of differentiation (Figure 4.11). The co-expression of Cdh1 
and T at day 3 of differentiation confirms the previous observation that the T-





expressing cells generated by the Id1 overexpressing cells represent the Cdh1-
positive T-positive cells expressed in the epiblast rather than an early mesodermal 
cell type. 
These observations suggest that Id1 overexpression can delay, but not prevent, the 
exit from a pluripotent post-implantation epiblast-like state. 
 
4.2.4.2 Id1 overexpression in neural differentiation generates mesodermal cells  
I then went on to test the expression of markers of differentiated lineages. The 
general EMT markers Cdh2, Vimentin and Zeb1 are expressed by cells differentiating 
into neural ectoderm or mesoderm. Interestingly the upregulation of these markers 
was delayed in Id1 overexpressing cells (Figure 4.9e). As expected, Id1 
overexpression also inhibits the expression of the neural marker Sox1, and it slightly 
inhibits the expression of the neural/mesenchymal marker Zfp521 (Figure 4.9f). It 
does not affect the expression of the endodermal marker Gata6 (Figure 4.9g). 
Surface ectoderm is a subset of ectoderm that differentiates without losing an 
epithelial character and Cdh1 expression, so it is a viable hypothesis that the effect of 
Id1 overexpression on the inhibition of the upregulation of EMT markers may result 
in differentiation towards this particular lineage. This does not appear to be the case, 
however, as there is no significant difference between control and Id1 overexpressing 
cells in the expression of Krt8 and Gata2, two markers of this lineage (Figure 4.9h). 
Finally, I tested the expression of a range of mesodermal markers. Id1 
overexpression appears to drive the expression of the late primitive streak markers 
Wnt3a and Snail at day 4 of differentiation, 24 hours after the peak in expression of 
the primitive streak determinants T and Eomes. It also appears to induce the 
upregulation of the paraxial mesoderm markers Pdgfra and Tcf15 (also commonly 
referred to as Paraxis) at days 4 and 5 of differentiation, and of the vascular, 
haematopoietic, lateral and extraembryonic mesoderm marker Kdr (also commonly 
referred to as Flk1 and Vegfr2) at day 5 of differentiation (Figure 4.9i). Thus, Id1 





overexpression appears to favour differentiation of ES cells cultured in serum-free 
unsupplemented N2B27 medium into cells of mesodermal lineages. 
Cdh2 replaces Cdh1 at the membrane of cells undergoing EMT as they ingress 
through the primitive streak to form mesoderm, and is expressed by a large number 
of mesodermal subtypes thereafter (Hirano et al. 2008, Nakamura et al. 2013, Radice 
et al. 1997). It is therefore surprising that, despite upregulating a range of 
mesodermal markers, the Id1 overexpressing cells do not appear to upregulate Cdh2 
transcript to the same levels as the control cells expressing the factor in neural 
ectoderm. I examined the expression of Cdh2 at the protein level by performing 
immunostains on empty vector control and Id1 overexpressing cells at day 3 and day 
5 of culture in N2B27 medium (Figure 4.12, also see Figure 4.8a for expression at 
day 3). Control cells express Cdh2 in a high proportion of cells at day 3 and are 
uniformly expressing the factor at day 5. Id1 overexpressing cells express Cdh2 in a 
few cells at day 3 and in a high proportion of cells at day 5. It appears that the cells at 
day 5 of differentiation are divided in two subsets, a first one with densely packed 
Cdh2-expressing cells and a second one with more loosely separated cells that appear 
to be stemming from the packed colony and downregulating Cdh2. This 
heterogeneity could explain the lower level of Cdh2 transcript in Id1 overexpressing 
cells than in control cells at day 5 of differentiation. 
I have also confirmed the findings presented in this section in independent 
experiments, for a subset of the markers described, using the Id1 reverted ES cells as 
a negative control (Malaguti et al. 2013). 
In conclusion, Id1 overexpression cannot prevent the exit from a pluripotent state, 
but it reroutes cells destined for neural commitment to mesodermal specification. 
 
 





4.2.5 Id1 expression in single wild-type differentiating cells is not responsible for 
the timing of the loss of pluripotency factors 
ES cells differentiate asynchronously (Lowell et al. 2006). Having observed that Id1 
overexpression is capable of delaying the loss of post-implantation pluripotency 
markers, I hypothesised that the heterogeneity in the rate of neural differentiation 
may be due to heterogeneity in Id1 expression during differentiation. I set out to test 
this by assaying whether there is a correlation between Id1 and pluripotency or 
neural marker expression at the single cell level. 
I therefore decided to perform qRT-PCR on RNA extracted from single cells at 
various timepoints of N2B27 differentiation, and to compare the pattern of 
expression of Id1 to that of a range of pluripotency and neural markers in the same 
single-cell samples. The expression pattern of the selected markers during the first 
four days of neural adherent monolayer differentiation at a whole population level is 
shown in Figure 4.13. These data confirm that the pluripotent epiblast markers Cdh1, 
Fgf5, Nanog and Oct4 are progressively lost during the course of the differentiation 
experiment, whereas the neural/EMT markers Cdh2, Sox1, Zeb1 and Zeb2 are 
progressively upregulated. 
I set up a first experiment with the aim of understanding how reliable this novel 
technique truly was, whilst at the same time obtaining some potentially valuable 
insight in the biological process I was studying. I made use of a fluorescence 
activated cell sorter to sort 90 E14tg2a ES cells cultured in LIF+FCS and 90 E14tg2a 
ES cells cultured in N2B27 for 4 days into single wells of a 96-well PCR plate. 
These cell numbers were chosen so that the maximum number of samples (180) 
could be loaded in duplicate on a 384-well qRT-PCR plate alongside positive and 
negative controls and a serial dilution of cDNA generated by sorting 32 cells into a 
well of a 96-well plate alongside the samples (see Materials and Methods paragraph 
2.2.2.3). I performed reverse transcription of the RNA into cDNA, and 22 cycles of 
pre-amplification of the cDNA using primers to detect Id1, the pluripotency markers 
Cdh1 and Oct4, the neural markers Cdh2 and Sox1, and the housekeeping gene Tbp. I 





performed qRT-PCR experiments on the samples to measure the expression level of 
the six factors listed above (Figure 4.14a). As expected, the majority of ES cells 
expressed Cdh1 and Oct4 at high levels and Cdh2 and Sox1 at basal levels, and the 
opposite was true for the differentiated cells. Two cells in the differentiated sample 
displayed an ES cell-like expression pattern, suggesting that they had yet to undergo 
neural commitment. Id1 was expressed heterogeneously in ES cells and in a similar 
pattern, yet to a lower level, in differentiated cells. Sox1 expression was very variable 
at day 4 of differentiation, in keeping with the flow cytometry profiles of 
differentiating Sox1-GFP reporter ES cells (Ying et al. 2003b). Expression of Cdh2 
expression was also heterogeneous in day 4 cultures. 
In order to understand how the expression of one factor may reflect the expression 
status of the others, I calculated Spearman’s rank correlation coefficients for the 
factors across all cells (Figure 4.14b). The coefficient is equal to +1 for a perfect 
positive correlation and to -1 for a perfect negative correlation. A value of 0 indicates 
a complete absence of correlation. Oct4 and Cdh1 displayed a statistically significant 
positive correlation with a coefficient of 0.82, as expected, given that both markers 
are expressed in ES cells and absent from neural cells. Cdh2 and Sox1 also displayed 
a statistically significant positive correlation with a coefficient of 0.5, as expected, 
given that both markers are expressed in neural cells and absent from ES cells. The 
ES cell markers were negatively correlated with the neural markers. 
The combination of these observations confirms that the differentiation process is 
heterogeneous, as previously reported (Lowell et al. 2006, Ying et al. 2003b). The 
observation of the expected correlations between neural and pluripotency markers 
validates the reliability of single-cell qRT-PCR as an analytical technique, and 
suggests that it can detect meaningful correlations within heterogeneous populations 
of cells. 
The analysis of the correlation of Id1 with the other markers allows us to address the 
question of whether Id1 expression is associated with cells that tend to resist 
differentiation. Id1 displayed a weak positive correlation with Cdh1 and Oct4 and a 





weak negative correlation with Sox1, but the rank correlation coefficients were low, 
and therefore unlikely to indicate true biologically meaningful correlations. It would 
appear that at the selected timepoints the shift of gene expression from a pluripotent 
signature to a neural signature has not yet started (ES cells) or has already been 
completed (day 4 of N2B27 culture). This in turn implies that the levels of 
pluripotency factors are low in the vast majority of differentiated cells, and thus that 
comparison of the levels of these with the levels of neural factors is not effectively 
giving an insightful indication into how the transition in expression from one to the 
other may operate. 
I therefore set up a second experiment to attempt to capture a better description of the 
transition from pluripotency to the neural lineage. In order to maximise the chances 
of identifying timepoints providing high information, but still have a sufficient 
number of cells to perform statistically relevant analyses, I chose to analyse E14tg2a 
ES cells cultured in N2B27 for 1, 2 or 3 days. I sorted 60 cells from each timepoint 
into single wells of 96-well PCR plates and performed RNA retrotranscription and 
22 cycles of cDNA pre-amplification with primers designed to amplify Id1, the 
pluripotency markers Cdh1, Fgf5, Nanog, Oct4, the neural and EMT markers Cdh2, 
Sox1, Zeb1, Zeb2 and the normalising gene Tbp. I then performed qRT-PCR 
experiments to measure the expression levels of these factors across all samples and 
calculated Spearman’s rank correlation coefficients for the factors separately for the 
three timepoints, in order to understand how the expression of the factors is 
correlated at specific times during the differentiation experiment (Figures 4.15, 4.16). 
The markers display heterogeneous expression both between different timepoints and 
within the same timepoint. As expected from the population-level qRT-PCR analysis 
presented (Figure 4.13), the levels of Cdh1 and Oct4 are downregulated over the 
course of the experiment, whereas the neural markers Cdh2, Sox1, Zeb1 and Zeb2 are 
upregulated as the differentiation progresses. The correlation analysis reveals that the 
markers behave as two separate sets of transcripts: a “pluripotent epiblast” set (Cdh1, 
Fgf5, Nanog, Oct4) and a “neural” set (Cdh2, Sox1, Zeb1, Zeb2). The markers within 





the two sets of transcripts display weak statistically significant correlations at day 1 
of differentiation. At days 2 and 3 of the differentiation experiment, the pluripotent 
epiblast markers are strongly correlated with one another, the neural markers are 
strongly correlated with one another, and the two sets are negatively correlated 
between each other. 
These observations confirm that cells differentiate heterogeneously. The observation 
of the expected correlations between pluripotency markers and between neural 
markers once again confirms the validity of single-cell qRT-PCR as a tool for 
expression analysis. Single-cell qRT-PCR can therefore detect the heterogeneity in 
the differentiation process between individual cells, and can successfully identify 
correlations between the expression of different genes within heterogeneous cultures. 
 
I proceeded to analyse the expression pattern of Id1 to understand whether 
expression of the HLH factor is associated with a resistance to differentiation. Id1 is 
expressed at extremely low levels in all cells on days 1 and 2 of differentiation, and 
is upregulated on day 3 by all cells. This suggests that it is unlikely to influence the 
rate of neural differentiation and suggests my initial hypothesis was wrong. 
A few more interesting insights can be gained by the analysis of these data. 
The first is the observation of the statistically significant positive association of Cdh1 
and Oct4 at all timepoints of the differentiation process. Cdh1 and Oct4 are co-
expressed from pre-implantation development until cells exit pluripotency in the 
post-implantation embryo (Fierro-González et al. 2013, Malaguti et al. 2013, Nichols 
et al. 1998, Palmieri et al. 1994), and the transcriptional association I observed may 
underlie a common mechanism promoting the expression of these factors. 
The second is the observation that the pattern of upregulation of the neural 
transcription factors differs. Sox1 is not expressed on day 1, is upregulated by few 
cells at low levels on day 2, and is then expressed at a higher level by a higher 
number of cells on day 3. Zeb1 is expressed by many cells at a low level on day 1, 
and is then expressed at a higher level on days 2 and 3. Zeb2 is expressed in some 





cells at a high level on day 1, and the proportion of expressing cells increases on days 
2 and 3. The three neural transcription factors therefore differ in the timing of their 
activation, the proportion of expressing cells and the level of expression upon 
activation. 
We can conclude that ES cells differentiating in N2B27 in an adherent monolayer 
switch from a pluripotent epiblast gene expression signature to an early neural gene 
expression signature, and are therefore following a differentiation route that is 
compatible with the normal development of the mouse embryo. This suggests that 
neural adherent monolayer differentiation is a valid method for the study of neural 
specification and of the early lineage decisions in which Id1 is involved. 
We can also conclude that in this differentiation system, Id1 does not appear to be 
expressed at a level which would allow it to influence the differentiation direction or 
kinetics of the cells. The initial hypothesis of the HLH factor influencing the 
heterogeneity of the neural differentiation process is therefore unlikely to be correct. 
Finally, single-cell qRT-PCR analysis revealed considerable variability between 
individual differentiating cells. This variability is not a simple artefact of the 
procedure (such as a lack of precision in the quantification of mRNA levels), since 
pluripotency and neural markers displayed the expected positive and negative 
correlations with each other. 
 
4.3 Discussion 
4.3.1 Id1 overexpression and the exit from naïve pluripotency 
Id1 is a transcriptional regulator with a critical function in the maintenance of the 
self-renewal status of ES cell cultures. Whilst its knockout does not have a 
phenotype in vivo, and does not result in overt differentiation of ES cells, it does 
affect the clonogenic properties of ES cells and their expression of Nanog and Rex1 





(Lyden et al. 1999, Romero-Lanman et al. 2011, Yan et al. 1997). The fact that this 
is the case despite ES cells expressing the structurally and functionally similar HLH 
factors Id2 and Id3 is testament to the importance that Id1 plays in cell fate decisions. 
In a 2010 study, Jing and colleagues investigate the effects of BMP4 in two distinct 
stages of ES cell differentiation: the transition from a pre-implantation to a post-
implantation type of pluripotency (referred to as ES cell to EpiSC transition), and the 
transition from post-implantation pluripotency to neural progenitor cells (Zhang et al. 
2010). They adopted a serum-free embryoid body (SFEB) differentiation protocol 
(Watanabe et al. 2005) in which ES cells are allowed to aggregate in suspension in 
basal medium containing KSR and no LIF. They demonstrated that after two days of 
culture in this medium, cells treated with BMP4 expressed higher levels of Klf4, 
Nanog and Rex1 and lower levels of Fgf5 than untreated controls. They set up a 
similar experiment using Id2 overexpressing cells in place of BMP4-treated cells and 
showed that the Id2 overexpressing cells expressed higher levels of Klf4, similar 
levels of Nanog and Rex1, and lower levels of Fgf5 to control cells. They also 
claimed that they obtained similar results with Id1 overexpressing ES cells, although 
they did not present these results. They therefore concluded that BMP4 and its 
targets Id1 and Id2 inhibit the ES cell to EpiSC transition. 
In paragraph 4.2.2, I presented data which indicate that Id1 overexpression does not 
seem to delay the loss of Klf4, Esrrb and Nanog in the differentiation of ES cells 
towards the neural lineage. I have also confirmed these findings using a cell line that 
allows for doxycycline-inducible expression of an Id1 transgene (Malaguti et al. 
2013). How can these apparently contradicting datasets be reconciled? 
The explanation may lie in timing differences between the two differentiation 
protocols used. The transition from pre-implantation to post-implantation 
pluripotency in the SFEB protocol takes between 48 and 72 hours, whereas the same 
transition in the N2B27 protocol occurs in approximately 24 hours. The delay in 
downregulation of Klf4 and upregulation of Fgf5 after 48 hours of SFEB 
differentiation reported by Zhang et al. (2010) for Id1 overexpressing cells may 





therefore be difficult to capture in Id1 overexpressing cells cultured for 24 hours in 
N2B27. The use of shorter timepoints in N2B27 culture may have allowed to make 
similar observations. The differences in expression of Klf4, Nanog and Rex1 between 
differentiated Id2-overexpressing and wild-type cells observed by Jing and 
colleagues were small in magnitude. Should their data for Id1-overexpressing cells 
reflect the expression levels of Klf4, Nanog and Rex1 in the Id2-overexpressing cells, 
it is also possible that these gene expression differences may be too subtle to detect 
in a short time window in N2B27 culture. 
 
4.3.2 The effects of Id1 overexpression on the loss of epiblast markers and the 
regional identity of differentiating cells 
Despite not affecting the kinetics of the loss of expression of markers of naïve 
pluripotency, Id1 overexpression has a clear effect on the kinetics of the 
downregulation of makers of the early post-implantation pluripotent epiblast. Id1 
overexpressing cells delayed the downregulation of Cdh1, Fgf5, Oct4 and the 
upregulation of Cdh2 until day 4 of differentiation, unlike control cells, which were 
mostly negative for Oct4 protein at day 3 and started expressing Cdh2 at day 2 of 
differentiation. Concomitantly with this maintenance of Cdh1 and Oct4 expression, 
Id1 overexpressing cells displayed an inhibited upregulation of neural markers and in 
their place expressed primitive streak determinants such as T, within the Cdh1- and 
Oct4-expressing compartment. This suggests that Id1 overexpression is inducing the 
formation of a cell type with the gene expression pattern of proximal posterior 
epiblast. 
 
4.3.2.1 Generation of a proximal posterior epiblast-like cell type 
It is not surprising that Id1 overexpression results in the formation of cells with a 
proximal posterior epiblast regional identity. A proportion of Bmp4 knockout mice 





fail to express T, and BMP4 stimulation has been used to generate T-expressing cells 
and to promote mesoderm differentiation of ES cells (Johansson & Wiles 1995, Park 
et al. 2004, Winnier et al. 1995). Bmp4 is expressed in the extraembryonic ectoderm 
adjacent to the proximal epiblast in E5.5, E6.5 and E7.5 embryos, with embryos at 
E7.5 displaying stronger expression of the morphogen in the posterior regions of the 
extraembryonic ectoderm adjacent to the proximal posterior epiblast expressing T 
and Gsc (Beddington et al. 1992, Coucouvanis & Martin 1999, Norris et al. 2002, 
Perea-Gómez et al. 1999, Perea-Gomez et al. 2001, Rivea-Pérez & Magnuson 2005, 
Tremblay et al. 2001, Wilkinson et al. 1990, Willison 1990). Id1 is also expressed in 
the proximal regions of the embryo between E5.5 and E7.5 (Jen et al. 1997). 
Although Id1 knockout embryos do not exhibit defects in the formation of the 
primitive streak (Fraidenraich et al. 2004, Lyden et al. 1999, Yan et a. 1997), it is 
conceivable one or more Id factors may be involved in instructing cells in the post-
implantation epiblast about their location in the embryo and the structures they 
should be generating. Both Id2 and Id3 are expressed in the proximal posterior 
epiblast, in agreement with this hypothesis (Jen et al. 1997, Lin et al. 2013, 
unpublished observations by Amy Pegg, a PhD student in our laboratory). 
 
4.3.2.2 Identity of the remaining cells in culture 
The observation that approximately 45% of Oct4-positive Id1 overexpressing cells 
express T on the third day of differentiation in N2B27 raises an interesting question. 
Are the remaining 55% of Oct4-expressing cells yet to acquire a proximal posterior 
identity, are they a set of proximal posterior epiblast-like cells which are not 
expressing T, are they the equivalent of lateral and anterior proximal epiblast or of 
epiblast with more distal character? The question is an open one. The cells are not 
expressing high levels of Sox1, which is expressed in the anterior epiblast. 
Expression of Sox1 in N2B27 culture occurs after downregulation of Cdh1 (Kamiya 
et al. 2009, Malaguti et al. 2013, Watanabe et al. 2005), and the Id1 overexpressing 
cells appear to be uniformly Cdh1-positive at day 3 of differentiation. A qRT-PCR 





for Dlx5, a gene expressed rostrally to Sox1 in E6.5 embryos and in the proximal 
anterior of E7.5 embryos, did not detect any transcript in either control or Id1 
overexpressing cells (data not shown). Markers of surface ectoderm, which has a 
proximal anterior component as E7.5, were not enriched in Id1 overexpressing cells. 
In the gastrulating embryo, T becomes restricted to cells at the posterior-most region 
of the embryo, rather than being widely expressed throughout the posterior half of 
the epiblast (Figures 5.2, 5.4), thus Oct4-positive T-negative cells exist in the 
proximal posterior epiblast. 
We can therefore infer that, if the Oct4-positive T-negative cells have an in vivo 
counterpart, it is either lateral epiblast, medial/distal posterior epiblast, proximal 
posterior epiblast not expressing T, or epiblast of an earlier character.  
 
4.3.2.3 Delay in the loss of post-implantation pluripotency factors 
Another matter of interest is the significance of the Id1-induced delay in the 
downregulation of markers of the pluripotent post-implantation epiblast. Is this 
action of Id1 independent of its role in regionalising the culture or is the expression 
of Cdh1, Fgf5 and Oct4 a secondary property of the cell type that is being generated 
(i.e. does posterior epiblast inherently differentiate slower than anterior epiblast)? 
The former possibility is certainly an intriguing one. Embryos lacking the BMP4 
receptor Bmpr1a exhibit premature loss of Fgf5 and Oct4 and premature 
differentiation into the neural lineage (Di-Gregorio et al. 2007). Furthermore, we 
have seen in Figure 4.1 that BMP4 treatment of cells cultured in N2B27 prevents the 
loss of Cdh1 expression and maintains colonies of Oct4-positive cells for at least 6 
days of differentiation, suggesting the factor has a strong anti-EMT effect. Id1 
overexpression seems to recapitulate this prolonged maintenance of Cdh1 until day 
3, after which the cells lose the expression of Cdh1 and upregulate Cdh2. The Id1 
transgene is downregulated during the course of the differentiation experiments, and 
reduced levels of Id1 protein may be unable to sustain Cdh1 expression past day 3. 
 





The second possibility is also very plausible. The expression of Oct4 and Cdh1 
persists for a longer time in the posterior epiblast than in the anterior epiblast, with 
expression of both factors stronger in the posterior of headfold stage embryos before 
complete loss of Oct4 transcript (Perea-Gómez et al. 1999, Stemmler et al. 2005). It 
is thus possible that the cells generated by overexpression of Id1 express Cdh1 and 
Oct4 because of the intrinsic properties of posterior proximal epiblast cells rather 
than because of an anti-differentiation action of Id1. 
As with the proverbial case of the chicken and the egg, it is not fundamental for the 
purposes of this investigation to distinguish between these two possibilities by asking 
whether the ability of Id1 to delay differentiation is secondary to its effects on 
positional identity, or vice versa. Whether Id1 has an intrinsic anti-differentiation 
effect or whether its primary effect is to generate a posterior cell type that expresses 
pluripotency factors because of the structure of its gene expression network, the end 
result is that overexpression of the HLH factor delays the kinetics of the exit from a 
post-implantation epiblast-like pluripotency transcriptional state. 
 
4.3.3 Mesodermal differentiation of Id1 overexpressing cells 
4.3.3.1 Id1 overexpression cannot prevent EMT 
Whilst BMP4 treatment can generate T-expressing cells in various differentiation 
systems (Johansson & Wiles 1995, Park et al. 2004), and favours mesendodermal 
gene expression in the SFEB culture experiments carried out by Zhang et al. (2010), 
it appears that in N2B27 adherent monolayer culture it results in a failure to 
downregulate Cdh1 and in the maintenance of Oct4-expressing colonies for at least 6 
days of differentiation. Despite its delay on the downregulation of Cdh1 and Oct4, 
Id1 overexpression in N2B27 culture cannot fully replicate the effects of BMP4, and 
eventually results in an EMT step, the expression of Cdh2, and differentiation 
towards the mesoderm lineage. 





Why this may be is unclear. Either other targets of BMP4 are critical for the 
maintenance of Cdh1 and Oct4 expression, or the downregulation of the Id1 
transgene during the course of the differentiation results in insufficient levels of Id1 
protein to effect this block of EMT. It is interesting to note that the Id1 
overexpression experiments in N2B27 carried out by Ying et al. (2003a) resulted in 
the generation of cells with two different morphologies. Constitutive Id1 
overexpression resulted in the generation of the “big flat cells” which can be 
obtained after culture of wild-type cells in N2B27+BMP4 (Figure 4.1). Episomal 
transfection of supertransfectable ES cells (cells with a genetic modification which 
allows replication of circular plasmids) generated cells with a mesenchymal 
morphology after 6 days of differentiation (Ying et al. 2003a). Episomal 
overexpression is not stably maintained after differentiation (unpublished 
observations in the Lowell laboratory), suggesting that a difference in the 
maintenance of Id1 overexpression may have resulted in the generation of this 
mesenchymal cell type. This, coupled to the fact that large Cdh1-positive epithelial 
cells could be generated in the constitutive stable overexpression experiment 
performed by Ying et al. (2003a), suggests that an insufficient maintenance of Id1 
expression may be the cause of the lack of long-term EMT inhibition in my own 
experiments. 
If this were the case, the situation would be similar to that described by Kobayashi & 
Kageyama (2010) for the bHLH factor Hes1. Hes1 overexpression in N2B27 culture 
results in expression of T, but in order for cells to express markers of the mesodermal 
lineage (Kdr, Nkx2.5) Hes1 levels need to be reduced. If they are not, the cells 
acquire a morphology reminiscent of that seen after N2B27+BMP4 culture of wild-
type ES cells (Kobayashi & Kageyama 2010, Zhou et al. 2013, Figure 4.17). 
Notably, both Id1 and Hes1 act in other contexts as generic inhibitors of bHLH 
transcription factor activity, raising the possibility that their functions may converge 
upon the regulation of an as yet unidentified bHLH transcription factor in the post-
implantation epiblast.  





4.3.3.2 Id1 overexpression results in differentiation towards mesoderm 
The Id1 overexpressing cells follow the normal sequence of marker expression seen 
during the specification of mesoderm in vivo (T, Eomes, Gsc at day 3; Wnt3a, Snail, 
Pdgfra, Tcf15 at day 4, Kdr at day 5). A previous overexpression experiment carried 
out with Id2 overexpressing EpiSCs by Zhang et al. (2010) also showed that the 
differentiating Id2 overexpressing cells upregulated T and Kdr and had reduced 
upregulation of Sox1 and Sox2 compared to control EpiSCs, and that unlike BMP4 
treated wild-type cells, they did not upregulate markers of endoderm and non-neural 
ectoderm upon differentiation. 
 
In conclusion, Id1 overexpression in N2B27 favours the generation of mesodermal 
cells without forcing cells to differentiate into other non-neural lineages. 
 
4.3.4 Single-cell transcriptional analysis of neural adherent monolayer 
differentiation 
4.3.4.1 Id1 is not responsible for the heterogeneity in the capacity for neural 
differentiation of ES cells 
The analysis of the levels of pluripotency and neural markers in single differentiating 
wild-type ES cells revealed that Id1 was not present at detectable levels in any cell 
from a sample of approximately 100 cells at days 1 and 2 of neural differentiation. 
The cells differentiated asynchronously, with some activating a neural transcriptional 
programme as early as days 1 and 2 of differentiation, and others still expressing 
pluripotency markers after 4 days of differentiation. Whilst I hypothesised that this 
effect could have been due to the capability of Id1 of delaying the downregulation of 
Cdh1 and Oct4, as seen in the overexpression experiments, the fact that none of the 
tested cells expressed Id1 at the timepoints in which these factors were lost suggests 
that Id1 is unlikely to play a major role in the differentiation of wild-type cells in 





N2B27. This does not exclude the possibility that Id1 may be responsible for 
delaying differentiation in a rare subpopulation of cells, but we can conclude that Id1 
is not likely to be a major factor in explaining the mechanisms behind heterogeneity 
in neural differentiation in monolayer cultures. 
 
4.3.4.2 N2B27 differentiation follows an appropriate developmental pathway 
The transcriptional analysis revealed that single differentiating ES cells exist in either 
of three stable states, a Cdh1- and Oct4-expressing ES cell, a Cdh1-, Fgf5- and Oct4-
expressing post-implantation epiblast-like cell, or a Cdh2-, Sox1-, Zeb1- and Zeb2-
expressing early neural cell. This in turn suggests that N2B27 neural adherent 
monolayer differentiation follows a similar pathway to what seen in vivo in 
embryonic development, and thus represents a valid model for studying early 
decisions in lineage segregation. 
It is remarkable that differentiating cells succeed in stably adopting distinct coherent 
identities in culture, despite the lack of extrinsic segregation of positional clues. This 
may be due to the stability of alternate transcriptional networks, which would have 
evolved in vivo in response to signals from a three-dimensional environment 
patterned by signals from embryonic and extraembryonic tissues. 
 
4.3.4.3 Zeb factors may be early neural inducers 
In the single-cell analysis, I identified a number of cells at day 1 and 2 of 
differentiation which expressed Zeb1 and Zeb2 at levels similar to those seen on the 
third day of differentiation. The activation of these factors precedes the expression of 
Sox1 and Cdh2, and the downregulation of Cdh1 and Oct4, and could indicate that 
these pro-EMT factors play a crucial role in driving the loss of Cdh1 and generating 
a Cdh2-positive Sox1-positive neuroepithelium. The finding that Zeb2 is essential for 





the neural differentiation of human ES cells provides support for this hypothesis 
(Chng et al. 2010). 
 
4.3.4.4 Significance of the correlation between Cdh1 and Oct4 transcription 
Throughout this chapter, I have presented data that show that Cdh1 and Oct4 are 
downregulated synchronously by differentiating ES cells. This was true irrespective 
of whether cells were differentiating to mesodermal or neural lineages, and of 
whether the analyses were performed at the population or at the single-cell level 
(Figures 4.7, 4.8, 4.9, 4.10, 4.13, 4.14, 4.15, 4.16). The two factors are co-expressed 
in pluripotent cells of the pre-implantation embryo (Fierro-González et al. 2013, 
Nichols et al. 1998, Palmieri et al. 1994), and they are downregulated synchronously 
upon the exit from pluripotency after implantation, both in the neural tube and in the 
posterior regions of the embryo (Malaguti et al. 2013, Perea-Gómez et al. 1999, 
Stemmler et al. 2005). Cdh1 expression will eventually be uncoupled from Oct4 
expression in the surface ectoderm and in the endoderm, but it is intriguing that a 
transmembrane protein and a transcription factor would exhibit strong correlation in 
pluripotent and differentiating cells at the single-cell level. It is possible that Oct4 
positively regulates the expression of Cdh1 as well as its own, but in that case loss of 
Oct4 mRNA should precede the loss of Cdh1 mRNA, and this is not apparent. Other 
uncharacterised factors may therefore be regulating the expression of both genes. 
The relationship between the two factors is not limited to a similar regulation of 
expression. Cdh1 can substitute for Oct4 in the generation of induced pluripotent 
stem cells (Redmer et al. 2011), and the two proteins have also been found to 
physically interact at the cell membrane (Faunes et al. 2013, Livigni et al. 2013). 
The significance of the coupling of Cdh1 and Oct4 expression throughout 
development and of the crosstalk between these molecules is currently unclear, but 
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Figure 4.1 – Culture of ES cells in BMP4 generates different cell types 
E14tg2a ES cells were cultured in N2B27 in the presence of 10ng/ml BMP4 for 6 
days. The cells were then fixed, stained with antibodies against Oct4, Cdh1 or 
Tcfap2a and imaged on an Olympus IX51 microscope. Scale bar: 100µm. 
Clusters of small cells express Oct4 whilst larger flattened cells express Tcfap2a. 











































Figure 4.2 – Characterisation of Id1 overexpressing ES cell lines 
a. Plasmid transfected into E14tg2a ES cells to generate clonal cell lines 
overexpressing Id1-IRES-Pac under the control of the strong CAG promoter. 
The Id1-IRES-Pac-pA sequence is flanked by loxP sites, allowing excision of 
the cassette and expression of a downstream GFP transgene upon transfection 
with a plasmid encoding Cre recombinase. pA: polyadenylation signal. 
b. Id1 mRNA levels in three puromycin-resistant clones and in a control clone 
generated by transfecting E14tg2a ES cells with a CAG-Pac-pA (empty 
vector) plasmid. All three Id1-transfected clones overexpress Id1. 
c. Western blots using anti-Id1 (SC-488) and anti-β-tubulin antibodies on cell 
lysates from the three Id1 overexpressing (FLID4, FLID7, FLID11) and the 
control (EVP1) clone, cultured in LIF+FCS and in N2B27 for 5 days. 
Arrowhead: wild-type Id1 band, red arrow: Flag-tagged exogenous Id1 band. 
The approximate size of the bands is indicated. β-tubulin was used as a 
loading control. 
d. Western blot using an anti-Flag antibody on the same cell lysates as in (c) and 
ES cells overexpressing Flag-Neurod1 as a positive control for Flag 
expression. 
Red arrow: size of Flag-Id1 band, green arrow: Flag-Neurod1 band. The 
approximate size of the bands is indicated. No bands were detected in any of 













Plasmid     ATGGACTACAAGGACGACGATGACAAGGTCGCCAGTGGCAGTGCC 
Id1 cDNA    ATG---------------------AAGGTCGCCAGTGGCAGTGCC 
***                     ********************* 
 
Plasmid     MDYKDDDDKVASGSA 
Id1 cDNA    M-------KVASGSA 















Figure 4.3 – Sequence analysis of Id1 overexpression plasmid 
a. Chromatogram from a sequencing read of the start of the Flag-Id1 open 
reading frame in the plasmid shown in Figure 4.2a. 
b. Alignment of the sequencing read in (a) to the open reading frame of Id1. 
c. Alignment of the translated sequencing read in (a) to the Id1 amino acid 

































































Figure 4.4 – Functional validation of Id1 overexpressing cells 
a. mRNA levels of Id1 and the neural marker Sox1 in a neural monolayer 
differentiation of an empty vector control (blue bars), Id1 overexpressing 
cells (red bars) and a control rescued clonal cell line in which the Id1-IRES-
Pac cassette was excised by Cre recombinase (“Id1 reverted”, green bars). 
Cells cultured in LIF+FCS (Day 0) were replated in N2B27 and RNA 
extracted at daily timepoints. 
Error bars: standard deviation of two biological replicates. 
b. Empty vector control, Id1 overexpressing and rescued cells (“Id1 reverted”) 
after 5 days of culture in N2B27 medium. The cells were stained with an anti-
Tubb3 antibody to detect neuronal differentiation, and nuclei were 
counterstained with DAPI. GFP expression indicates loss of the Id1-IRES- 
Pac cassette (see Fig.4.2a). The samples were imaged on an Olympus IX51 















a – Id1 
 
















Figure 4.5 – Id1 does not delay the exit from naïve pluripotency 
qRT-PCR on mRNA samples extracted from empty vector control (blue bars) and 
Id1-overexpressing (red bars) ES cells during the first three days of neural adherent 
monolayer differentiation. 
ES cells cultured in LIF+FCS (Day 0) were replated in N2B27 and RNA extracted at 
daily timepoints. 






































Figure 4.6 – Id1 does not prevent the loss of naïve pluripotency markers 
a. Immunostaining for Klf4 and Esrrb in empty vector control and Id1-
overexpressing ES cells cultured in N2B27+LIF+BMP4 (Day 0) and in 
N2B27 alone for 2 days (Day 2). Nuclei were counterstained with DAPI. 
Scale bar: 30µm. Images were acquired with a Leica TCS SPE confocal 
microscope. 
b. Immunostaining quantification of Klf4 and Esrrb nuclear signal in the 




















a – Pluripotent epiblast 
 
b – Proximal posterior epiblast 
 







Figure 4.7 – Id1 delays the exit from a pluripotent epiblast-like state while 
promoting a proximal posterior identity 
qRT-PCR on mRNA samples extracted from empty vector control (blue bars) and 
Id1-overexpressing (red bars) ES cells during the first three days of neural adherent 
monolayer differentiation (same RNA samples as in Figure 4.5). 
ES cells cultured in LIF+FCS (Day 0) were replated in N2B27 and RNA extracted at 
daily timepoints. 
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Figure 4.8 – Id1 delays a switch from E- to N-cadherin and the loss of Oct4 
whilst promoting upregulation of T 
a. Immunostaining for Cdh1 and Cdh2 in control and Id1-overexpressing ES 
cells cultured in LIF+FCS (Day 0) and in N2B27 for 1, 2 and 3 days. The 
cells were imaged on an Olympus IX51 microscope. Scale bar: 100µm. 
b. Immunostaining for Oct4 and T in control and Id1-overexpressing ES cells 
cultured in LIF+FCS (Day 0) and in N2B27 for 1, 2 and 3 days. The cells 
were imaged on an Olympus IX51 microscope. Scale bar: 100µm. 
c. Immunostaining quantification of Oct4 and T nuclear signal in control and 
Id1-overexpressing ES cells cultured in LIF+FCS (Day 0) or in N2B27 for 3 
days (Day 3). Five random fields were quantified for each of three biological 
replicates for each of the four conditions. A minimum of 3000 nuclei were 
quantified for each condition. 















a – Id1      b – Naïve pluripotency 
    
c – Pluripotent epiblast 
 
d – Proximal posterior epiblast 
 
e – Exit from epiblast (multilineage markers) 
 
f – Exit from epiblast (neural ectoderm) 
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g – Exit from epiblast (endoderm) 
 
h – Exit from epiblast (surface ectoderm) 
 









Figure 4.9 – Id1 ultimately favours mesodermal differentiation 
qRT-PCR on empty vector control (blue bars) and Id1-overexpressing (red bars) ES 
cells at days 3, 4 and 5 of neural adherent monolayer differentiation. 
ES cells cultured in LIF+FCS (Day 0) were replated in N2B27 and RNA extracted 
after 3, 4 and 5 days. 
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Figure 4.10 – Id1 delays but does not prevent the loss of Cdh1 and Oct4 
Empty vector control and Id1 overexpressing ES cells differentiated for 3 and 5 days 
in N2B27 and immunostained for Cdh1 and Oct4. Nuclei were counterstained with 
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Figure 4.11 – Id1 promotes the generation of a Cdh1+T+ proximal posterior 
epiblast-like cell type but cannot maintain it 
Empty vector control and Id1 overexpressing ES cells differentiated for 3 and 5 days 
in N2B27 and immunostained for Cdh1 and T. Nuclei were counterstained with 
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Figure 4.12 – Id1-overexpressing cells eventually acquire Cdh2 expression 
Empty vector control and Id1 overexpressing ES cells differentiated for 3 and 5 days 
in N2B27 and immunostained for Cdh2. Nuclei were counterstained with DAPI. The 























a – Id1 
 
b – Pluripotent epiblast 
  
 





Figure 4.13 – Behaviour of markers selected for single-cell qRT-PCR on a whole 
population level in neural differentiation of ES cells 
qRT-PCR on nine early neural and pluripotent epiblast markers during the first four 
days of neural adherent monolayer differentiation. E14tg2a ES cells cultured in 
LIF+FCS (Day 0) were replated in N2B27 and RNA extracted daily for 4 days. 




































Figure 4.14 – qRT-PCR on single ES and neural differentiated cells 
a. mRNA levels for five genes in single E14tg2a ES cells cultured in LIF+FCS 
and in cells cultured for 4 days in N2B27. The levels of the normalising gene 
Tbp were measure in 90 cells for each timepoint. The cells with a Tbp value 
within a range of 0.5-1.5-fold the value of a 1:32 dilution of cDNA generated 
from 32 sorted cells were analysed for expression of the other factors. The 
final cell numbers for each timepoint were: ES cells: 57 cells, Day 4: 48 cells. 
b. Spearman’s rank correlation coefficients (ρ) for the five genes across all cells. 
A value of +1 would indicate a perfect positive correlation, a value of -1 a 
























Figure 4.15 – qRT-PCR on single cells during early neural differentiation 
mRNA levels for nine genes in single E14tg2a ES cells cultured in N2B27 for 1, 2 or 
3 days. The levels of the normalising gene Tbp were measured in 60 cells for each 
timepoint. The cells with a Tbp value within a range of 0.5-1.5-fold the value of a 
1:32 dilution of cDNA generated from 32 sorted cells were analysed for expression 
of the other factors. The final cell numbers for each timepoint were: Day 1: 52, Day 





























Figure 4.16 – Distinct pluripotent epiblast and neural gene expression 
signatures in differentiating ES cells 
Spearman’s rank correlation coefficients for the nine genes plotted in Fig.4.15 at day 
1 (blue table), 2 (red table) and 3 (purple table) of neural differentiation. 
A value of 1 would indicate a perfect positive correlation, a value of -1 a perfect 
negative correlation. Asymptotic p-values of less than 0.05 are plotted as asterisks. 
Green boxes: statistically significant positive correlations between pluripotent 
epiblast markers, red boxes: statistically significant positive correlations between 
neural markers, blue boxes: statistically significant negative correlations between 
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Figure 4.17 – Hes1 overexpression recapitulates the effects of BMP4 in N2B27 
culture 
TRE-Hes1 ES cells (cells with a doxycycline-inducible Hes1 transgene, see Zhou et 
al. 2013) were cultured in N2B27 in the presence or absence of 1µg/ml doxycycline 
for 6 days. The cells were then fixed, stained with an antibody against Cdh1 and 









The expression pattern of Id1 in the developing embryo has been addressed by means 
of in situ hybridisation by numerous research groups ever since the factor was first 
discovered (Duncan et al. 1992, Duncan et al. 1994, Evans & O’Brien 1993, Gray et 
al. 2004, Jen et al. 1996, Jen et al. 1997, Li et al. 2013, Wang et al. 1992). 
Until recently, only two of these studies include images of Id1 expression in early 
post-implantation embryos (Jen et al. 1997, Wang et al. 1992). Id1 is expressed in 
the proximal regions of the embryo from pre-streak stages, in accordance with the 
expression of BMP4 in proximal extraembryonic tissues, and remains expressed 
throughout embryonic development. 
In both of the aforementioned studies, the researchers made use of radioactively 
labelled hybridisation probes, resulting in low-definition images with unclear 
expression boundaries between embryonic and extraembryonic tissues and between 
different germ layers. It is for example hard to interpret whether Id1 message is 
detected in the embryo proper or in visceral endoderm at pre- and peri-gastrulation 
stages. 
A recent publication by Li et al. (2013) confirmed the proximal expression pattern of 
Id1 between E6.5 and E7.5 and appears to indicate that Id1 is expressed in the 
embryo proper, but did not fully clarify how Id1 expression is distributed amongst 
the three germ layers. 
In order to characterise the embryonic expression pattern of Id1 in more detail, I 
made use of Id1-Venus reporter ES cell lines, which express an Id1-Venus fusion 
 




protein from one endogenous Id1 locus (see sections 2.2.4.1.5-2.2.4.1.7 and 3.2.4 in 
previous chapters for more detail on these cells), to generate high-contribution 
chimaeric embryos. The analysis of Venus fluorescence in chimaeras dissected at 
different stages should allow the painting of a high-resolution picture of the 
localisation of Id1 protein in early post-implantation embryonic development, as well 




5.2.1 Id1 is expressed in the proximal regions of E6.5 chimaeras 
In order to verify the feasibility of the use of chimaeric embryos to study the 
expression pattern of Id1 in the early stages of post-implantation development, I set 
out to assess the degree of contribution of ES cells to chimaeras and to verify 
whether the pattern of Id1-Venus expression reproduces previously published in situ 
hybridisation data. 
I made use of Id1-Venus reporter ES cells (IdV) stably expressing the red fluorescent 
protein mKate2, fused at its C-terminus to three SV40 nuclear localisation signals, 
under the control of the strong CAG promoter. mKate2-NLS serves as a constitutive 
lineage label to allow all ES-derived cells to be identified within chimaeric embryos. 
This clonal cell line was named IdVnK1. For further information on this cell line, 
please refer to section 2.2.4.1.7 of the Materials and Methods chapter. 
ES cells were aggregated to morulae overnight and blastocysts were transferred into 
pseudopregnant females the next day. Embryos were dissected out of the 
impregnated uteri after 4 days, at an approximate equivalent of embryonic day 6.5 
for a normal pregnancy. The embryos were fixed and stained with a polyclonal anti-
GFP antibody capable of recognising the Venus epitope, and imaged by confocal 
 




microscopy (Figure 5.1). The staging of the embryos was performed by assessing 
their morphological features, and comparing them to those described by Downs & 
Davies (1993), whose staging system will be used throughout this thesis. 
The contribution of the ES cells to the conceptuses was very high for 13 out of 15 
embryos, as judged by the expression of mKate2-NLS in the embryo proper.  
In accordance with the in situ hybridisation data published by Jen et al. (1997) and Li 
et al. (2013), Id1-Venus expression is detected in the proximal regions of the 
embryos. This pattern is compatible with the published expression pattern for Bmp4 
in these early post-implantation stages. Bmp4 is expressed in the regions of the 
extraembryonic ectoderm adjacent to the proximal epiblast at E6.5 and E7.5 
(Coucouvanis & Martin 1999, Norris et al. 2002, Perea-Gómez et al. 1999, Perea-
Gomez et al. 2001, Tremblay et al. 2001). 
The smallest pre-streak stage embryos (Figure 5a,b) appear to harbour some Venus-
expressing cells in more distal regions than the bigger early- and mid-streak stage 
embryos (Figure 5e-o). 
Some of the bigger early- and mid-streak stage embryos (Figure 5g-k) appear to have 
a domain of high Id1-Venus expression in the proximal anterior epiblast, the 
epithelial cells in this region appearing to be brighter than their counterparts in the 
proximal posterior epiblast. This matches the in situ hybridisation data for Id1 at 
E7.0 (Li et al. 2013). 
 
5.2.2 Id1 is co-expressed with Nanog and T in the mid-streak stage epiblast 
Having established that chimaeras generated from morula aggregation display high 
levels of ES cell contribution, I decided to investigate the relationship between Id1-
Venus and other proteins in E6.5 embryos. The non-lineage labelled IdV ES cell line 
was used for morula aggregation, so that expression of other proteins could be 
 




visualised with red and far red secondary antibodies. It should be kept in mind that 
while conclusions regarding co-expression of Id1-Venus with other factors may be 
drawn for Id1-Venus-expressing cells, there is no way of discerning whether Id1-
Venus-negative cells within the chimaeras are not expressing Id1 or are not ES-cell 
derived, so no conclusion may be drawn regarding these cells. 
A mid-streak stage chimaera was sectioned transversally. Seven adjacent 7µm-thick 
sections of the proximal regions of the epiblast were stained with antibodies against 
GFP, Nanog and T (Figure 5.2). Nanog is expressed in the posterior regions of E6.5 
embryos (Morkel et al. 2003, Osorno et al. 2012); T is expressed in the primitive 
streak, both in the epiblast and in the ingressing mesoderm (Beddington et al. 1992, 
Rivea-Pérez & Magnuson 2005, Wilkinson et al. 1990, Willison 1990). 
Id1-Venus is co-expressed with both Nanog and T, and is found in the anterior and 
posterior regions of the embryo (Figure 5.2a,b). In order to quantify the expression 
levels and patterns of the three factors in the anterior and posterior epiblast, I split 
each section into anterior and posterior regions of interest based on expression of 
Nanog. I took care to exclude visceral endoderm and other extraembryonic tissue 
from the analysis. The regions of interest for one of the seven sections are shown in 
Figure 5.2b. 
I used Multicell3D (see Chapter 2 section 2.2.3.2.8) to quantify the fluorescence 
intensity signals for the three factors in each nucleus across all sections. I used the 
background fluorescence intensity signals detected in the nuclei of two 7µm-thick 
sections of extraembryonic ectoderm to establish a threshold to discriminate between 
cells expressing or not expressing the three factors of interest (Figure 5.3a). I 
generated dot plots to compare the level of each factor against the others in the whole 
of the proximal epiblast or in the anterior and posterior regions of interest I defined 
(Figure 5.3a). The absence of T-expressing cells within the anterior region of interest 
suggests a correct demarcation of anterior and posterior epiblast. 
 




Many Id1-Venus-positive cells express Nanog, and there is no obvious negative 
relationship between the two factors at high levels of expression. Id1-Venus-positive 
cells do not appear to be enriched in, or depleted of, Nanog expression in comparison 
with the proximal epiblast as a whole: approximately 65% of Id1-Venus-positive 
cells are Nanog-positive, and approximately 62% of cells within the whole proximal 
epiblast are Nanog-positive (Figure 5.3b). The percentage of Nanog-positive Id1-
Venus-positive cells increases to approximately 83% in the posterior epiblast, in 
keeping with the higher proportion of Nanog-expressing cells in this region as a 
whole (Figures 5.3c). 
Similarly, Id1-Venus-positive cells can express high levels of T, although the 
majority of Id1-Venus-expressing cells is T-negative, as is expected by the broad 
distribution of Venus fluorescence throughout the embryo and the restriction of T to 
the primitive streak region (Figure 5.3d). 
There appears to be a positive relationship between T and Nanog, as over 85% of T-
expressing cells co-express Nanog (Figure 5.3e). This suggests that at this 
developmental stage T is primarily marking the region of the epiblast where the 
primitive streak is located, rather than mesodermal cells ingressing through the 
streak, since Nanog is downregulated as epiblast cells start to ingress (Morkel et al. 
2003). 
The pattern of Id1-Venus expression is similar in the whole, anterior and posterior 
regions of the proximal epiblast. Nanog and T, on the other hand, are enriched in the 










5.2.3 Id1 is co-expressed with Nanog and T in the early bud stage epiblast 
I set out to investigate whether the co-expression of Id1-Venus and Nanog in the 
epiblast and the positive relationship between Nanog and T perdured later in 
development. 
Chimaeras were generated by morula aggregation of IdV ES cells, and embryos were 
dissected after 5 days of blastocyst transfer to pseudopregnant females, at a stage 
approximately equivalent to wild-type E7.5 embryos. 
I stained an early bud stage embryo with antibodies against GFP, Nanog and T and 
imaged the conceptus by confocal microscopy (Figure 5.4a). Id1-Venus is expressed 
proximally, but its domain of expression is expanded and includes the migrating 
mesoderm and endoderm. Nanog is still expressed at this stage and it is enriched, but 
not rigidly confined to, the posterior half of the embryo. T is expressed in the 
primitive streak and along the developing notochord. 
The embryo was then sectioned in 7µm-thick sections, some of which were restained 
with antibodies against the same three markers (Figure 5.4b). Id1-Venus is expressed 
by the majority of cells in the proximal section shown in Figure 5.4b, both in the 
epiblast and in the migrating mesodermal and endodermal layers. Nanog is expressed 
in the posterior half of the epiblast, and is downregulated after migration through the 
primitive streak. It is interesting to observe that the downregulation of Nanog protein 
does not occur until after the migratory event, in contrast to Nanog mRNA, which is 
downregulated immediately prior to EMT (Morkel et al. 2003). T is expressed in the 
primitive streak region of the epiblast and by cells migrating through it. The 
expression of each of these markers does not appear to exclude the expression of the 
other two, so that Id1-Venus is co-expressed with Nanog in the posterior half of the 
epiblast, and both of these are co-expressed with T at the primitive streak. 
 
 




5.2.4 Id1 is expressed proximally in headfold stage embryos 
I proceeded with my investigation into the expression pattern of Id1 in later stages of 
embryonic development by making use of the lineage-labelled IdVnK1 ES cells. The 
analysis described in the previous section made use of IdV ES cells lacking the 
mKate2-NLS lineage label, in order to allow 3-colour marker analysis. 
IdVnK1 ES cells were aggregated to morulae and chimaeras were dissected after 5 
days of blastocyst transfer to pseudopregnant females, at a stage approximately 
equivalent to E7.5 embryos from a natural pregnancy. 
I stained five embryos with an anti-GFP antibody and imaged them for expression of 
Id1-Venus and mKate2-NLS by confocal microscopy (Figure 5.5). The contribution 
of ES cells to all five chimaeras was very high, with the majority of embryonic cells 
expressing mKate2-NLS. Id1-Venus was expressed proximally in all five embryos, 
both in the anterior, lateral and posterior regions of the chimaeras. This expression 
pattern is once again in accordance to the expression domains of Bmp2 and Bmp4 in 
the extraembryonic ectoderm adjacent to the proximal regions of the embryo proper 
(Du et al. 2010, García-García & Anderson 2003, Madabhushi & Lacy 2011, Zakin 
& De Robertis 2004). Interestingly, in one of the embryos Id1-Venus appears to be 
expressed in a ring of cells surrounding the node (Figure 5.5c), an expression pattern 
reminiscent of that of Nodal (Nakaya et al. 2005). 
 
5.2.5 Id1 is expressed in the foregut primordium, cardiac crescent, lateral 
mesoderm and allantois 
The latest stage of embryonic development I analysed was the late headfold/cardiac 
crescent stage. Chimaeras were generated from IdV cells and dissected after 5.5 days 
of blastocyst transfer to pseudopregnant females, at a stage approximately equivalent 
to E7.5-E8.0 embryos from a natural pregnancy. 
 




I stained seven embryos with an anti-GFP antibody and imaged them by confocal 
microscopy (Figure 5.7a). The expression pattern of Id1-Venus is well defined, and 
confined anteriorly to the cardiac crescent mesoderm and the underlying foregut 
primordium endoderm, and posteriorly to the lateral mesoderm and allantois. Id1-
Venus expression can once again be detected at the node of some of the embryos 
(Figure 5.7a embryos i, iv, v, vii). It is impossible to draw a conclusion on whether 
this expression is transitory, and hence can only be observed for some embryos, or 
whether the chimaeras which do not exhibit Id1-Venus expression in the node are 
imaged from the wrong angle or have no ES cell contribution to this embryonic 
structure. 
I then stained one embryo with antibodies against GFP and Nkx2.5, a transcription 
factor expressed in the cardiac crescent and foregut primordium (Lints et al. 1993) 
(Figure 5.7b). Id1-Venus and Nkx2.5 are co-expressed in the foregut primordium and 
in the cardiac crescent mesoderm. Nkx2.5 is expressed at similar levels in both 
regions, whilst Id1-Venus is expressed at a higher level in the foregut primordium. 
To confirm this expression pattern with lineage-labelled cells, chimaeras generated 
from IdVnK1 ES cells were dissected at the same stage of development. I stained 
them with polyclonal antibodies against GFP and tagRFP, this second antibody being 
capable of recognising the mKate2 epitope. I imaged three embryos by confocal 
microscopy (Figure 5.7c,d). The contribution of the ES cells was very high, with the 
majority of cells in the embryos expressing mKate2-NLS. I confirmed the expression 
pattern seen for IdV chimaeras, Id1-Venus being expressed in the cardiac crescent, 
the foregut primordium, lateral mesoderm and, for two out of three embryos (Figure 
5.7c embryos i, iii), the node. None of the embryos had an intact allantois so I was 









I made use of morula aggregation to generate chimaeras harbouring an Id1-Venus 
reporter allele in the ES-cell derived tissues. This allowed me to assess the 
expression of Id1 at high resolution at the single cell level within the embryo proper. 
The use of two different ES cell lines for the morula aggregation experiments offered 
the possibility to address different aspects of the expression of Id1 in vivo: the 
lineage-labelled line expressing mKate2-NLS from the ubiquitous CAG promoter 
was used to assess the status of Id1 expression both in Id1-Venus expressing and 
non-expressing labelled cells throughout the embryo; the non-lineage labelled line 
was used to assess whether Id1 was co-expressed with other transcription factors in 
the early post-implantation epiblast and across all germ layers. 
 
5.3.1 Id1 expression in pre- and early-streak stage epiblast 
I initially assessed the expression of Id1 in pre- and early-streak stage embryos by 
using the lineage-labelled Id1-Venus reporter ES cell line (IdVnK1). I observed that 
Id1-Venus is expressed in the proximal regions of the epiblast, both anteriorly and 
posteriorly (Figure 5.1). This expression pattern complements the data reported by 
Jen et al. (1997), who had observed Id1 mRNA expression in the proximal regions of 
the embryo, without fully clarifying whether the expression was detected in the 
embryonic epiblast or limited to the visceral endoderm, and is in accordance with the 
recent in situ hybridisation data of Li et al. (2013). The expression pattern also fits 
with in situ hybridisation experiments analysing Bmp4 expression, a key inducer of 
Id1 transcription. Bmp4 is expressed by extraembryonic tissue adjacent to the 
proximal regions of the epiblast at E5.5 and E6.5 (Coucouvanis & Martin 1999, 
Norris et al. 2002, Perea-Gomez et al. 2001, Polydorou & Georgiades 2013). 
 




The embryos of the smallest size appeared to exhibit Id1-Venus expression not only 
in the proximal regions, but to a lower level, in some cells located more distally. It is 
an intriguing possibility that this may be due to the distance which can be covered by 
the morphogen BMP4 from its lieu of expression in the extraembryonic ectoderm. 
Alternatively, other molecules of the BMP family may be responsible for Id1 
expression in these more distal cells: Bmp2 is expressed throughout the visceral 
endoderm at E5.5 before localising to the proximal anterior epiblast at E6.5, Bmp7 is 
expressed at the distal tip and in the anterior primitive streak at E6.5 (Arkell & 
Beddington 1997, Coucouvanis & Martin 1999, Madabhushi & Lacy 2011, Solloway 
& Robertson 1999). Whatever BMP factor or combination of factors may be 
responsible for Id1-Venus induction, it is reassuring that this pattern coincides with 
the localisation of phosphorylated Smad1 protein, which is observed throughout the 
embryo at the pre-streak stage, and is subsequently lost in the distal tip and detected 
only in the proximal regions of gastrulating embryos (Aoyama et al. 2012, Di-
Gregorio et al. 2007). 
 
5.3.2 Id1 expression in mid- and late-streak stage epiblast 
I proceeded to analyse the expression pattern of Id1-Venus in mid- and late-streak 
stage embryonic cells making use of chimaeras derived from both the lineage-
labelled reporter ES cells and from the non-lineage labelled reporter ES cells, co-
staining the latter to detect expression of Nanog and T in a mid-streak stage chimaera 
(Figures 5.1, 5.2). 
The proximal expression of Id1-Venus was conserved in mid- and late-streak stage 
chimaeric embryos, the HLH factor being expressed both in the epiblast and in the 
migrating mesoderm. This is again fitting with the observations of Jen et al. (1997), 
and with the reported expression of Bmp4. In some of the embryos, the expression of 
Id1-Venus appeared to be more intense in the anterior than in the posterior proximal 
 




epiblast, coinciding with an area of the embryos that at the late-streak stage is 
characterised by expression of Bmp2 and Dlx5 and fated for surface ectoderm (Cajal 
et al. 2012, Madabhushi & Lacy 2011, Tam & Behringer 1997). It is an interesting 
possibility that BMP2 could be responsible for inducing Id1 expression in the 
anterior to complement the Id1-inducing action of BMP4 in the posterior. 
Bmp7 is expressed around the node at this stage (Arkell & Beddington 1997, 
Solloway & Robertson 1999), but Id1-Venus does not appear to be expressed in this 
structure in any of the imaged embryos in Figure 5.1 (see below for discussion on 
this point). Bmp5 displays a similar pattern of expression to Bmp4 at these embryonic 
stages, and could also play a role in driving Id1 expression (Solloway & Robertson 
1999). 
Immunostaining of sections of a chimaera generated with non-lineage labelled Id1-
Venus reporter ES cells with antibodies against GFP, Nanog and T revealed that Id1-
Venus expression is localised equally in the anterior and posterior proximal epiblast 
and does not appear to be preferentially associated with expression of Nanog or T 
(Figures 5.2, 5.3). Nanog was expressed by the majority of Id1-Venus-expressing 
cells, suggesting that there is no negative relationship between the two factors in the 
gastrulating epiblast, and that the majority of Id1-Venus-expressing cells reside in 
the pluripotent epiblast at the mid-streak stage. T-expressing cells were mostly 
Nanog-positive, suggesting they represent cells of the epiblast surrounding the 
primitive streak as opposed to migrating mesoderm. Approximately 13% of Id1-
Venus-expressing cells co-expressed T, compared with approximately 14% of all 
epiblast cells. This suggests once more that Id1-Venus expression is not 
preferentially associated with the expression of T, and suggests that Id1 expression is 









5.3.3 Id1 expression in early bud stage epiblast 
I stained an early bud stage chimaera generated from Id1-Venus non-lineage labelled 
ES cells with antibodies against GFP, Nanog and T, and imaged it both as an intact 
embryo and after sectioning (Figure 5.4). I showed that Id1-Venus was co-expressed 
in a proportion of Nanog- and T-expressing cells at this stage, and that it was no 
longer confined to the epiblast, but also expressed in the migrating mesoderm and 
endoderm, an observation that had not been clarified by the in situ hybridisation 
images of Jen et al. (1997) and Li et al. (2013). The expression of Id1-Venus 
declined from proximal to distal epiblast, confirming published observations. This 
stronger proximal expression is in accordance to the expression of Bmp4 at this stage 
(Du et al. 2010, García-García & Anderson 2003, Madabhushi & Lacy 2011, Perea-
Gómez et al. 1999, Tremblay et al. 2001). Id1-Venus expression in the migrating 
cells may reflect the phosphorylation of Smad1 in the proximal epiblast and visceral 
endoderm of early bud stage embryos (Di-Gregorio et al. 2007). It appears the 
expression of Id1-Venus, Nanog and T do not directly influence each other: Id1-
Venus is expressed proximally and in mesendoderm, Nanog is expressed in the 
posterior half of the embryo, and T is expressed in the primitive streak and 
notochord. There is no apparent rise or decline in levels of any of the three factors 
when the others are or are not expressed. 
It was interesting to notice that Nanog protein appears to persist shortly after cells 
migrate through the primitive streak (Figure 5.4b), suggestive of a dismantling of the 
pluripotency network of the cells after their delamination from the epiblast, as 
opposed to prior to migration through the primitive streak. 
 
5.3.4 Id1 expression in early headfold stage chimaeras 
I imaged chimaeras generated from lineage-labelled IdVnK1 ES cells at the early 
headfold stage (Figure 5.5). The expression of Id1-Venus, which at the early bud 
 




stage had been detected in vast regions of migrating mesoderm and epiblast, appears 
to have been once again restricted to the proximal regions of the embryo, both in the 
anterior and in the posterior. At this stage, Bmp4 is expressed in the extraembryonic 
regions adjacent to proximal posterior ectoderm, as well as in the surface ectoderm 
surrounding the neural folds (Perea-Gómez et al. 1999, Tremblay et al. 2001, Zakin 
& De Robertis 2004), so the pattern of expression of Id1-Venus fits the expression 
pattern of the morphogen. 
 
5.3.5 Id1 expression in late headfold stage chimaeras 
I imaged chimaeras generated from both lineage-labelled IdVnK1 ES cells and non-
lineage labelled IdV ES cells at the late headfold stage (Figure 5.6). The expression 
of Id1-Venus was once again restricted to defined embryonic regions, the fluorescent 
reporter allele being expressed in cardiac crescent, lateral and allantoic mesoderm, 
and in the endoderm of the foregut primordium. The expression in the cardiac 
crescent and lateral mesoderm can also be observed in the in situ hybridisation 
experiment of Li et al. (2013). The expression pattern of Id1-Venus directly reflects 
that of Bmp2, Bmp4, Bmp5, Bmp7 and Bmpr1a at this stage (Arkell & Beddington 
1997, Danesh et al. 2009, Madabhushi & Lacy 2011, Mishina et al. 1995, Solloway 
& Robertson 1999, Zakin & De Robertis 2004). Whilst mice lacking the BMP2/4 
receptor Bmpr1a exhibit premature neural differentiation and fail to express markers 
of the primitive streak (Mishina et al. 1995, Di-Gregorio et al. 2007), mice in which 
the receptor is inactivated in a mosaic pattern within the epiblast progress passed 
gastrulation. These embryos exhibit defects in the formation of the allantois and of 
the cardiac crescent (Miura et al. 2006), suggesting BMP signalling, potentially 
through the action of Id1, is required autonomously for the establishment of these 
structures. 
 




Id1-Venus appears to be absent from the Sox1-expressing neural plate (Cajal et al. 
2012, Perea-Gómez et al. 1999) at this stage, an observation which is interesting in 
the light of the anti-neural effect of Id1 in ES cell differentiation. Noggin, a BMP 
signalling inhibitor, is expressed in this tissue, and could thus explain the lack of Id1-
Venus expression (Danesh et al. 2009, Mine et al. 2008). 
The most intriguing of discoveries was the expression of Id1-Venus in a ring of cells 
surrounding the node in many of the headfold stage embryos, an unexpected 
observation that has not been described in the literature. A similar ring of expression 
was previously reported for Nodal (Conlon et al. 1994, Nakaya et al. 2005, Norris & 
Robertson 1999), so a straightforward hypothesis would be that of Nodal signalling 
driving expression of Id1 in this region. This, however, is an unlikely possibility. I 
have presented data in Chapter 3 showing that Activin/Nodal signalling can repress 
the expression of Id1-Venus in pluripotent cultured cells. Mutual antagonism 
between Nodal and BMP signalling have also been reported at this stage of 
development (Mine et al. 2008, Pereira et al. 2012, Yang et al. 2010), as well as in 
ES cells and other organisms (Dale et al. 1992, Galvin et al. 2010, Veerkamp et al. 
2013, Yamamoto et al. 2009). It is therefore unlikely that Nodal sustains the 
expression of Id1. 
Bmp2 is expressed at the node at the early bud stage, but it disappears by the late bud 
stage (Madabhushi & Lacy 2011), and is therefore unlikely to be capable of 
maintaining Id1-Venus expression at the node until the late headfold stage. 
Bmp7 is expressed in cardiac crescent and allantoic mesoderm, but also in the node 
(Arkell & Beddington 1997, Danesh et al. 2009). It appears therefore the most likely 
candidate for the promotion of Id1-Venus expression at the node. However, the BMP 
inhibitors Chordin and Noggin are also expressed at the node in late headfold stage 
embryos (Danesh et al. 2009, McMahon et al. 1998, Mine et al. 2008, Rhinn et al. 
1998), where they play a crucial role in establishment of this structure: Nodal  is not 




 embryos (Yang et al. 2010). Noggin 
inhibits BMP signalling by directly binding to BMP molecules, and has strong 
 




affinity for BMP2 and BMP4. It also binds BMP7, but with lower affinity (Chang & 
Hemmati-Brivanlou 1999, Groppe et al. 2002, Zhu et al. 2006, Zimmerman et al. 
1996). It is therefore possible that if the levels of BMP7 were high enough they could 
overcome the inhibition by Noggin and promote Id1 expression at the node. Should 
this be the case, it is unclear why Id1 expression at the node is not detectable in 
earlier embryos, since Bmp7 is expressed at the node from no later than late streak 
stage (Arkell & Beddington 1997). It is possible that the larger domain of expression 
of Nodal at these earlier stages (Di-Gregorio et al. 1997, Du et al. 2010, Faust et al. 
1995, Norris et al. 2002, Perea-Gomez et al. 2001) is epistatically suppressing the 
potential BMP7-driven induction of Id1. 
It would appear that the expression of Id1-Venus at the node might be controlled by 
the integration of stimuli from a multitude of positive and negative regulators. 
Whether Id1 is playing an active role in the processes occurring around the node at 
this stage, from primitive streak elongation to left-right patterning, can only be the 
subject of speculation at this point. Its involvement in many lineage specification 
events and in many self-renewal versus differentiation decisions throughout 
development would make the HLH factor a fitting candidate for the crucial processes 
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Figure 5.1 – Id1-Venus expression at E6.5 
Chimaeras generated from morula aggregation of IdV ES cells stably expressing a 
CAG-mKate2-NLS-IRES-Pac transgene (IdVnK1). The chimaeras were dissected 4 
days after transferring the overnight cultured embryos to pseudopregnant females, at 
an approximate equivalent developmental stage to wild-type E6.5 embryos. All 15 
analysed embryos are displayed in figure. 
The embryos are ordered from smallest to biggest. The embryos on the last row are 
low contribution chimaeras. The proximal/distal and anterior/posterior embryonic 
axes are displayed. Embryos a, b, c, and d lacked an evident thickening of visceral 
endoderm on one side of the embryo, so the anterior/posterior axis may not be 
aligned from the left to the right of the image. 
The images were acquired as a single focal plane on a Leica TCS SPE inverted 
confocal microscope. The fluorescence intensity was optimised singularly for each 
embryo, so the intensity of Id1-Venus and mKate2-NLS expression between 





































Figure 5.2 – Id1-Venus is coexpressed with Nanog and T in the proximal post-
implantation epiblast 
a. Mid-streak stage chimaera generated from morula aggregation of IdV ES 
cells. The embryo was sectioned transversally and stained with antibodies 
against GFP, Nanog and T. The nuclei were counterstained with DAPI. The 
sections are ordered from most proximal to most distal. The sections were 
imaged on a Leica TCS SPE inverted confocal microscope. Scale bar: 30µm.  
b. Definition of anterior and posterior regions of interest for nuclear 
immunostaining quantification based on Nanog expression. Visceral 
endoderm was excluded from the regions of interest. A: anterior, P: posterior. 





































Figure 5.3 – Immunostaining quantification of Id1-Venus, Nanog, T in E6.5 
chimaera sections 
a. Dot plots illustrating the levels of Id1-Venus, Nanog and T in the nuclei of 
single cells of whole, anterior and posterior regions of the proximal epiblast, 
in the sections shown in Fig.5.2. Stained sections of extraembryonic tissue 
were used to set expression gates. Number of nuclei scored: whole proximal 
epiblast: 1265, anterior epiblast: 395, posterior epiblast: 870, extraembryonic 
tissue: 363. 
b. Quantification of Nanog positive cells amongst Id1-Venus positive cells and 
all cells in the proximal epiblast. 
c. Quantification of Nanog positive cells amongst Id1-Venus positive cells in 
the whole and in the posterior proximal epiblast. 
d. Quantification of T positive cells amongst Id1-Venus positive cells in the 
proximal epiblast. 
e. Quantification of Nanog positive cells amongst T positive cells in the 
proximal epiblast. 
f. Flow cytometry-like plots illustrating the intensity of Id1-Venus, Nanog and 
T in extraembryonic tissue (ExE), and in whole, anterior and posterior 
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Figure 5.4 – Id1-Venus is coexpressed with Nanog and T in the early bud stage 
epiblast 
a. Three-dimensional rendering of an early bud stage chimaera generated from 
morula aggregation of IdV ES cells, stained with anti-GFP, anti-Nanog and 
anti-T antibodies. The embryo was imaged on a Leica TCS SPE inverted 
confocal microscope. The anterior side of the embryo is on the left of the 
image. Scale bar: 100µm. The same Id1-Venus expression was observed in 3 
IdV chimaeras and 6 IdVnK1 chimaeras. 
b. Transverse section through the embryo in (a). The anterior side of the embryo 
in on the left of the image. The section was imaged on an Olympus IX51 
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Figure 5.5 - Id1-Venus expression at the headfold stage 
Three-dimensional rendering of chimaeras generated from morula aggregation of 
IdVnK1 ES cells, dissected 5 days after blastocyst transfer to pseudopregnant 
females, the approximate equivalent of wild-type E7.5 embryos, and stained with an 
anti-GFP antibody. All 5 analysed embryos are displayed in figure. The embryos are 
ordered from smallest to biggest and the anterior side is aligned on the left of the 
image. Embryo (c) is slightly tilted so that the node (Nd) is visible. The embryos 
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Figure 5.6 - Id1-Venus expression at the cardiac crescent stage 
a. Three-dimensional rendering of chimaeras generated from morula 
aggregation of IdV ES cells, dissected at embryonic day 7.5 and stained with 
an anti-GFP antibody. Images within a white box are different views of the 
same embryo. The depicted side of the embryo is described under each 
image. Embryos are numbered in Roman numerals for ease of identification. 
Fg: foregut primordium, Cc: cardiac crescent, Lm: lateral mesoderm, Al: 
allantois, Nd: node. Scale bar: 100µm. 
b. Three-dimensional rendering of the anterior view of a chimaera generated 
from morula aggregation of IdV ES cells, dissected at embryonic day 7.5 and 
stained with anti-GFP and anti-Nkx2.5 antibodies. Scale bar: 100µm. 
c. Three-dimensional rendering of chimaeras generated from morula 
aggregation of IdVnK1 ES cells, dissected at embryonic day 7.5 and stained 
with anti-GFP and anti-tagRFP antibodies. The images within the white box 
are anterior and posterior views of the same embryo, the other two embryos 
are viewed from the anterior. Embryos are numbered in Roman numerals for 
ease of identification. Scale bar: 100µm. 
d. Single focal plane of embryo “i” in (c). Scale bar: 100µm. 
All embryos were imaged on a Leica TCS SPE inverted confocal microscope. All 11 







6.1 The regulation of Id1 expression 
6.1.1 Id1 expression is regulated by a multitude of inputs 
The data presented in this thesis indicate that the regulation of Id1 expression is a 
point of convergence of many signalling pathways involved in the regulation of 
pluripotency and differentiation (Figure 6.1). 
Three major signalling pathways appear to converge on the expression of this factor: 
BMP, Activin/Nodal/TGFβ and mitogen-activated protein kinase. 
 
6.1.1.1 Bone morphogenic protein 
BMP is a positive regulator of Id1 expression. Various BMP family members have 
been reported to induce Id1 transcription in numerous cell types from different 
species (Galvin et al. 2010, Hollnagel et al. 1999, Kang et al. 2003, Katagiri et al. 
1994, Katagiri et al. 2002, Korchynskyi & ten Dijke 2002, López-Rovira et al. 2002, 
Ogata et al. 1993, Ying et al. 2003a). My experiments confirmed that the stimulation 
of Id1 expression by BMP occurs in mouse ES cells cultured in LIF+FCS and 2i 
medium, as well as in epiblast stem cells. Furthermore, the expression pattern of Id1 
in vivo was shown to recapitulate that of BMP signals present in the developing 
embryo. 
 














Figure 6.1 – Regulation of Id1 expression 
Diagram illustrating the molecules involved in the regulation of Id1 expression. BMP 
signalling induces Id1 via phosphorylated Smad1/5/8-Smad4 complexes. 
Activin/Nodal/TGFβ signalling represses Id1 via phosphorylated Smad2/3. The 
inhibition of Id1 may involve DNA association in complex with Smad4, and in 
human cell lines it is achieved through the formation of a complex with the 
transcriptional repressor ATF3, a direct target of the Smad2/3-Smad4 complex. 
Smad6 can inhibit both BMP and Activin/Nodal/TGFβ signalling through 
sequestration of Smad1/5/8 and Smad2/3, Smad7 can inhibit BMP signalling through 
the same mechanism. Induction of the mitogen-activated protein kinase pathway 
results in Mek phosphorylation, which leads to the repression of Nanog. Nanog can 
interact with Smad1 and prevent its activation of Id1 transcription. It is unclear 
whether Nanog can bind inactive, active or both forms of Smad1. Mek activity may 
also induce Id1 transcription through alternative mechanisms. A complex involving 
Egr1 is responsible for Id1 induction in response to serum. C/EBPβ can induce Id1 
expression in pro-B-cells. The depicted binding of factors to the promoter of Id1 is 
not representative of the actual position of their binding sites. The processes inhibited 
by the small molecule inhibitors LDN-193189, PD0325901 and SB431542 are also 













Activin/Nodal/TGFβ signalling results in repression of Id1 transcription in mouse 
and human cells (Galvin et al. 2010, Kang et al. 2003, Lee et al. 2011b, Veerkamp et 
al. 2013). In human cells lines this repression is achieved through the interaction of 
SMAD3 with the SMAD2/3 target ATF3 (Kang et al. 2003). TGFβ has been 
reported to induce ID1 transcription in human breast cancer cells through the action 
of SMAD3/4 and the CBP/p300 co-activator, suggesting that under certain 
conditions SMAD3 may change its interaction partner from ATF3 to CBP/p300 and 
activate ID1 expression (Padua et al. 2008, Stankic et al. 2013). It is unclear whether 
this mechanism is conserved in healthy cells or is an artefact of cancer cell lines. In 
my experiments, the small molecule SB431542, an inhibitor of the 
Activin/Nodal/TGFβ receptors Acvr1b, Acvr1c and Tgfbr1, resulted in upregulation 
of Id1 expression in pluripotent cultures, suggesting Activin/Nodal/TGFβ exerts a 
repressive role on Id1 transcription in these cultures. 
Interestingly, whilst SB431542 treatment of mouse ES cells results in a reduction of 
Smad2 phosphorylation (Galvin et al. 2010), it also leads to a relocalisation of 
Smad2 protein on the Id1 locus, and stronger binding in the region of the promoter 
containing the Smad-responsive elements as well as in the Id1 gene body (Lee et al. 
2011b). This suggests that Smad2 may not be involved in the repression of Id1 
transcription in mouse ES cells, and that it may rather act as an activator; that Smad2 
interaction with other regions of the locus may be responsible for its inhibitory 
activity; or that SB431542 treatment of ES cells may result in the downregulation of 
other factors required for the Smad2-mediated repression of Id1 transcription. Atf3 
expression is not affected by SB431542 treatment in the microarray data of Lee et al. 
(2011b), but ATF3 was not identified as an interactor of SMAD2 in the study by 
Kang et al. (2003), suggesting Smad2 repression of Id1 may occur through 
interaction with alternative factors. 
 




SB431542 treatment of mouse ES cells results in an increase in Smad1/5 
phosphorylation, that can be rescued by supplementation with the BMP signalling 
inhibitor LDN-193189 (Galvin et al. 2010), suggesting the SB431542 induction of 
Id1 may also occur through the stimulation of BMP signalling, potentially by 
relieving the inhibitory cross-talk of Activin/Nodal/TGFβ signals on the BMP 
pathway. Whilst simultaneous addition of LDN-193189 and SB431542 to ES cells 
suppresses Smad1/5 phosphorylation (Galvin et al. 2010), my flow cytometry 
experiments have shown that this combination of molecules does not suppress the 
expression of Id1 in LIF+FCS culture (Figure 3.8c,d), implying that the inhibitory 
activity of SB431542 on the Activin/Nodal TGFβ pathway plays an important role in 
the induction of Id1 expression. 
 
6.1.1.3 Mitogen activated protein kinase 
Inhibition of the mitogen-activated protein kinase transducer Mek with the small 
molecule PD0325901 results in the inhibition of Id1 expression. This may be an 
indirect effect resulting from the upregulation of Nanog in cells treated with 
PD0325901, as Nanog has been characterised as a negative regulator of Id1 
transcription. Nanog can in fact bind and inhibit the transcriptional activity of Smad1 
(Suzuki et al. 2006). It is however possible that Mek may induce Id1 expression 
through alternative mechanisms. Although PD0352901 has been reported to decrease 
the phosphorylation of Smad1/5 and Smad2 (Galvin et al. 2010), its effects appears 
to be independent of BMP and Activin/Nodal/TGFβ signalling, as BMP stimulation 
promotes Id1 expression in the presence of the inhibitor, and both LDN-193189 and 
Activin A promote further downregulation of Id1 in PD0325901-treated cells. 
The use of Nanog-null ES cells would allow us to address the mechanism of action 
of PD0325901 in the downregulation of Id1 expression: should PD0325901 fail to 
inhibit Id1 expression in these cells, we would be able to conclude that Nanog is the 
key mediator of the negative role of Mek inhibition on Id1 expression. 
 




Supplementation of ES cells with Fgf2 did not result in the upregulation of Id1. This 
is puzzling in the light of the strong effect of Mek inhibition on Id1 expression. 
Possible explanations of this phenomenon are that Fgf signals may already be present 
at high levels in ES cell cultures, that Mek inhibition of Nanog expression cannot be 
increased by further stimulation of Mek phosphorylation, or that other mitogens are 
required for Mek induction in these cultures. 
 
6.1.1.4 A direct role for Nanog in Id1 repression 
The negative input of Nanog on Id1 expression may not be limited to its interaction 
with Smad1. Festuccia et al. (2012) performed a microarray on Nanog-null ES cells 
following tamoxifen-induced nuclear translocation of a transgenic Nanog-ERT2 
fusion protein. Analysis of this dataset reveals that Id1 is the transcript displaying the 
strongest level of downregulation following the nuclear translocation of Nanog. 
Smad1 is phosphorylated in the cytoplasm before it enters the nucleus and drives 
transcription of Id1. If Nanog inhibited Id1 expression only through its association 
with Smad1, it should result in Id1 inhibition when forced to localise to the 
cytoplasm. The observation that it promotes a rapid and strong downregulation of Id1 
transcription upon nuclear localisation suggests it can inhibit Id1 expression in 
further ways, potentially through the direct binding and repression of the Id1 locus. 
Analysis of the ChIP-Seq data of Chen et al. (2008), Marson et al. (2008) and Whyte 
et al. (2013) reveals the potential presence of Nanog binding sites at the Id1 locus 
(Figure 6.2), confirming that Nanog repression of Id1 expression may occur through 
both direct and indirect mechanisms. 
 
 





Figure 6.2 – ChIP-Seq identifies Nanog binding peaks in the Id1 locus 
Analysis of the Nanog ChIP-Seq data of Chen et al. (2008), Marson et al. (2008) and 
Whyte et al. (2013) with the GeneProf online resource (Halbritter et al. 2012) reveals 
peaks of Nanog binding upstream and downstream of the Id1 exonic DNA (black 
box). 
 
6.1.2 Id1 is expressed heterogeneously in pluripotent cells 
The integration of multiple positive and negative signals resulted in a heterogeneous 
expression pattern for Id1 in LIF+FCS and epiblast stem cell cultures. In EpiSCs, the 
heterogeneity in Id1 expression became even more evident upon stimulation with 
BMP4, with only a proportion of cells capable of responding to the signal by 
upregulating Id1. The resolution of this bimodal distribution through the inhibition of 
Activin/Nodal signalling suggests that agonists of this pathway can inhibit the 
capability of pluripotent cells to respond to BMP stimulation, and suggests that 
expression of Id1 in pluripotent cultures reflects the balance of active Smad1/5/8 and 
Smad2/3 in individual cells. This raises an important question. How can cells 
 




cultured as an adherent monolayer respond differently to uniform signals provided in 
the culture medium? 
I believe the answer to lie in the cross-repressive action of Activin/Nodal/TGFβ and 
BMP, and in the heterogeneity in expression of other factors independent of these 
uniform signals. Nanog is expressed heterogeneously in LIF+FCS culture, and this 
heterogeneity is intrinsic to the culture system. Purification of cells expressing high 
levels of Nanog will result in the restoration of the original distribution of Nanog 
expression after approximately one week of culture (Chambers et al. 2007). Nanog 
can repress its own expression (Fidalgo et al. 2012, Navarro et al. 2012), implying 
that cells with high levels of Nanog protein will downregulate Nanog transcription 
and become cells with low levels of Nanog protein over time. The levels of Nanog 
transcript and protein in ES cells are not regulated by Nanog alone, which implies 
that the oscillatory mechanism described above is over-simplified, but it is a useful 
model nonetheless, as it allows us to understand how cells may establish 
heterogeneity in expression in a uniform culture system. 
Nanog is a negative regulator of Smad1 activity, it may act as a direct repressor of 
Id1 transcription (Figure 6.2), and I have shown that ES cells are rarely observed in a 
status of high Nanog and high Id1 expression. In human ES cells, the transcription of 
NANOG is induced by SMAD2/3, and NANOG can bind and modulate the activity 
of SMAD2/3 (Vallier et al. 2009, Xu et al. 2008). BMP-induced and 
Activin/Nodal/TGFβ-induced Smad’s have been reported to inhibit the activity of 
each other (Yamamoto et al. 2009), and Smad2 and Smad3 can also antagonise one 
another (Míguez et al. 2013). This results in the establishment of a complex 
Smad1/5/8-Smad2/3-Nanog network in which every factor has the potential to 
influence the expression or the activity of every other factor, and where one of the 
components (Nanog) is heterogeneously expressed. It is therefore straightforward to 
hypothesise that the intracellular balance of the repressive activities of Smad2/3 and 
Nanog and the inductive action of Smad1/5/8 on Id1 expression may vary between 
 




different cells due to variable levels of Nanog and to the consequent variation in 
levels and activity phosphorylated Smad’s. 
In light of these considerations, it is encouraging to observe that in 2i medium Nanog 
is expressed homogeneously at a high level, and Id1 is not expressed. BMP and 
SB431542 can induce expression of Id1, but this inductive potential is repressed by 
Activin A and LDN-193189 respectively, implying that the balance of positive over 
negative regulation of Id1 is skewed in favour of the negative regulators. 
Future studies on the regulation of Id1 expression in pluripotent cultures would gain 
considerable insight with the use of Nanog-null ES cells. These cells would allow us 
to test whether Id1 is expressed in a more homogeneous pattern in LIF+FCS and 
epiblast stem cell culture, and whether Id1 expression is de-repressed in 2i culture. 
They could be used to address whether simultaneous stimulation of BMP and 
inhibition of Activin/Nodal can result in a homogeneous state of high Id1 expression, 
as opposed to the increased Id1 expression and unaffected heterogeneity observed in 
wild-type cells. It would also be interesting to test whether full repression of Id1 can 
be achieved in the absence of Nanog, or whether this factor is essential for a full 
transcriptional shutdown of the Id1 locus. 
 
6.1.3 The regulation of Id1 expression in vivo 
The expression of Id1 throughout development mirrors that of BMP signals. In small 
pre-streak stage embryos, I detected Id1 expression both proximally and in some 
cells in distal regions, probably as a result of the short distance between the distal 
portions of the embryos and the BMP source in extraembryonic ectoderm 
(Coucouvanis & Martin 1999). Id1 later remained expressed proximally and in 
migrating mesoderm, and at late headfold stage was found in the cardiac crescent, 
lateral mesoderm and allantois, close to sources of BMP (Perea-Gómez et al. 1999, 
 




Tremblay et al. 2001, Zakin & De Robertis 2004). A few interesting points were 
raised by the expression pattern I characterised. 
 
6.1.3.1 The role of Nodal in Id1 expression in vivo 
Id1 was found to be expressed by cells in proximal and distal regions in small early 
post-implantation embryos (Figure 5.1a,b). At this stage, Nodal is expressed 
throughout the egg cylinder (Varlet et al. 1997), and it is surprising that it does not 
suppress the expression of Id1. It therefore likely that BMP stimulation of epiblast 
cells has a dominant effect over Nodal activity at this stage of development. 
The embryo later expands, distancing the source of BMP from the distal tip. The 
DVE and the AVE then secrete BMP inhibitors, suppressing Id1 expression in the 
overlying epiblast. Nodal localises to the primitive streak and the node secretes BMP 
inhibitors (Arnold & Robertson 1999, Varlet et al. 1997). Whilst Id1 expression is 
still observed in the proximal posterior epiblast, suggesting BMP signalling is still 
dominant over repression of Id1 by Nodal, the highest levels of Id1 can be detected 
in the proximal anterior regions (Figure 5.1d-m), fated for surface ectoderm 
specification (Cajal et al. 2012, Madabhushi & Lacy 2011, Tam & Behringer 1997). 
This observation is confirmed by the in situ hybridisation data of Li et al. (2013), and 
suggests that Nodal acts as a repressor of Id1 expression in vivo. 
 
6.1.3.2 Id1 expression at the node in headfold stage embryos 
I identified a previously uncharacterised expression pattern for Id1 in a ring of cells 
surrounding the node (Figures 5.5, 5.6). This expression was unexpected due to the 
expression of BMP inhibitors in this region and the expression of Nodal in a similar 
ring of cells (Conlon et al. 1994, Danesh et al. 2009, McMahon et al. 1998, Mine et 
al. 2008, Nakaya et al. 2005, Norris & Robertson 1999, Rhinn et al. 1998). BMP7 is 
 




expressed at the node at this stage and may be responsible for this induction (Arkell 
& Beddington 1997, Danesh et al. 2009). It would be interesting to verify whether 
BMP and Nodal signalling are responsible for the establishment of this particular 
expression pattern. The dissection of embryos at E6.5/E7.0 followed by their culture 
in medium supplemented with agonists and antagonists of Nodal and BMP should 
allow to gain valuable insights into the roles of these signalling pathways in the 
establishment of this expression pattern. 
 
6.1.3.3 The relationship between Nanog and Id1 in vivo 
Nanog negatively regulates Id1 expression in pluripotent cultures, and the two 
factors are not co-expressed at high levels in ES cells. This negative relationship 
does not appear to be conserved in the post-implantation pluripotent epiblast. Id1 and 
Nanog are co-expressed in the proximal posterior epiblast, and the levels of Id1 do 
not appear to be affected by the expression of Nanog (Figures 5.2, 5.3, 5.4). It is 
unclear why this should be the case. One possibility is that BMP signalling induces 
the preferential phosphorylation of Smad5 and Smad8 over Smad1 in the proximal 
posterior epiblast, and the binding of Nanog to Smad1 is thus unable to exert is 
negative influence on Id1 expression. If Nanog is able to directly bind to the Id1 
locus, as proposed in section 6.1.1.4, it is possible that the Nanog binding sites are 
inaccessible due to their occupancy by other factors or to epigenetic changes in the 
locus. A third possibility is that the levels of Nanog in these cells are low compared 
to the levels in ES cells, and are unable to overcome BMP stimulation of Id1 
transcription. The last possibility could be addressed by microdissection of proximal 
posterior epiblast followed by qRT-PCR comparing this sample to ES cells. 
The use of EpiSC lines to positively and negatively alter the levels of Nanog may 
provide some insight into whether Nanog is involved in the regulation of Id1 in the in 
vitro equivalent of post-implantation epiblast and into its role in relation to BMP 
signalling. 
 




6.1.3.4 The expression of Id1 in pre-implantation embryos 
Phosphorylated Smad1 and Smad2 have been detected in the blastocyst. In particular, 
phosphorylated Smad1 was found in a few cells, whereas phosphorylated Smad2 was 
detected in most if not all cells (James et al. 2005). The single-cell qRT-PCR 
experiments of Tang et al. (2010) suggest that Id1 is expressed heterogeneously in 
the inner cell mass of E3.5 and E4.5 blastocysts, and this raises the question of 
whether Activin/Nodal/TGFβ and BMP are regulating the expression of the factor in 
the pre-implantation embryo. We are currently attempting to generate a mouse line 
from the Id1-Venus reporter ES cells, which will allow us to perform a detailed 
analysis of the expression pattern of Id1 in pre-implantation development and to 
measure the levels of Id1-Venus and phosphorylated Smad’s in single cells of pre-
implantation embryos. The culture of morula and blastocyst stage embryos in the 
presence of agonists and antagonists of BMP and Activin/Nodal/TGFβ will also aid 
in the understanding of the roles of these pathways in the regulation of Id1 
expression in pre-implantation development. In situ hybridisation experiments could 
also be used for the embryo culture experiments, but would not be amenable for the 
simultaneous measurement of the levels of Smad phosphorylation in Id1-expressing 
cells. 
 
6.2 The roles of Id1 in lineage specification 
6.2.1 Possible identity of the factors inhibited by Id1 in differentiation 
In Chapter 4 I presented data indicating that Id1 delays the exit from a state of post-
implantation epiblast pluripotency, and that it promotes the regionalisation of cells in 
culture to the equivalent of proximal posterior epiblast. Id1 is a dominant negative 
inhibitor of DNA binding, and its function is therefore dependent on the inductive or 
repressive transcriptional outputs of the factors it is inhibiting via direct binding or 
 




sequestration of E proteins. What factor(s) is Id1 inhibiting during the differentiation 
process? 
 
6.2.1.1 Neurod1, Tcf15, Twist1 
A yeast two-hybrid screen was performed in our laboratory to identify the interacting 
partners of Id1 and E12/E47 in ES cells cultured in LIF+FCS. Id1 was found to 
interact with E12 and E47 only, whereas these proteins were found to interact with 
Id1, Id3 and the pro-differentiation bHLH factors Neurod1, Tcf15 and Twist1 
(Davies et al. 2013). All three of these bHLH proteins have the capability to induce 
differentiation to a variable extent when episomally overexpressed in ES cell culture: 
Tcf15 drives the downregulation of Nanog and Oct4 and is negatively associated 
with pluripotency markers (Davies et al. 2013), Twist1 drives an EMT event and the 
differentiation of ES cells into Vimentin-expressing mesenchyme when expressed in 
a fusion with E47 (but not as a monomer) (Malaguti et al. 2013), and Neurod1 can 
induce the formation of Tubb3-positive neurones (unpublished observations in the 
Lowell laboratory), which is unsurprising considering its overexpression is used to 
generate neurones from mesodermal cells (Pang et al. 2011). It is however unlikely 
that the inhibition of any of these factors is responsible for the delay in the exit from 
primed pluripotency and in the induction of proximal posterior epiblast gene 
expression in Id1 overexpressing cells. Twist1 is not expressed in post-implantation 
embryos until the early bud stage, when its transcription is activated in mesodermal 
cells; knockdown of Twist1 expression in N2B27 culture does not hinder neural 
specification (unpublished observations by Dr. Paul Nistor in our laboratory). 
Neurod1 is expressed at low levels in a subset of ES cells characterised by low 
expression of Id genes, but its expression is not associated with lower levels of 
pluripotency factors nor with higher levels of neural markers (data not shown). This, 
coupled to the fact that Neurod1 is a terminal differentiation factor activated late in 
the cascade of pro-neural genes (Ma et al. 1999), suggests it is also unlikely to be 
 




involved in the exit from pluripotency and the specification of neural ectoderm. 
Tcf15 is downregulated by day 1 of N2B27 differentiation in both control and Id1 
overexpressing cells, suggesting it cannot be responsible for the loss of Cdh1 and 
Oct4 that occurs between day 2 and day 4 of differentiation in control cells (Malaguti 
et al. 2013). 
The relationship between Id1 and Tcf15 appears to be complicated by the interaction 
of both of these factors with Nanog. Tcf15 can repress Nanog expression in ES cell 
culture, Id1 expression is inhibited by Nanog, and Id1 can inhibit the activity of 
Tcf15, resulting in the generation of a feedback loop between these factors that has 
the potential to regulate the pluripotent status of ES cells (Figure 6.3). It was 
interesting to note that in the sorted Id1-Venus Nanog-tagRFP reporter ES cells, 
Tcf15 expression was enriched in the Nanog-tagRFP-low expressing subpopulations 
(both Id1-Venus-high and –low), and that the expression of its target Otx2 (Davies et 
al. 2013), as well as that of other epiblast markers, was enriched in the Id1-Venus-
low Nanog-tagRFP-low  subpopulation (Figure 3.18), suggesting Id1 may be acting 











Figure 6.3 – Cross-regulation between Id1, Tcf15 and Nanog 
Tcf15/E47 dimers can repress the expression of Nanog. Nanog can repress the 
expression of Id1. Id1 can inhibit the transcriptional activity of Tcf15 by sequestering 
E47. The direct binding of Tcf15/E47 at the Nanog promoter and of Nanog at the Id1 
promoter has not been demonstrated and is illustrated here in speculative terms only. 
T15: Tcf15. 
 
6.2.1.2 E proteins 
The factor(s) inhibited by Id1 to delay the loss of pluripotency markers and to 
promote a proximal posterior identity must therefore be other interactors of Id1. This 
leaves two possibilities amongst the known interactors of Id1 expressed in 
differentiating ES cells: E proteins and Ets family members. 
E47 can directly bind to E-boxes in the Cdh1 promoter and repress the transcription 
of the gene (Pérez-Moreno et al. 2001). E proteins can homodimerise, and thus 
require no other bHLH factor for their DNA binding activity (Murre et al. 1989a). It 
is therefore possible that the E47-mediated downregulation of Cdh1 expression is 
carried out by E47 homodimers. As Id1 is sharply downregulated at the onset of 
differentiation (Figure 1.2), E47 would no longer be prevented from 
heterodimerising by Id1 and could induce the downregulation of Cdh1. This could in 
turn drive the exit from pluripotency and the acquisition of a “default” neural state 
 




(Figure 6.5a,b). The overexpression of Id1 would therefore account for the delayed 
exit from pluripotency, but it is unclear how it would cause a shift in the regional 
identity of the differentiating cells. It is possible that an E47-interacting bHLH factor 
not expressed in ES cells (or not detected by the yeast two-hybrid screen) is 
upregulated at the onset of differentiation and is capable of inhibiting proximal 
posterior epiblast specification, or it is possible that the extended period of 
pluripotent gene expression would result in a transcriptional equilibrium being 
established, with a number of cells activating the expression of markers of proximal 
posterior epiblast, as seen in epiblast stem cells, where T expression is observed 
(Tesar et al. 2007). 
E47 regulates the downregulation of Cdh1 and promotes epithelial-to-mesenchymal 
transitions in a number of cell types (Lee et al. 2011a, Slattery et al. 2006, Slattery & 
McMorrow 2008), and Id1 has been shown to inhibit this activity in cultured cells 
(Cubillo et al. 2013, Kondo et al. 2004). It is therefore possible that Id1 may act as 
an anti-EMT factor during various stages of embryonic development. For example, 
preliminary observations suggest Id1 may be involved in the regulation of the 
formation of the notochord by cells delaminating from the hindgut (Figure 6.4) 











Figure 6.4 – Id1-Venus is not expressed by cells undergoing EMT in the hindgut 
Transverse section through the caudal region of an E8.5 chimaera generated by 
morula aggregation of IdV ES cells. Id1-Venus expression is not detected in T-
expressing cells that are delaminating (*) from the hindgut (Hg) to form the 
developing notochord (Nc). 
 
6.2.1.3 Ets protein family 
Id1 has also been shown to interact with the Ets family members Elk1 and Ets2 and 
to repress their transcriptional activity (Ohtani et al. 2001, Yates et al. 1999). The Ets 
protein family comprises many proteins involved in various biological processes, 
which include the transcriptional activation of Zeb factors. Ets1 can induce the 
transcription of Zeb1 and Zeb2, and this activity can be inhibited by Id2 (Shirakihara 
et al. 2007). Zeb (zinc-finger E-box binding homeobox) factors can bind to the E-
boxes present in the Cdh1 promoter and repress the transcription of the gene (Comjin 
et al. 2001, Shirakihara et al. 2007). In my single-cell qRT-PCR analysis of ES cells 
undergoing neural differentiation, I observed that the upregulation of Zeb1 and Zeb2 
in a subset of cells at day 1 of differentiation preceded the downregulation of Cdh1 
and the upregulation of Sox1 (Figure 4.15), and that expression of the two Zeb genes 
displayed a weak but statistically significant correlation at this timepoint (Figure 
4.16), suggesting that a common mechanism for the induction of the transcription of 
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both Zeb genes may be in place. Ets1 and other Ets family members, such as the Fgf 
target Etv4, are expressed during neural adherent monolayer in N2B27 medium 
(Aiba et al. 2006, Aiba et al. 2009, data not shown). It is therefore possible that upon 
loss of Id1 expression in wild-type cells one or more Ets family members may induce 
the expression of Zeb1 and Zeb2, which could in turn downregulate Cdh1 expression 
and induce neural differentiation. Zeb2 is required for the neural specification of 
human ES cells, consistent with a possible role of the transcription factor in this 
process (Chng et al. 2010). In this model, the overexpression of Id1 would inhibit the 
transcriptional activity of target Ets proteins and thus prevent the upregulation of Zeb 
factors. The level of Zeb transcripts in Id1 overexpressing cells is lower than in 
control cells throughout differentiation, in accordance with this hypothesis (Figures 
4.7, 4.9). The repression of Zeb1 and Zeb2 transcription would in turn result in the 
maintenance of Cdh1 expression and pluripotency, and the inhibition of a neural 
specification transcriptional programme (Figure 6.5c,d). 
 





Figure 6.5 – Alternative models for the maintenance of Cdh1 expression by Id1 
Id1 delays the downregulation of Cdh1 in ES cell differentiation. (a,b) It may achieve 
this by repressing the transcriptional downregulation of Cdh1 by E47 homodimers (a: 
wild-type cell, b: Id1 overexpressing cell). (c,d) Inhibition of an Ets protein may 
prevent expression of Zeb1 and Zeb2, which can repress Cdh1 expression (c: wild-
type cell, d: Id1 overexpressing cell).  
 




6.2.2 Id1 and the specification of surface ectoderm 
The differentiation of ES cells in N2B27 in the presence of BMP leads to the 
formation of two types of Cdh1-expressing cells: pluripotent colonies expressing 
Oct4 and T, and differentiated “big flat cells” expressing the surface ectoderm and 
trophectoderm marker Tcfap2a (Figure 4.1, Malaguti et al. 2013). Ying et al. (2003a) 
demonstrated that Id1 overexpression in N2B27 culture can also generate these big 
flat cells. Furthermore, I observed high levels of Id1 expression in the proximal 
anterior regions of gastrulation stage embryos, where cells destined for surface 
ectoderm specification reside (Cajal et al. 2012, Madabhushi & Lacy 2011, Tam & 
Behringer 1997), an observation confirmed by the in situ hybridisation data of Li et 
al. (2013). This would suggest an ability for Id1 to induce surface ectoderm 
differentiation, possibly through the inhibition of an EMT event. I did not observe 
differentiation of Id1 overexpressing cells into surface ectoderm nor other epithelial 
cell types in my experiments. As suggested in paragraph 4.3.3.1, it is possible that 
different levels of Id1 expression influence the direction of differentiation, with high 
levels driving surface ectoderm formation, medium levels driving mesodermal 
specification and low levels allowing neural differentiation. The generation of novel 
cell lines that consent the expression of high levels of Id1 during differentiation, 
through the use of alternative promoters or multiple transgenes, may help to test the 
veracity of this hypothesis. 
 
6.3 Concluding remarks 
Id1 is a transcriptional modulator of tremendous potential. Its activity as a dominant 
negative regulator of gene expression implies that it has the capability to affect all 
biological processes involving the activity of its heterodimerisation partners, and of 
the molecules regulated by them. 
 




This work has shown that Id1 is expressed in the post-implantation embryo at the 
appropriate locations in time and space for it to influence early lineage specification 
events, and that it is capable of affecting these developmental decisions in an in vitro 
model of embryonic development: embryonic stem cell differentiation. Furthermore, 
a novel expression pattern for Id1 has been observed at the node of headfold stage 
embryos, raising the question of whether it may play a role in the regulation of this 
signalling centre. 
The regulation of Id1 expression by extracellular signalling pathways has also been 
characterised extensively in various types of pluripotent cultures, providing a clear 
picture of the effect of these pathways on Id1 expression in isolation and with respect 
to one another, thus increasing our understanding of the mechanisms that may 
regulate the expression of this molecule in the development of the mouse. 
Many avenues remain open for exploration. The significance of the negative 
relationship between Nanog and Id1 is still unclear. The roles of Id1 in promoting 
pluripotency and regionalising cells in culture have not been uncoupled, as the 
factors inhibited by Id1 in differentiation have not been identified. The expression of 
Id1 at the node requires further characterisation, as it is currently unclear what 
signals drive the establishment of this expression pattern and what the significance of 
Id1 expression in this structure is. It is to be hoped that future research will allow us 
to answer these questions and thereby improve our understanding of the biology of 
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